Advertisement

D

  • F. von Bruchhausen
  • S. Ebel
  • A. W. Frahm
  • E. Hackenthal
  • Margitta Albinus
  • Hassan-Fahmy Ali
  • Syed Laik Ali
  • Gudrun Amschler
  • Uwe Amschler
  • Erwin von Angerer
  • Peter Barth
  • Wolfgang Barthel
  • Kurt Bauer
  • Andrea Bauer
  • Jürgen Beckmann
  • Winfried Beil
  • Jürgen Beitz
  • Günther Bellmann
  • Thorsten Beyrich
  • Franz Bossle
  • Helmut Bräunlich
  • Matthias Bräutigam
  • Kerstin Brinkmann
  • Adalbert Brinz
  • Franz von Bruchhausen
  • Kay Brune
  • Axel Büge
  • Ulrich Bürger
  • Wolfram Christ
  • Klaus Daneck
  • Gerd Dannhardt
  • Helga Doering
  • Siegfried Ebel
  • Kurt Eger
  • Peter Emig
  • Thomas Erker
  • Bernhard Feil
  • Monika Fett
  • August Wilhelm Frahm
  • Margarete Frahm
  • Klaus-Jürgen Freundt
  • Wolfram Gaida
  • Detlef Geffken
  • Ulrich Geis
  • Klaus Geldsetzer
  • Ulrich Gessner
  • Erika Glusa
  • Berthold Göber
  • Margarete Goppelt-Strübe
  • Wilhelm Gössling
  • Eberhard Gottwald
  • Beate Grates
  • Annette Graul
  • Sibylle Greiner
  • Adolf Grisk
  • Michael Grosam
  • Jan Gustafsson
  • Hartmut Gustmann
  • Jürgen Haas
  • Axel Haberkorn
  • Eberhard Hackenthal
  • Annette Häfner
  • Boris Haluszczynski
  • Achim Harder
  • Susanne Hartmann
  • Heribert Häusler
  • Marcus Heidenreich
  • Gerhard Heinemeyer
  • Bernd Hempel
  • Monika Herboth
  • Klaus Herbrand
  • Sibylle Hoedt-Schmidt
  • Wolfgang Hoefke
  • Hermann Hoffmann
  • Ute Hoffmann-Schollmayer
  • Bernhard Hofmann
  • Ulrike Holzgrabe
  • Anette Hornberger
  • Ute Hübner-Steiner
  • Martin Hug
  • Wolfgang Ibrom
  • Walter Janßen
  • Angela Jördens
  • Ilmar Jurna
  • Günther Kaiser
  • Dieter-Abbo Kalbhen
  • Petra Kisser
  • Christoph Klett
  • Stephanie Klett
  • Gerd Kobal
  • Johannes Koehler
  • Axel Kramer
  • Birgit Krammer
  • Gottfried Kreutz
  • Reinhard Kroker
  • Markus Kuhn
  • Norbert Kühn
  • Dorothea Landsiedel
  • Andreas Langner
  • Martina Laudszun
  • Jochen Lehmann
  • Marion Sylvia Lehner
  • Stefan Leiner
  • Hans Löwe
  • Johannes Mann
  • Detlef Manns
  • Wolfgang Matthiessen
  • Rainer Maue
  • Peter Maul
  • Andreas Maurer
  • Ralf Mayer
  • Wolfgang Meindl
  • Werner Meise
  • Klaus Menges
  • Paul Messinger
  • Hans-Jürgen Mest
  • Frank Peter Meyer
  • J. Mollière
  • Rudolf Morgenstern
  • Wolfgang Morick
  • Joachim Mössner
  • Alfred Müller
  • Walter E. Müller
  • Klaus Müller
  • Christa Müller
  • Daniel Müller
  • Michael Neugebauer
  • Ottmar Neugebauer
  • Peter Nickel
  • Peter Nuhn
  • Bernd Nürnberg
  • Joachim Oertel
  • Michael Oettel
  • Tilmann Ott
  • Thomas Otzen
  • Hartmut Oßwald
  • Peter Pachaly
  • Helmut Pelzer
  • Karl-Uwe Petersen
  • Siegfried Pfeifer
  • Klaus Pietrzik
  • Kathrin Pöllath
  • Olaf Queckenberg
  • Bernd Raffelsberger
  • Eberhard Reimann
  • Jörg Remien
  • Markus Reuß
  • Andreas Reymann
  • Joachim Richter
  • Peter H. Richter
  • Hubert Richter
  • Klaus Rittinghaus
  • Hans Rommelspacher
  • Gerhard Rücker
  • Gerhard Schaefer
  • Klaus Schaefer
  • Jutta Schcerer
  • Helmut Schlager
  • Hildegard Schleinitz
  • Wolfgang Schlichter
  • Gerhard Schmidt
  • Wolfgang Schmutzler
  • Johannes Schräder
  • Thomas Schulz-Schalge
  • Harald Schütz
  • Helmut Schwilden
  • Gisela Skopp
  • Ulrich Speck
  • Marcus Spohn
  • Ralf Stahlmann
  • Johannes-Peter Stasch
  • E. Staubli
  • Jürgen Steinmeyer
  • Karl-Heinz Stiefvater
  • Michael Streek
  • Günther Strippel
  • Karl-Heinz Surborg
  • Ulf Sürig
  • Istvan Szelenyi
  • Alfred Thomas
  • Herbert Trampisch
  • Reinhard Troschütz
  • Bernard Unterhalt
  • Eugen J. Verspohl
  • Sabine Vogel
  • Franz-Josef Volk
  • Sven Völkl
  • Heinz Walther
  • Horst Weber
  • Martin Wenzel
  • Marion Weyandt-Spangenberg
  • Sandra Wich
  • Burkhard Wichert
  • Hilke Winterhoff
  • Peter Witte
  • Monika Wolff

References

  1. 1.
    Shealy YF, Krauth CA, Montgomery JA (1962) J Org Chem 27:2150–2154Google Scholar
  2. 2.
    Playle AC (1976) Drugs of Today 12:20–23Google Scholar
  3. 3.
    Kazemifard G, Moattar F, Zia H (1979) Arch Pharm 312:573–577Google Scholar

WM

  1. 1.
    Loo TL, Householder GE, Gerulath AH et al. (1976) Cancer Treat Rep 60:149–152PubMedGoogle Scholar
  2. 2.
    Mizuno NS, Decker RW (1976) Biochem Pharmacol 25:2643–2647PubMedGoogle Scholar
  3. 3.
    Audette RCS, Connors TA, Mandel HG et al. (1973) Biochem Pharmacol 22:1855–1864PubMedGoogle Scholar
  4. 4.
    Lown JW, Singh R (1982) Biochem Pharmacol 31:1257–1266PubMedGoogle Scholar
  5. 5.
    Beal DD, Skibba JL, Whitnable KK et al. (1976) Cancer Res 36:2827–2831PubMedGoogle Scholar
  6. 6.
    Lonn U, Löhn S (1987) Cancer Res 47:26–30PubMedGoogle Scholar
  7. 7.
    Loo TL, Luce JK, Jardine H et al. (1968) Cancer Res 28:2448–2453PubMedGoogle Scholar
  8. 8.
    Skibba JL, Ramirez G, Beal DD (1969) Cancer Res 29:1944–1951PubMedGoogle Scholar
  9. 9.
    Breithaupt H, Dammann A, Aigner K (1982) Cancer Chemother Pharmacol 9:103–109PubMedGoogle Scholar
  10. 10.
    Benvenuto JA, Hall SW, Farquar D et al. (1979) Chromatogr Sci 10:377–395Google Scholar
  11. 11.
    Householder GE, Loo TL (1971) J Pharmacol Exp Ther 179:386–395Google Scholar
  12. 12.
    Comis RL (1976) Cancer Treat Rep 60:165–176PubMedGoogle Scholar
  13. 13.
    Bonadonna G, Zucali R, Monfardini S et al. (1975) Cancer 36:252–259PubMedGoogle Scholar
  14. 14.
    Bonadonna G, Valagussa P, Santoro A (1986) Ann Intern Med 104:739–746PubMedGoogle Scholar
  15. 15.
    Moore GE, Meiselbaugh D (1976) Cancer Treat Rep 60:219PubMedGoogle Scholar
  16. 16.
    Feaux de Lacroix W, Runne U, Hauk H et al. (1983) Cancer Treat Rep 67:779–784PubMedGoogle Scholar
  17. 17.
    Carey RW,Kunz VS (1987) Am J Hematol 25:119–121PubMedGoogle Scholar

OJ

  1. 1.
    Brockmann H, Lackner H (1964) Die Naturwissenschaften 16:384–385Google Scholar
  2. 2.
    Okawa K, Nakajima K, Tanaka T (1980) J Heterocycl Chem 17:1815–1816Google Scholar

WM

  1. 1.
    Frei E (1974) Cancer Chemother Rep 58:49–54PubMedGoogle Scholar
  2. 2.
    Schmoll H-J, Peters H-D, Fink U (1986) Kompendium internistische Onkologie, Teill. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  3. 3.
    Heenen M, Preumont AM, Galand P (1973) Cancer Res 33:2.624–2.626Google Scholar
  4. 4.
    Ross WE, Glaubiger DL, Kohn KW (1979) Biochem Biophys Acta 562:41–50PubMedGoogle Scholar
  5. 5.
    Gause GF, Dudnik YV (1980) Antibiot Chemother 28:102–108PubMedGoogle Scholar
  6. 6.
    Neidle S, Abraham Z (1984) CRC Crit Rev Biochem 17:73–121PubMedGoogle Scholar
  7. 7.
    Sobell HM (1973) Progr Nucleic Acid Res Mol Biol 13:153–159Google Scholar
  8. 8.
    Chabner BA, Myers CE (1982) Clinical pharmacology of cancer chemotherapy. In: De Vita jr V, Hellmann S, Rosenberg SA (Hrsg.) Cancer. Principles and Practice of Oncology. Lipincott, Philadelphia Toronto, S. 156–197Google Scholar
  9. 9.
    Dabrowiak JC (1983) Life Sci 32:2.915–2.931Google Scholar
  10. 10.
    Giannini L, Bonadonna G (1988) Antitumor antibiotics. In: Bonadonna G, Robustelli delle Cuna G (Hrsg.) Handbook of Medical Oncology, Masson, Milano Parigi Barcelona Mesico, S. 359–360, 1.063Google Scholar
  11. 11.
    Reich E, Franklin RM, Shatkin AJ (1962) Proc Natl Acad Sci USA 48:1.238–1.245Google Scholar
  12. 12.
    Biedler JL Chang TD, Meyers MB, Peterson RH, Spengler BA (1983) Cancer Treat Rep 67:859–867PubMedGoogle Scholar
  13. 13.
    Kessel D (1986) Cancer Surv 5:109–127PubMedGoogle Scholar
  14. 14.
    Grossberg SE (1972) 2. N Engl J Med 287:79–85PubMedGoogle Scholar
  15. 15.
    Vermund H (1971) Acta Radiol Suppl Stockh 311:1–78PubMedGoogle Scholar
  16. 16.
    Goffinet DR, Bagshaw MA (1974) Cancer Treat Rev 1:15–26PubMedGoogle Scholar
  17. 17.
    Thiel HJ, Fietkau R, Sauer R (1988) Rec Res Cancer Res 108:205–226Google Scholar
  18. 18.
    Fromm M, Littman P, Raney RB, Nelson L, Handler S, Diamond G, Stanley C (1986) Cancer 57:2.070–2.076Google Scholar
  19. 19.
    Galbraith WM, Mellet LB (1975) Cancer Chemother Rep 59:1.061–1.069Google Scholar
  20. 20.
    Tattersall MHN, Sodergren JE, Sengupta SK, Trites DH, Modest EJ, Frei III E (1975) Clin Pharmacol Ther 17:701–708PubMedGoogle Scholar
  21. 21.
    Emmanuel IC (1969) B J Radiol 42:948–952Google Scholar
  22. 22.
    Jereb B (1971) Acta Radiol Ther Biol 10:417–426Google Scholar
  23. 23.
    Haas RJ, Devens K, Helmig M, Janka G, Klose H, Lampert F (1978) Onkologie 1:142–148PubMedGoogle Scholar
  24. 24.
    Meuret (1978) Dtsch Med Wochenschr 103:308–313PubMedGoogle Scholar
  25. 25.
    Tebbi CK, Gaeta J (1988) Pediatr Ann 17:283–300Google Scholar
  26. 26.
    Ebeling K, Bielek K (1978) Zentralbl Gynäkol 100:897–912PubMedGoogle Scholar
  27. 27.
    Edson M (1979) J Urol 122:763–765PubMedGoogle Scholar
  28. 28.
    Tscherne H, (1979) Wien Klin Wochenschr Suppl 103:1–21PubMedGoogle Scholar
  29. 29.
    Obrist R, Hartmann D, Obrecht JP (1978) Onkologie 1:20–22PubMedGoogle Scholar
  30. 30.
    Baas PC, Hoekstra HJ, Schraffordt-Koops H, Oosterhuis JW, Oldhoff J (1989) Arch Surg 124:373–376PubMedGoogle Scholar
  31. 31.
    Chakravorty NK (1979) Gerontology 25:151–158PubMedGoogle Scholar
  32. 32.
    Strian F, Maurach R (1980) Med Klin 75:478–484PubMedGoogle Scholar
  33. 33.
    Levantine A, Almeyda J (1974) B J Dermatol 90:239–242Google Scholar
  34. 34.
    Ferguson MK (1982) Surg Gynecol Obstet 154:421–429PubMedGoogle Scholar
  35. 35.
    Harris CC (1976) Cancer 37:1.014–1.023Google Scholar
  36. 36.
    Best JB, Morita M (1982) Teratogenesis Carcinog Mutagen 2:277–291PubMedGoogle Scholar

Mw

  1. 1.
    Barbieri RL, Lee H, Ryan KJ (1979) Fertil Steril 31:182–186PubMedGoogle Scholar
  2. 2.
    Shaw RW (1992) Lancet 340:1.267–1.271Google Scholar
  3. 3.
    Barbieri RL, Canick JA, Makris A, Davies IJ, Ryan KJ (1977) Fertil Steril 28:809–813PubMedGoogle Scholar
  4. 4.
    Barbieri RL (1990) Drugs 39:501–510Google Scholar
  5. 5.
    Hooper WD, Eadie MJ, Dickinson RG (1991) Biopharm Drug Dispos 12:577–582PubMedGoogle Scholar
  6. 6.
    Saltiel E, Garabendian-Ruffalo SM (1991) Clin Pharm 10:518–531PubMedGoogle Scholar
  7. 7.
    Deeny M, Hawthorn R, McKay-Hart D (1991) Postgrad Med J 67:450–454PubMedGoogle Scholar
  8. 8.
    Holt JP, Keller D (1984) Fertil Steril 41:70–74PubMedGoogle Scholar
  9. 9.
    Barbieri RL, Evans S, Kistner RW (1982) Fertil Steril 37:737–746PubMedGoogle Scholar

vB

  1. 1.
    White R, Schwan TJ (1976) J Pharm Sci 65:135Google Scholar
  2. 2.
    Clarke’s Isolation and Identification of Drugs (1986) The Pharmaceutical Press, London, S. 508Google Scholar
  3. 3.
    Kracmar J, Alvarez Sotolongo M, Kracmarova J (1978) Pharmazie 33:659–661 (UV)PubMedGoogle Scholar
  4. 4.
    Hollifield RD, Conklin JD (1973) J Pharm Sci 62:271PubMedGoogle Scholar
  5. 5.
    Lalande M, Mills P, Peterson RG (1988) J Chromatogr 430(1):187PubMedGoogle Scholar
  6. 6.
    Wuis EW, Grutters ACLM, Vree TB, van der Kleyn E (1982) J Chromatogr 231(1):401PubMedGoogle Scholar

DG

  1. 1.
    Cedarbaum JM, Schleifer LS (1990) Drugs for Parkinson’s disease, spasticity and acute muscle spasms. In: Gilman AG, Rall TW, Nies AS, Taylor P (Hrsg.), Goodman and Gillman’s the pharmacological basis of therapeutics, 8. Aufl., Pergamon Press, New York, S. 463–484Google Scholar
  2. 2.
    Greef K, Wirth KE (1987) Pharmakologische Beeinflussung der cholinergen Erregungsübertragung. Pharmakotherapeutische Anwendung von Parasympathomimetia, Parasympatholytika und peripheren Muskelrelaxantien. In: Forth W, Hentschler D, Rummel W (Hrsg.) Allgemeine und spezielle Pharmakologie und Toxikologie,5. Aufl., Bibliographisches Institut & F.A. Brockhaus, Mannheim, S. 103–121Google Scholar
  3. 3.
    Winkle van B (1976) Science 193:1130–1131PubMedGoogle Scholar
  4. 4.
    Putney SW, Bianchi CP (1973) Fed Proc 32 (part 1):772Google Scholar
  5. 5.
    Butterfield AC, Ellis KO (1973) Fed Proc 32 (part 1):772Google Scholar
  6. 6.
    Monster AW, Tamai Y, Mc Henry J, (1974) Arch Phys Med Rehabil 55:355–362PubMedGoogle Scholar
  7. 7.
    Hermann R, Mayer N, Mecomber SA (1972) Am J Physiol Med 51:296–311Google Scholar
  8. 8.
    Ellis KO, Castellion AW, Honkomp LJ et al. (1973) J Pharm Sci 62:948–951PubMedGoogle Scholar
  9. 9.
    Ward A, Caffman MO, Sorkin EM (1986) Drugs 32:130–168PubMedGoogle Scholar
  10. 10.
    Büch HP, Büch U (1987) Narkotika, Narkose. In: Forth W, Henschler D, Rummel W (Hrsg.) Allgemeine und spezielle Pharmakologie und Toxikologie, 5. Aufl., Bibliographisches Institut & F.A. Brockhaus, Mannheim, S. 1203–1219Google Scholar
  11. 11.
    Wislon RD, Dent TE, Traber DL, McCoy NR, Allen CR (1967) J Amer Med Ass 202:183Google Scholar
  12. 12.
    Dykes MHM (1975) J Amer Med Ass 231:862Google Scholar
  13. 13.
    Product information: Dantrium, Norwich-Eaton, 1985Google Scholar
  14. 14.
    Morrison DH (1983) Anesthesiology 59:265Google Scholar
  15. 15.
    Hollifield RS, Conklin JD (1973) J Pharm Sci 62:271PubMedGoogle Scholar
  16. 16.
    Meyler WJ, Vermeer GA, Agoston S, Wesseling H (1980) Excretion pattern of dantrolen sodium and metabolites in patients with and without cholecystectomy. Abstract No. 0796. Proceeding of the World Conference on Clinical Pharmacology and Therapeutics, LondonGoogle Scholar
  17. 17.
    Mar 29, S. 1232Google Scholar

NB

  1. 1.
    Mar 29, S. 1.086Google Scholar

vB

  1. 1.
    Orzech CE, Nash NG, Daley RD (1976) in Ana 5:87Google Scholar
  2. 2.
    Beilstein 13:536, EII 300, EIII, S. 1246Google Scholar
  3. 3.
    Gordon GR, Ghoul DC, Peters JH (1975) J Pharm Sci 64.1.205–1.210Google Scholar
  4. 4.
    Tomicek O (1948) Collect Czech Chem Commun 13:116–130Google Scholar
  5. 5.
    Wojahn H (1948) Süddtsch Apoth Ztg 88:395–96Google Scholar
  6. 6.
    Murray JF, Gordon GR, Gulledge CC, Peters JH (1975) J Chromatogr 107:67–72PubMedGoogle Scholar

Ot

  1. 1.
    Hastings RC, Franzblau SG (1988) Ann Rev Pharmacol Toxicol 28:231–245Google Scholar
  2. 2.
    Mandell GL, Sande MA (1990) Antimicrobial Agents. Drugs Used in the Chemotherapy of Tuberculosis and Leprosy. In: Goodman Gilman A, Rall TW, Nies AS, Taylor P (Hrsg.) The Pharmacological Basis of Therapeutics, 8. Aufl., Pergamon Press, New York Oxford Beijing Frankfurt Sao Paulo Sydney Tokyo Toronto, S.1.146–1.164Google Scholar
  3. 3.
    Venkatesan K (1989) Clin Pharmcokin 16:365–368Google Scholar
  4. 4.
    N.N.. (1988) Lancet II:487–488Google Scholar
  5. 5.
    Treatment of Leprosy, Mar 29, S. 551–552Google Scholar
  6. 6.
    Monographie Acedapsone, Mar 29, S.553Google Scholar
  7. 7.
    Monographie Dapsone, Mar 29, S. 558–560Google Scholar
  8. 8.
    Twose TM (1989) Dapsone and Sulphapyridine. In: Greaves MW, Shuster S (Hrsg.) Pharmacology of the Skin II. Handb Exp Pharmacol 87,II:543–552Google Scholar
  9. 9.
    Meyer H, Baumann HR, Leuenberger P, Sonntag R (1988) Drugs Used in Tuberculosis and Leprosy. In: Dukes MNG (Hrsg.) Meylers Side Effects of Drugs, 11. Aufl., Elsevier, Amsterdam New York Oxford, S. 633–650Google Scholar
  10. 10.
    Goldsmith P, Burton JL, Staughton RCD (1989) Immunosuppressive (Cytotoxic) and Immunostimulant Drugs. In: Greaves MW, Shuster S (Hrsg.) Pharmacology of the Skin II. Handb Exp Pharmac 87, II:307–327Google Scholar
  11. 11.
    Fernex M (1984) Internist 25:208–215PubMedGoogle Scholar
  12. 12.
    N.N. (1989) Arzneimittelbrief 23:1–4Google Scholar
  13. 13.
    Kastrup EK (1988) Drugs, Facts and Comparison. Lippincott, St. Louis, S. 1.589–1.591Google Scholar
  14. 14.
    Fränz J, Windorfer A (1990) Arzneimittel in Schwangerschaft und Stillzeit, 3. Aufl., Wissenschaftliche Verlagsgesellschaft, Stuttgart, S.59Google Scholar
  15. 15.
    N.N. (1989) Arznei-telegramm 10/89:91–92Google Scholar

Ry

  1. 1.
    Di Marco A, Acarmone F (1975) Adriamycin and its mechanism of action. In: Staquet M, Tagnon H, Kenis Y (Hrsg.) Adriamycin and its mechanism of action. Adriamycin Review, European Press Medicon, Ghent, Belgium, S. 11–24Google Scholar
  2. 2.
    Pigram WJ, Fuller W, Hamilton LD (1972) Nature (New Biol) 235:17–19Google Scholar
  3. 3.
    Chaires JB (1990) Biophys Chem 35:191–202PubMedGoogle Scholar
  4. 4.
    Schwartz HS (1975) Res Commun Chem Pathol Pharmacol 10:51–64PubMedGoogle Scholar
  5. 5.
    Casazza AM, Isetta AM, Giuliani M, Di Marco A (1975) Immunodepressive activity of daunomycin and adriamycin. In: Staquet M, Tagnon H, Kenis Y (Hrsg.) Adriamycin and its mechanism of action, Adriamycin Review, European Press Medikon, Ghent, Belgium, S. 121–131Google Scholar
  6. 6.
    Maral RJ, Jouanne M (1981) Cancer Treat Rep 65(Suppl4):9–18PubMedGoogle Scholar
  7. 7.
    Peterson C, Paul C (1983) Pharmacokinetics of doxorubicin and daunorubicin. In: Hansen HH (Hrsg.) Anthracyclines and cancer therapy. Excerpta Medica, Elsevier Science Publishers BV, Amsterdam, S.7–12Google Scholar
  8. 8.
    Bachur NR, Riggs jr CE, Green MR, Langone JJ, Van Vunakis H, Levine L (1977) Clin Pharmacol Ther 21:70–77PubMedGoogle Scholar
  9. 9.
    Paul C, Liliemark J, Tidefelt U, Gahrton G, Peterson C (1989) Therapeutic Drug Monitoring 11:140–148PubMedGoogle Scholar
  10. 10.
    Lenaz L, Di Fronzo G, Molinari R (1975) Distribution of daunomycin and adriamycin in man. In: Staquet M, Tagnon H, Kenis Y (Hrsg.) Adriamycin and its mechanism of action. Adriamycin Review, European Press Medicon, Ghent, Belgium, S. 89–99Google Scholar
  11. 11.
    Speth PA, Linssen PCM, Termond EFS, Boeseman JBM, Wessels HMC, Haanen C (1989) Drug Metab Dispos 17:98–105PubMedGoogle Scholar
  12. 12.
    Noel G, Trouet A, Zenebergh A, Tulkens P (1975) Comparative cell pharmacokinetics of daunorubicin and adriamycin. In: Staquet M, Tagnon H, Kenis Y (Hrsg.) Adriamycin and its mechanism of action. Adriamycin Review, European Press Medicon, Ghent, Belgium, S. 99–105Google Scholar
  13. 13.
    Nooter K, Sonneveld P, Martens A, Hagenbeek A, Schultz F (1986) Eur J Clin Oncol 2:801–806Google Scholar
  14. 14.
    Benjamin RS, Riggs CE, Bachur NR (1977) Cancer Res 37:1.416–1.420Google Scholar
  15. 15.
    Huffman DH, Bachur NR (1972) Cancer Res 32:600PubMedGoogle Scholar
  16. 16.
    Le Bot MA, Bégué JM, Kernaleguen D, Robert J, Ratanasavanh D, Airiau J, Riche C, Guillouzo A (1988) Biochem Pharmacol 37:3.877–3.887Google Scholar
  17. 17.
    Goldin A, Johnson RK (1975) Antitumor effect of adriamycin in comparison with related drugs, and in combination chemotherapy. In: Staquet M, Tagnon H, Kenis Y (Hrsg.) Adriamycin and its mechanism of action. Adriamycin Review, European Press Medicon, Ghent, Belgium, S. 7–54Google Scholar
  18. 18.
    Walters TR (1976) Med Clin North Am 60:987–1.000PubMedGoogle Scholar
  19. 19.
    Gale RP (1984) Ann Intern Med 101:702–705PubMedGoogle Scholar
  20. 20.
    Steuber CP (1981) Am J Pediatr Hematol Oncol 3:379–388PubMedGoogle Scholar
  21. 21.
    Von Hoff DD, Rozencweig M, Layard M, Slavik M, MuggiaFM(1977) Am J Med 62:200–208Google Scholar
  22. 22.
    Von Hoff DD, Layard M (1981) Cancer Treat Rep 65(Suppl4):19–23Google Scholar
  23. 23.
    Uzuka Y, Saito Y, Takahashi H, Komatu M, Ito T (1989) Rinshoe Ketsueki 30:980–987Google Scholar
  24. 24.
    Reszka K, Hartley JA, Lown JW (1990) Biophys Chem 35:313–323PubMedGoogle Scholar
  25. 25.
    Arena E, D’Alessandro N, Dusonchet L, Gebbia N, Gerbasi F, Rausa L (1973) J Antibiotics 26:338Google Scholar
  26. 26.
    Marzin D, Jasmin C, Maral R, Mathe G (1983) Eur J Cancer Clin Oncol 19:641–647PubMedGoogle Scholar

Mw

  1. 1.
    Robinson C (1980) Drugs of Today 16:371–373Google Scholar

WM

  1. 1.
    Haubrich DR, Gerber NH, Pflueger AB (1981) J Neurochem 37:476–482PubMedGoogle Scholar
  2. 2.
    Lohr J, Acara M (1990) J Pharmacol Exp Ther 252:154–158PubMedGoogle Scholar
  3. 3.
    Pepeu G, Freedman DX, Giarman NJ (1960) J Pharmacol Exp Ther 129:291–295PubMedGoogle Scholar
  4. 4.
    Rimland B (1988) J Child Neurol 3(Suppl):68–72Google Scholar

hr

  1. 1.
    Wenner W (1965) J Med Chem 8:125–126PubMedGoogle Scholar

LJ

  1. 1.
    Moe RA, Bates HM, Palkoski ZM, Banziger R (1964) Curr Ther 193:194–208Google Scholar
  2. 2.
    Luria HM, Freis ED (1965) Curr Ther Res 7:289–296PubMedGoogle Scholar
  3. 3.
    Adi FC, Eze CJ, Anwunah A (1975) Brit Med J 1:482–485PubMedGoogle Scholar
  4. 4.
    Silas JH, Lennard MS, Tucker GT, Smith AJ, Malcolm SL, Marten TR (1977) Br Med J I:422–425Google Scholar
  5. 5.
    McMahon FG (1984) Peripheral adrenergic blocking agents. In: McMahon FG (Hrsg.) Management of essential hypertension: The new low-dose era, Futura Publishing Company, Inc, Mount Kisco New York, S. 457–497Google Scholar
  6. 6.
    Medina MA, Giachetti A, Shore PA (1969) Biochem Pharmacol 18:891–901PubMedGoogle Scholar
  7. 7.
    Allen JG, East PB, Francis JR, Haigh JL (1975) Drug Metab Dispos 3:332–337PubMedGoogle Scholar
  8. 8.
    Mahgoub A, Dring LG, Idle JR, Lancaster R, Smith RL (1977) Lancet II:584–586Google Scholar

GW

  1. 1.
  2. 2.
    Wenner W (1965) J Med Chem 8:125–126PubMedGoogle Scholar
  3. 3.
    Malcolm SL, Marten TR (1976) Analyt Chem 48:807–809Google Scholar

LJ

  1. 1.
    Blomquist AT, Hallam BF, Josey AD (1959) J Am Chem Soc 81:678–680Google Scholar
  2. 2.
    Clarke’s Isolation and Identification of Drugs (1986) The Pharmaceutical Press, London, S.510Google Scholar

DG

  1. 1.
    Negwer M (1987) Organic-chemical Drugs and their Synonyms, Akademie-Verlag, BerlinGoogle Scholar

vB

  1. 1.
    Bickel H et al (1960) Helv Clim Acta 43: 2118Google Scholar

HU

  1. 1.
    Keberle H (1964) Ann N Y Acad Sci 119:758–768PubMedGoogle Scholar
  2. 2.
    Day JP (1986) Chemical aspects of aluminium chelation by desferrioxamine. In: Taylor A (Hrsg.) Aluminium and other trace elements in renal disease, Baillière Tindall, London, S. 184–192Google Scholar
  3. 3.
    Pippard MJ, Callender ST, Finch CA (1982) Blood 60:288–294PubMedGoogle Scholar
  4. 4.
    Allain P, Chaleil D, Mauras Y, Beaudeau G, Varin MC, Poignet JL, Ciancioni C, Ang KS, Cam G, Simon P (1987) Clin Chim Acta 170:331–338PubMedGoogle Scholar
  5. 5.
    Allain P, Mauras Y, Chaleil D, Simon P, Ang KS, Cam G, Le Mignon L, Simon M (1987) Br J Clin Pharmac 24:207–212Google Scholar
  6. 6.
    Stremmel W, Niederau C, Strohmeyer G (1988) Dtsch Med Wochenschr 113:1648–1650PubMedGoogle Scholar
  7. 7.
    Zoller WG, Hehlmann R (1986) Klin Wschr 64:417–422PubMedGoogle Scholar
  8. 8.
    Hümpfner A (1989) Aluminiumintoxikation bei Niereninsuffizienz, Zuckschwerdt, München, S. 63–68Google Scholar
  9. 9.
    Milliner DS, Nebeker HG, Ott SM (1984) Ann Intern Med 101:775–780PubMedGoogle Scholar
  10. 10.
    Gallant T, Boyden MH, Gallant LA, Carley H, Freedman MH (1987) Am J Med 83:1085–1090PubMedGoogle Scholar
  11. 11.
    Cases A, Kelly J, Sabater J, Campistol JM, Torras A, Montoliu J, Lopez I, Revert L (1988) Clin Nephrol 29:176–178PubMedGoogle Scholar
  12. 12.
    Gabutti V, Sandri A, Capalbo P, D’Oria A, Sacchetti L, Tricta F, Piga A (1989) Toxicity of desferrioxamine treatment. In: Kattamis C (Hrsg.) Iron overload and chelation in thalassaemia, Hans Huber Publishers, Toronto, S. 26–33Google Scholar
  13. 13.
    Walker JA, Sherman RA, Eisinger RP (1985) Am J Kidney Dis 6:254–256PubMedGoogle Scholar

Fk

  1. 1.
    Negwer M (1987) Organic-chemical Drugs and their Synonyms, Akademie-Verlag, BerlinGoogle Scholar

vB

  1. 1.
    Mar 29, S. 1.359Google Scholar

vB

  1. 1.
    Beil Erg. Werk 4, Bd. 10, Teil 5, S.3478Google Scholar

Rj

  1. 1.
    Okolicsanyi L, Lirussi F, Strazzabosco M, Jemmolo R, Orlando R, Nassuato G, Muraca M, Crepaldi G (1986) Drugs 31:430–448PubMedGoogle Scholar
  2. 2.
    Bobowiec R, Studzinski T, Sikorska M (1990) Acta Physiol Polon 41:146–154PubMedGoogle Scholar
  3. 3.
    Boyer J, Klatskin G (1970) Gastroenterology 59:853–859PubMedGoogle Scholar
  4. 4.
    Bloomer J, Boyer J, Klatskin G (1973) Gastroenterology 65:929–935PubMedGoogle Scholar
  5. 5.
    Eulenburg F, Bode J (1976) Zeitschr Gastroenterologie 14:354–364Google Scholar
  6. 6.
    Maurer C (1971) Arzneim Forsch 21:1.375–1.379Google Scholar
  7. 7.
    Soloway R, Hofmann A, Thomas P, Schoenfield L, Klein P (1973) J Clin Invest 52:715–724PubMedGoogle Scholar
  8. 8.
    Hardison W (1971) J Lab Clin Med 77:811–820PubMedGoogle Scholar
  9. 9.
    Yousef I, Mignault D, Weber A, Tuchweber B (1990) Digestion 45:40–51PubMedGoogle Scholar
  10. 10.
    Roma M, Marinelli R, Rodriguez Garay E (1991) Biochem Pharmacol 42:1.775–1.781Google Scholar
  11. 11.
    Binder H (1981) Colonic secretion. In: Johnson L (Hrsg.) Physiology of the gastrointestinal tract, Raven Press, New York, S. 1.003–1.019Google Scholar
  12. 12.
    Hofmann A (1989) The enterohepatic circulation of bile acids in health and disease. In: Sleisenger M, Fordtran J (Hrsg.) Gastrointestinal disease, 4. Aufl., Vol.1, Saunders, Philadelphia, S. 144–161Google Scholar
  13. 13.
    Cowen A, Korman M, Hofmann A, Thomas P (1975) Gastroenterology 68:1.567–1.573Google Scholar
  14. 14.
    Yoneda M, Makino I, Tamasawa N, Takebe K, Sakuraba K, Goto J, Nambara T (1989) Amer J Gastroenterol 84:290–295Google Scholar
  15. 15.
    Adinolfi L, Utili R, Gaeta G, Abernathy C, Zimmerman H (1982) Hepatology 2: Abstract No. 121, S.703Google Scholar
  16. 16.
    Peters G, Witten D (1971) Minnesota Med 54:787–788PubMedGoogle Scholar
  17. 17.
    Lindholm A, Henricsson S, Dahlquist R (1990) Br J Clin Pharmacol 29:541–548PubMedGoogle Scholar
  18. 18.
    Vonk R, Scholtens E, Keulemans G, Meijer D (1978) Naunyn-Schmiedeberg’s Arch Pharmacol 302:1–9Google Scholar
  19. 19.
    Silverman S, Andrews A (1977) J Natl Cancer Inst 59:1.557–1.559Google Scholar
  20. 20.
    Cohen B, Raicht R, Deschner E, Takahashi M, Sarwal A, Fazzini E (1980) J Natl Cancer Inst 64:573–578PubMedGoogle Scholar

BJ

  1. 1.
    Blanc F, Nosny Y, Armgengaud M, Sankale M, Martin M, Charmot G, Nosny P (1961) Bull Soc Pathd Exotique (Paris) 54:29–38Google Scholar
  2. 2.
    Manson-Bahr PEC, Apted FIC (1982) Manson’s tropical diseases, 18. Aufl., Ballière Tindall, London, S. 132–140Google Scholar
  3. 3.
    Steck EA (1971) Walter Reed Army Institute of Research, Washington 1:3.132–3.137Google Scholar
  4. 4.
    Rees PH (1982) Drugs. In: Manson-Bahr PEC, Apted FIC (Hrsg.) Manson’s tropical diseases, 18. Aufl., Ballière Tindall, London, S. 610–636Google Scholar
  5. 5.
    Powell SJ, Wilmot AJ, MacLeod IN (1967) Ann Trop Med Parasitol 61:26–28PubMedGoogle Scholar
  6. 6.
    Merchant HC, Shikaripurkar NK (1964) Ind J Med Sci 18:200–209Google Scholar
  7. 7.
    Werner GT, Stickl H (1976) Med Klin 71:2.254–2.259Google Scholar
  8. 8.
    Al-Khateeb GH, Molan AL (1981) Chemotherapy 27:117–125PubMedGoogle Scholar
  9. 9.
    Fourage M, Dewulf M, Couvreur P, Roland M, Vranchx H (1989) J Microencapsul 6:29–34Google Scholar
  10. 10.
    Bienzle U, Ebert F, Dietrich M (1978) Tropenmed Parasitol 29:188–197PubMedGoogle Scholar
  11. 11.
    Aguirre Errasti C, Merino Angulo J, Flores Torres M, Rios A de los (1981) Med Clin (Barc.) 76:125–128Google Scholar
  12. 12.
    Farid Z, Trabolsi B, Boctor F, Hafez A (1986) J Inf Dis 154:920–921Google Scholar
  13. 13.
    Auer H, Aspoeck H, Picher O, Ploier R, Tulzer W (1981) Wien Klin Wochenschr 93:360–366PubMedGoogle Scholar
  14. 14.
    Muangmanee L, Aswapokee N, Jaroonvesama N, Viranuvatti V (1974) Southeast Asian J Trop Med Pub Hlth 5:581–585Google Scholar
  15. 15.
    Hernandez-Perez E (1980) Cutis 25:424–426PubMedGoogle Scholar
  16. 16.
    Salako LA (1972) J Pharm Pharmac 24:32–39Google Scholar
  17. 17.
    Webster LT jr (1985) Drugs used in the chemotherapy of protozoal infections amebiasis, giardiasis and trichomoniasis. In: Goodman and Gillman’s the pharmacological basis of therapeutics, 7. Aufl., McMillan, New York Toronto London, S. 1.049–1.057Google Scholar
  18. 18.
    Rollo IM (1980) Drugs used in the chemotherapy of amebiasis. In: Goodman and Gilman’s The pharmacological basis of therapeutics, 6. Aufl., McMillan, New York, S. 1.066–1.067Google Scholar
  19. 19.
    Salako LA (1974) W Afr J Pharmac Drug Res 1:13–17Google Scholar
  20. 20.
    Sharma S (1976) Indian J Med Sci 30:239–240PubMedGoogle Scholar

HA

  1. 1.
    Miyake A, Itoh K, Oka Y (1986) Chem Pharm Bull 34:2852–2858PubMedGoogle Scholar

MA

  1. 1.
    Salvetti A (1990) Drugs 40:800–828PubMedGoogle Scholar

MJ

  1. 1.
    Miyake A, Itoh K, Oka Y (1986) Chem Pharm Bull 34:2.852PubMedGoogle Scholar
  2. 2.
    Hiroyukil, Mikio Y, Yoshiru U (1985) Fukuoka Igaku Zasshi 76(9):441–450; CA (1986) 104:104902cGoogle Scholar

MA

  1. 1.
    Mar 29, S. 1396Google Scholar

vB

  1. 1.
    Mar 29, S. 728Google Scholar

vB

  1. 1.
    Keck J, Pueschmann S, Krueger G, Noll K (Thomae, Dr. Karl G.m.b.H.) (1972/74) Dt Pat Ger offen 2251891, zit. nach CA (1974) 81:25327Google Scholar

KU

  1. 1.
    Walther H, Meyer FP (1987) Klinische Pharmakologie antibakterieller Arzneimittel, Urban & Schwarzenberg, München Wien Baltimore, S. 245–262Google Scholar
  2. 2.
    Toon S, Rowland M (1979) J Pharm Pharmacol 31:43PGoogle Scholar
  3. 3.
    Münch R (1981) Schweiz Apoth Ztg 119:222–226Google Scholar

fm

  1. 1.
    McCormick JRD et al. (1957), J Am Chem Soc 79:4561–4563Google Scholar
  2. 2.
    Casy AF, Yasin A (1983), J Pharm Biomed Anal 1:281–292PubMedGoogle Scholar
  3. 3.
    Asleson GL, Frank CW (1975), J Am Chem Soc 97: 6246–6248Google Scholar
  4. 4.
    Am Cyanamid Co, USP 2878289 (1959), zit. nach CA (1959) 53:9584cGoogle Scholar

Gd

  1. 1.
    Clarke EGC (1974) Isolation and Identification of Drugs, The Pharmaceutical Press, London, S. 21Google Scholar
  2. 2.
    Fox RH (1969) Paper Chromatography. In: Clarke EGC (Hrsg.) Isolation and Identification of Drugs, The Pharmaceutical Press, London, S. 34Google Scholar
  3. 3.
    Curry AS (1969) Thin-layer Chromatography In: Clarke ECG (Hrsg.) Isolation and Identification of Drugs, The Pharmaceutical Press, London, S. 46Google Scholar

WM

  1. 1.
    Negwer M (1987) Organic-chemical Drugs and their Synonyms, Akademie-Verlag, BerlinGoogle Scholar

vB

  1. 1.
    McCormick JRD et al. (1957) Jam Chem Soc 79:4561–4562Google Scholar

Gd

  1. 1.
    Negwer M (1987) Organic-chemical Drugs and their Synonyms, Akademie-Verlag, BerlinGoogle Scholar

vB

  1. 1.
    Hafely W, Kyburz E, Gerecke M, Möhler H (1985) Adv Drug Res 14:165–322Google Scholar
  2. 2.
    Greenblatt DJ, Shader RI (1974) Benzodiazepines in clinical practice, Raven Press, New YorkGoogle Scholar

Wm

  1. 1.
    Nardi D, Tajana A, Leonardo A, Pennini R, Portioli F,Magistretti MJ, Subissi A (1981) J Med Chem 24:727PubMedGoogle Scholar
  2. 2.
    Tajana A, Sibili C, Cappeletti R, Cova A, Nardi D (1986) Boll Chim Farm 125:7–20PubMedGoogle Scholar

PA

  1. 1.
    Mar 29, S.400Google Scholar

vB

  1. 1.
    Tajana A, Sibili C, Cappeletti R, Cova A, Nardi D (1986) Boll Chim Farm 125:7–20PubMedGoogle Scholar

PA

  1. 1.
    Van der Stelt C, Harms AF, Nauta WT (1961) J Med Pharm Chem 4:335–349PubMedGoogle Scholar
  2. 2.
    Beilsteins Handbuch der Organischen Chemie EV21/1,S.224Google Scholar
  3. 3.
    Moffat AC, Jackson AV, Moss MS, Widdop B (Hrsg.) (1986) Clarke’s Isolation and Identification of Drugs, The Pharmaceutical Press, LondonGoogle Scholar
  4. 4.
    Van der Stelt C, Funcke ABH, Tersteege HM, Nau taWT (1966) Arzneim Forsch 16:1342–1345Google Scholar

MP

  1. 1.
    Mar 29, S.451Google Scholar

EH

  1. 1.
    Austin WC, Potter MD, Taylor EP (1958) J Chem Soc:1.489–1.898Google Scholar
  2. 2.
    Aka T, Soda K, Adachi T, Kitano K, Ono S (1965) Jap Pat 5835 (’65), zit. nach CA 62:16213 fGoogle Scholar
  3. 3.
    Attwood D, Natarajan R (1979) J Pharm Pharmacol 32:460–462Google Scholar
  4. 4.
    Eigene UntersuchungenGoogle Scholar
  5. 5.
    Surmann JP, Glienke M (1988) Fresenius’ Z Anal Chem 331:630–633Google Scholar
  6. 6.
    Pinzauti S, La Porta E (1977) Analyst 102:938–942Google Scholar

hh

  1. 1.
    Kramer A, Wallhäußer KH (im Druck) Wirkungsspektrum und Anwendungseigenschaften häufig aus prophylaktischer Indikation angewendeter Antiseptika. In: Kramer A, Weuffen W, Gröschel D, Heeg P, Hingst V, Lippert H, Rotter M (Hrsg.) Klinische Anwendung von Antiseptika, Springer-Verlag, Berlin Heidelberg New York London Paris Tokyo Hing Kong BarcelonaGoogle Scholar
  2. 2.
    Tatra G (1972) Muench Med Wochenschr 114:773–776Google Scholar
  3. 3.
    Mühlbauer W (1972) Therapiewoche 22:1.416–1.417Google Scholar
  4. 4.
    Gjermo P, Baastad KL, Rölla G (1970) J Periodont Res 5:102–109PubMedGoogle Scholar
  5. 5.
    Raitano A (1981) Disinfettanti, Medico Farmaceutica, MilanoGoogle Scholar
  6. 6.
    Kramer A, Rozsahegyi I, Weuffen W (1985) Chronische Vergiftungen durch Antiseptika. In: Kramer A, Berencsi G, Weuffen W (Hrsg.) Handbuch der Antiseptik, Bd. I/5, Toxische und allergische Nebenwirkungen von Antiseptika, Volk Und Gesundheit, Berlin, S.218Google Scholar
  7. 7.
    Ludewig R, Lohs KH (1988) Akute Vergiftungen, Fischer Verlag, Jena, S. 49–50Google Scholar

ak

  1. 1.
    Bláha L, Weichet J, Žváćek J, Šmolík S, Kakáć B (1960) Coll Czech Chem Commun 25:237–243Google Scholar
  2. 2.
    Klohs MW, Keller F, Williams RE, Kusserow GW (1955) J Am Chem Soc 77:4.084–4.087Google Scholar
  3. 3.
    Stoll A, Hoffmann A (1955) J Am Chem Soc 77:820–821Google Scholar
  4. 4.
    Neuss N, Boaz HE, Forbes JW (1955) J Am Chem Soc 77:4.087–4.090Google Scholar
  5. 5.
    Kle 82, S.272Google Scholar

LJ

  1. 1.
    Cicco C F (BOC Inc) Eur Pat Appl Ep 388,144 ( Cl. C07C41/22) 1990, US Appl 323,579 1985, zit. nach CA (1991) 114:121477sGoogle Scholar
  2. 2.
    Robin M L, Halpern D F, (BOC Inc) Eur Pat Appl Ep 341,004, zit. nach CA (1990) 112:178052nGoogle Scholar

QO

  1. 1.
    Mar 29, S.476Google Scholar

EH

  1. 1.
    Eger EI (1992) Anesth Anaig 75: Suppl 4, S3–S7Google Scholar
  2. 2.
    Rampil IJ, Lockhart SH, Zwass MS, Peterson N, Yasuda N, Eger EI, Weiskopf RB, Damask MC (1991) Anesthesiol 74:429–433Google Scholar
  3. 3.
    Ghouri AF, Bodner M, White PF (1991) Anesthesiol 74:419–424Google Scholar
  4. 4.
    Litt L, Lockhart S, Cohen Y, Yasuda N, Kim F, Freire B, Laster M, Peterson N, Taheri S, Chang LH (1991) Ann N Y Acad Sci 625:707–724PubMedGoogle Scholar
  5. 5.
    Smiley RM (1992) Anesth Anaig 75:Suppl 4, S38–S44Google Scholar
  6. 6.
    White PF (1992) Anesth Anaig 75: Suppl 4, S47–S53Google Scholar
  7. 7.
    Yasuda N, Lockhart SH, Eger EI; Weiskopf RB, Johnson BH, Freire BA, Fassoulaki A (1991) Anesthesiol 74:489–498Google Scholar
  8. 8.
    Koblin DD (1992) Anaesth Anaig 75:Suppl 4, S10–S16Google Scholar
  9. 9.
    Fassoulaki A, Lockhart SH, Freire BA, Yasuda N, Eger EI, Weiskopf RB, Johnson BH (1991) Anesthesiol 74:479–483Google Scholar
  10. 10.
    Zwass MS, Fisher DM, Welborn LG, Cote CJ, Davis PJ, Dinner M, Hannallah RS, Liu LM, Sarner J, McGill WA (1992) Anesthesiol 76:373–378Google Scholar
  11. 11.
    Wedel DJ, Iaizzo PA, Milde JH (1991) Anesthesiol 74:508–512Google Scholar
  12. 12.
    Sebel PS, Glass PS, Fletcher JE, Murphy MR, Gallagher C, Quill T (1992) Anesthesiol 76:52–59Google Scholar

vB

  1. 1.
    Kielholz P, Labhardt F, Battegay R, Rümmele W, Feer H (1963) Dt Med Wochenschr 88:1.617–1.624Google Scholar
  2. 2.
    Bickel MH (1968) Untersuchungen zur Biochemie und Pharmakologie der Thymoleptika. In: Jucker E (Hrsg.) Fortschritte der Arzneimittelforschung, Bd. 11, Birkhäuser Verlag, Basel Stuttgart, S. 121–225Google Scholar
  3. 3.
    Baldessarini RJ (1982) McLean Hosp J 7:1–27Google Scholar
  4. 4.
    Baldessarini RJ (1989) J Clin Psychiat 50:117–126Google Scholar
  5. 5.
    Baldessarini RJ (1990) Drugs and the treatment of psychiatric disorders. In: Goodman Gilman A, Rall TW, Nies AS, Taylor P (Hrsg.) Goodman and Gilman’s The pharmacological basis of therapeutics, 8th edition, Macmillan, New York, S. 383–435Google Scholar
  6. 6.
    Shopsin B, Cassano GB, Conti L (1981) An overview of new “second generation” antidepressant compounds: research and treatment implications. In: Enna SJ, Malick JB, Richelson E (Hrsg.) Antidepressants: Neurochemical, behavioral, and clinical perspectives. Raven Press, New York, S.219–251Google Scholar
  7. 7.
    Richelson E, Pfenning M (1984) Eur J Pharmacol 104:277–286PubMedGoogle Scholar
  8. 8.
    Shein K, Smith SE (1978) Br J Pharmacol 62:567–571PubMedGoogle Scholar
  9. 9.
    Richelson E, Nelson A (1984) J Pharmacol Exp Ther 230:94–102PubMedGoogle Scholar
  10. 10.
    Sulser F (1983) Psychopharmacol Bull 19:300–304PubMedGoogle Scholar
  11. 11.
    Nielsen M, Braestrup C (1977) Naunyn-Schmiedeberg’s Arch Pharmacol 300:87–92Google Scholar
  12. 12.
    Mobley PL, Sulser F (1981) Down-regulation of the central noradrenergic receptor system by antidepressant therapies: biochemical and clinical aspects. In: Enna SJ, Malick JB, Richelson E (Hrsg.) Antidepressants: Neurochemical, behavioral, and clinical perspectives. Raven Press, New York, S. 31–51Google Scholar
  13. 13.
    MacMillan BA, Warnack W, German DC, Shore PA (1980) Eur J Pharmacol 61:239–246Google Scholar
  14. 14.
    Pi EH, Simpson GH, Cooper TB (1986) Am J Psychiat 143:1.174–1.176Google Scholar
  15. 15.
    Pollock BG, Perel JM (1989) Can J Psychiat 34:609–617Google Scholar
  16. 16.
    Ciraulo D, Barnhill JA, Jaffe JH (1988) Clin Pharmacol Ther 43:509–518PubMedGoogle Scholar
  17. 17.
    Ciraulo DA, Barnhill J, Boxenbaum H (1985) Am J Psychiat 142:1.373–1.374Google Scholar
  18. 18.
    Abernethy DR, Greenblatt DJ, Shader RI (1985) J Pharmacol Exp Ther 232:183–188PubMedGoogle Scholar
  19. 19.
    Steiner E, Spina E (1987) Clin Pharmacol Ther 42:278–282PubMedGoogle Scholar
  20. 20.
    Spina E, Steiner E, Ericsson Ö, Sjöquist F (1987) Clin Pharmacol Ther 41:314–319PubMedGoogle Scholar
  21. 21.
    Brøsen K, Otton SV, Gram LF (1986) Clin Pharmacol Ther 40:543–549Google Scholar
  22. 22.
    Brøsen K, Gram LF, Klysner R, Bech P (1986) Eur J Clin Pharmacol 30:43–49PubMedGoogle Scholar
  23. 23.
    Liebermann JA, Cooper TB, Suckow RF, Steinberg H, Borenstein M, Brenner R, Kane JM (1985) Clin Pharmacol Ther 37:103–107Google Scholar
  24. 24.
    Sieberns S (1985) Therapiewoche 35:5.804–5.815Google Scholar
  25. 25.
    Spina E, Pacifici GM, van Bahr C, Rane A (1986) Acta Pharmacol Toxicol 5:277–281Google Scholar

RM

  1. 1.
    Kirkeby CJ, Risoe C (1984) Acta Chir Scand 150:91–92PubMedGoogle Scholar
  2. 2.
    De-Luca B, Cerciello A, Monda M (1982) Neuropharmacology 21:1.211–1.214Google Scholar
  3. 3.
    Helke CJ, Keller KJ, Gillis RA (1978) Eur J Pharmacol 52:47–55PubMedGoogle Scholar
  4. 4.
    Helke CJ, Keller KJ, Gillis RA (1979) Arch Int Pharmacodyn Ther 242:44–49PubMedGoogle Scholar
  5. 5.
    Marzo A, Ghirardi P, Brusoni B, Marchetti G (1978) Arch Int Pharmacodyn Ther 233:156–165PubMedGoogle Scholar
  6. 6.
    Ambrosioni E, Costa FV, Bracchetti D (1979) Int J Clin Pharmacol Biopharm 17:416–420PubMedGoogle Scholar
  7. 7.
    Bekke DM, Lehmann V, Lien E (1981) J Cardiovasc Pharmacol 3:1.015–1.025Google Scholar

  1. 1.
    Andersson KE (1988) Drugs of Today 24:509–528Google Scholar
  2. 2.
    Dinnendahl V, Fricke U (1987) Arzneistoff-Profile: Desmopressin, Govi-Verlag, Frankfurt/MainGoogle Scholar

js

  1. 1.
    Zeelen FJ (1990) Medicinal chemistry of steroids, Elsevier, Amsterdam Oxford New York Tokyo, S. 107–110Google Scholar
  2. 2.
    de Visser J, de Jager E, de Jongh HP, van de Vies J, Zeelen FJ (1975) Actaendocr Copenh 10 (Suppl 199):405–420Google Scholar
  3. 3.
    Widholm O, Alapapiessa U (1977) Contraception 15:1–13PubMedGoogle Scholar
  4. 4.
    Cyran W, Feldmann HM (1981) Gyne Heft 8, H.U.F.-Verlag, EssenGoogle Scholar
  5. 5.
    Oviol22, Oviol 28, Informationsschrift der Fa. Nourypharma, 1990Google Scholar
  6. 6.
    Dik M, Hönes S, Schindler AE, Donath EM (1986) Gynäkol Prax 10:265–275Google Scholar
  7. 7.
    Levrier M (1988) Therapiewoche 3:1.225–1.231Google Scholar
  8. 8.
    Wynants P (1986) Contraception 33:149–157PubMedGoogle Scholar
  9. 9.
    Käär K (1984) Scand J Clin Lab Invest 44:623–627PubMedGoogle Scholar
  10. 10.
    März W, Jung-Hoffmann C, Heidt F, Gross W, Kuhl H (1990) Contraception 41:245–250PubMedGoogle Scholar
  11. 11.
    Chez RA (1989) Am J Obstet Gynecol 160:1.296–1.300Google Scholar
  12. 12.
    Kuhnz W, Pfeffer M, Al-Yacoub G (1990) J Steroid Biochem 35:313–318PubMedGoogle Scholar

OM

  1. 1.
    Miller JA, Munro DD (1980) Drugs 19:119–134PubMedGoogle Scholar
  2. 2.
    Goa KL (1988) Drugs 36 S5:51–61PubMedGoogle Scholar
  3. 3.
    Pichl J, Schell H (1990) Z Hautkrankheiten 65:527–533Google Scholar
  4. 4.
    Tronnier H (1987) Aerztl Kosmetol 17:458–482Google Scholar
  5. 5.
    Leiferman KM, Schroeter A, Kirschner MK, Spelsberg TC(1983) J Inv Dermatol 81:355–360Google Scholar
  6. 6.
    Munck A, Mendel DB, Smith LI, Orti E (1990) Am Rev Respir Dis 141 S2:S2–10PubMedGoogle Scholar
  7. 7.
    Miesfeld RL (1990) Am Rev Respir Dis 141 S2:S11–17PubMedGoogle Scholar
  8. 8.
    Bowen DL, Fauci AS (1988) Adrenal corticosteroids. In: Gallin JI, Goldstein IM, Snyderman R (Hrsg.) Inflammation: basic principles and clinical correlates, Raven Press, New York, S. 877–897Google Scholar
  9. 9.
    Barry BW, Woodford R (1974) Br J Dermatol 91:323–338PubMedGoogle Scholar
  10. 10.
    Meyer E, Smith EW, Haigh JM, Kanfer I (1988) Arzneim Forsch 38:1840–1843Google Scholar
  11. 11.
    Laasko L (1981) Curr Ther Res 30:19Google Scholar
  12. 12.
    Niedner R (1989) Dtsch Aerztebl 86:1798–1803Google Scholar
  13. 13.
    Takeda K, Arase S, Takahashi S (1988) Drugs 36:15–23PubMedGoogle Scholar
  14. 14.
    Karl HJ (1980) Muench Med Wochenschr 122:1191–1194Google Scholar

GM

  1. 1.
    Munck A, Mendel DB, Smith LI, Orti E (1990) Am Rev Respir Dis 141 S2:S2–10PubMedGoogle Scholar
  2. 2.
    Schleimer RP (1985) Ann Rev Pharmacol Toxicol 25:381–412Google Scholar
  3. 3.
    Hahn HL (1990) Wirkungsmechanismen der Glukokortikoide bei Asthma, bronchialer Entzündungsreaktion und Hyperreaktivität. In: Nolte D (Hrsg.) Glukokortikoide bei obstruktiven Atemwegserkrankungen, de Gruyter, Berlin New York, S. 23–56Google Scholar
  4. 4.
    Heel RC, Brogden RN, Speight TM, Avery GS (1978) Drugs 16:302–321PubMedGoogle Scholar
  5. 5.
    Alpermann HG, Sandow J, Vogel HG (1986) Z Hautkrkh61:S7–17Google Scholar
  6. 6.
    Hein R, Krieg T (1989) Z Hautkrkh 64 S1:13–17Google Scholar
  7. 7.
    Hornke I, Cavagna F, Christ O, Fehlhaber HW, Kellner HM, Sandow J (1980) Arzneim Forsch 30:47–51Google Scholar
  8. 8.
    Kim KH, Henderson NL (1989) Z Hautkrkh 64 Sl:19–22Google Scholar
  9. 9.
    Niedner R (1989) Dtsch Aerztebl 86:1.798–1.803Google Scholar
  10. 10.
    Miller JA, Munro DD (1990) Drugs 19:119–134Google Scholar
  11. 11.
    Takeda K, Arase S, Takahashi S (1988) Drugs 36 S5:15–23PubMedGoogle Scholar
  12. 12.
    Karl HK (1980) Muench Med Wochenschr 122:1.191–1.194Google Scholar

GM

  1. 1.
    Fieser LF, Rajagopalan S (1949) Am Soc 71:3935–3937Google Scholar
  2. 2.
    Fieser LF, Fieser M (1959) Steroids, Reinhold, New YorkGoogle Scholar
  3. 3.
    Beil Erg. Werk 3, Bd. 10, Teil 2, S. 1641Google Scholar
  4. 4.
    Gattermann-Wieland (1961) Praxis des organischen Chemikers, 40. Aufl., de Gruyter, Berlin, S. 361Google Scholar
  5. 5.
    Wieland H, Siebert W (1939) Z Physiol Chem 262:1Google Scholar
  6. 6.
    Garcia Valdes J, Cabrara Vazquez N (1987) Rev Cubana Farm 21:217–230, zit. nach CA 108 (14):118794pGoogle Scholar
  7. 7.
    Hag 4, S. 492Google Scholar
  8. 8.
  9. 9.
    Dictionary of Organic Compounds 5th ed 1982 and SupplementsGoogle Scholar
  10. 10.
    Hag 2, S. 799Google Scholar
  11. 11.
    Hag 4, S. 492Google Scholar
  12. 12.
    Grinbaum R, Marchlewski L (1937) Bl Acad Polon 1937A:171–186Google Scholar
  13. 13.
    StofflisteGoogle Scholar
  14. 14.
    Silberman H, Silberman-Martybcewa S (1946) J Biol Chem 165:359–362PubMedGoogle Scholar
  15. 15.
    Kaziro K, Shimada T (1938) Z Physiol Chem 254:57,58Google Scholar
  16. 16.
    Vold RD, McBain JW (1941) Am Soc 63:1296Google Scholar
  17. 17.
    Shimada T (1939) J Biochem Tokyo 29:41Google Scholar
  18. 18.
    Zhang Q, Qian L (1991) Tianran Chanwu Yanjiu Yu Kaifa 3:56–60, zit. nach CA 115 (18):189551n u M, Cheng Z, Hong M (1990) Zhongguo Yaoxue Zazhi 25:524–528, zit. nach CA 114 (16):149998mGoogle Scholar
  19. 19.
    Shen F, Fu D, Wen H (1990) Zhongguo Yaoxue Zazhi 25:457–459, zit. nach CA 114 (8):68913cGoogle Scholar
  20. 20.
    Yokota Y, Ishida M, Arisawa M, Murakuwi M, Ejiri Ch, Saito H (1988) Toyama-Ken Yakuji Kenkyusho Nenpo 16:103–113; zit. nach CA 114 (2):12281c Zhang Q, Li S, Cheng J, Yan K, Tian S (1990) Zhongguo Zhonggao Zazhi 15:360–362, zit nach CA 113 (26):237916t Li H, Zhou J, Wu G (1989) Yaowu Fenxi Zazhi 9:284–287, zit. nach CA 112 (2):11978g Ni K, Zhong G, Hong H (1989) Zhongguo Yaoke Daxue Xuebao 20:22–24, zit. nach CA 110 (22):199296u Li W, Wang J, Chen L, Hu Z (1981) Proc. Sino-West Ger. Symp. Chromatogr. 447–462, zit. nach CA 102 (10):89376x ark JD, Yoo SJ (1984) Saengyak Hakhoechi 15:139–146, zit. nach CA 102 (8):67461uGoogle Scholar
  21. 21.
    Wang Y, Wang Q, Guo Y, Cheng H (1989) Zhongguo Yaoxue Zazhi 24:732–734, zit. nach CA 113 (18): 158761k Ni K, Chang L, Chen F (1989) Zhongguo Yaoke Daxue Xuebao 20:100–102, zit. nach CA 112 (14):125307t Li J (1988) Yaoxue Tongbao 23:355–358, zit. nach CA 109 (22): 197298b Liu L, Xu D, Xie D (1987) 18:361–362, zit. nach CA 107 (20):183699e Han X, Han L (1986) Yaoxue Xuebao 21:864–867, zit.nach CA 106 (10):72990cGoogle Scholar
  22. 22.
    Wang Y, Yang Z (1989) Shenyang Yaoxueyuan Xuebao 6:157–163, zit. nach CA 111 (26):239621aGoogle Scholar
  23. 23.
    Tankano I, Yasuda I, Seto T, Hamano T, Akiyama K (1986) 37:73–78, zit. nach CA 106 (22):182736gGoogle Scholar
  24. 24.
    Maeda M, Tsuji A (1985) Analyst (London) 110:665–668, zit. nach CA 103 (20):171205vGoogle Scholar
  25. 25.
    Bottari E, Festa MR, Jasionowksa R (1988) Ann. Chim. (Rome), 78:261–271, zit. nach CA 109 (20): 177572hGoogle Scholar
  26. 26.
    Preti C, Tassi L, Tosi G (1985) Ann. Chim. (Rome) 75:201–206, zit. nach CA 103 (14):115391rGoogle Scholar
  27. 27.
    Johns MR, Chong R, Maddox IS (1982) Can. J. Microbiol. 28:1019–1021, zit. nach CA 97 (21):180067m (by Curvularia coicis) Ascher RH, Maddox IS, Chong R (1981) Eur. J. Appl. Microbiol. Biotechnol. 12:46–52, zit. nach CA 95 (5):40825r (by Clostridium bifermentans) Google Scholar
  28. 28.
    Neubert R, Fuerst W, Amlacher R, Haertl A (18. Juli 1991) DD 291927 A5, zit. nach CA 115 (20):214888nGoogle Scholar
  29. 29.
    Simon B, Menaste L (10. Okt. 1990) EP 391369 A2, zit. nach CA 114 (26):254013jGoogle Scholar
  30. 30.
    Luecke L, Fries G, Voigt G, Neubert R, Fuerst W, Slapke J, Schewe T (3. Okt. 1990) EP 389773 A2, zit. nach CA 114(24):235054g Ueda Y, Shimojo F, Myatake T, Ozoki M (22. Mai 1989) JP 01128926 A2, zit. nach CA 112 (2):11933p Behl ChR, Unowsky J (6. Okt. 1987) EP 87–114589, zit. nach CA 110 (14):121391b Ueda Y, Shimojo F, Miyatake T, Ozaki M (18. Nov. 1987) JP 62265226, zit. nach CA 108 (26):226860r Andonova V, Radeva K (1987) Farmatsiya (Sofia) 37:32–36, zit. nach CA 108 (14):118859n Wu Q, Wu Q (1986) Yaoxue tongbao 21:457–459, zit. nach CA 106 (12):90092r Lee SJ, Yang BR (1984) Han’guk Saenghwa Hakhoechi 17:456–461, zit. nach CA 102 (8):67335fGoogle Scholar
  31. 31.
    Fujita S (10. Juli 1989) Heisei JP 01174355 A2, zit. nach CA 112 (20):185809t Niazy EM, Molokhia AM, ElGorashi AS (1989) Int. J. Pharm. 56:181–185, zit. nach CA 112 (8):62492bGoogle Scholar
  32. 32.
    Hermens WAJJ, Hooymans PM, Verhoef JC, Merkus FWHH (1990) Pharm. Res. 7:144–146, zit. nach CA 112 (14):125099b Sekline K, Araki D, Suzuki Y (7. Jan. 1988) Showa JP 63002932 A2, zit. nach CA HO (2):13573d Hersey SJ, Kackson RT (1987) J. Pharm. Sci. 76:876–879, zit. nach CA 108 (8):62354a Duchateau GSMJE (1987) Pharm. Veekbl. 122:281–286, zit. nach CA 107 (4):28286zPubMedGoogle Scholar
  33. 33.
    Yokota T, Fukukura I, Yamaguchi M (13.Dez. 1988) Showa JP 6330530 A2, zit. nach CA 110 (18):160198pGoogle Scholar
  34. 34.
    Ritschel WA, Ritschel GB, Ritschel BEC, Luecker PW (1988) Methods Find. Exp. Clin. Pharmacol. 10:645–656, zit. nach CA 109 (26):236908xPubMedGoogle Scholar
  35. 35.
    Roemisch J, Heimburger N (11. Okt. 1990) DE 3911629 Al, zit. nach CA 114 (22):214406h Daddona PE, Davis HM, Fogler WE, Klug TL, Le-Donne NC, McKinney S (5. Mai 1989) WO 8903885 Al, zit. nach CA 112 (12):104896uGoogle Scholar

Rj

  1. 1.
    Funder JW, Feldman D, Edelman IS (1973) Endocrinol 92:994–1.004Google Scholar
  2. 2.
    Morris DJ, Souness GW (1990) Am J Physiol 258:F756–759PubMedGoogle Scholar
  3. 3.
    Marra CA, de Alaniz MJ (1990) Biochem Int 22:483–493PubMedGoogle Scholar
  4. 4.
    Janiak PC, Lewis SJ, Brody MJ (1990) Am J Physiol 259:R1.025–1.034Google Scholar
  5. 5.
    Gomez-Sanchez EP (1991) Am J Hypertens 4:374–381PubMedGoogle Scholar
  6. 6.
    Majima M, Katori M, Hanazuka M, Mizogami S, Nakano T, Nakao Y, Mikami R, Uryu H, Okamura R, Mohsin St, Ohnishi S (1991) Hypertension 17:806–813PubMedGoogle Scholar
  7. 7.
    Zappia A, Hwang BH, Wu JY (1990) Anat Rec 227:518–522PubMedGoogle Scholar
  8. 8.
    Milosovich SM, Hussain AA, Hussain M, Dittert L (1989) Prog Clin Biol Res 292:273–277PubMedGoogle Scholar

vB

  1. 1.
    Kadac B, Vejdelek ZJ, Photometric (1977), Bd.2, S.1096Google Scholar

Rh

  1. 1.
    Beil Erg. Werk 4, Bd. 9, Teil 3, S. 1760 RhGoogle Scholar

Vb

  1. 1.
    Bergeron RJ, McManis JS (1987) J Org Chem 52:1.700–1.703Google Scholar
  2. 2.
    Yamashita K, Watanabe K, Koga R, Mizuguchi S, Hashimoto Y, Nakamura T, Umezawa H (1988) J Chromatogr 424:39–48PubMedGoogle Scholar

us

  1. 1.
    Hibasami H, Midorikawa Y, Gasaluck P, Yoshimura H, Masuji A, Takaji S, Nakashima K, Imai M (1991) Chemother 37:202–205Google Scholar
  2. 2.
    Dickneite G, Walter P, Schorlemmer HU, Sedlacek HH (1985) In: Ishigami J (Hrsg.), Rec Adv Chemotherp, Tokyo, Univ of TokyoGoogle Scholar
  3. 3.
    Hibasami H, Tsukada T, Suzuki R, Takano K, Takaji S, Takeuchi T, Shirakawa S, Murata T, Nakashima K (1991) Anticancer Res 11:325–330PubMedGoogle Scholar
  4. 4.
    Dickneite G, Schorlemmer HU, Sedlacek HH, Falk W, Ulrichs K, Müller-Ruchholtz W (1987) Transplant Proc 19:1.301–1.304Google Scholar
  5. 5.
    Dickneite G, Schorlemmer HU, Racenberg J, Sedlacek HH (1989) Transplantat Proc 21:1.097–1.098Google Scholar
  6. 6.
    Kerr PG, Atkins RC (1989) Transplant 48:1.048–1.052Google Scholar
  7. 7.
    Takasu S, Sagakami K, Orita K (1989) Transplant Proc 21:1.081–1.084Google Scholar
  8. 8.
    Müller WE, Weissmann N, Maidhof A, Bachmann M, Schröder HC (1987) J Antibiot 40:1.028–1.035Google Scholar
  9. 9.
    Amemiya H, Suzuki S, Ota K, Takahashi K, Sonoda T, Ishibashi M, Omoto R, Koyama I, Dohi K, Fukuda Y, Fukao K (1990) Transplant 49:337–343Google Scholar
  10. 10.
    Okubo M, Inoue K, Umetani N, Sato N, Kamata K, Masaki Y, Uchiyama T, Yan XJ, Aoyagi T, Shirai T (1988) Kidney Int 34:467–473PubMedGoogle Scholar
  11. 11.
    Ishigaki Y, Sato T, Tonglin S, Hayashi K (1988) Ann N Y Acad Sci 540:551–553PubMedGoogle Scholar
  12. 12.
    Nemoto K, Abe F, Takita T, Nakamura T, Takeuchi T, Umezawa H (1987) J Antibiot 40:1.193–1.194Google Scholar
  13. 13.
    Muindi JF, Lee S-J, Baltzer L, Jakubowski A, Scher HI, Sprancmanis LA, Riley CM, Vander Velde D, Young CW(1991) Cancer Res 51:3.096–3.101Google Scholar

vB

  1. 1.
    East Germany Pat. 82731 (1971), zit. nach CA (1971) 77:19864Google Scholar

ms

  1. 1.
    Vaughan-Williams EM (1975) Pharmac Ther 31:115–138Google Scholar
  2. 2.
    Wruck C, Hofmann H, Sziegoleit W, Forster W (1982) Z Ges Inn Med 37:519–525PubMedGoogle Scholar
  3. 3.
    MollekenK,RugerK(1980) Z Ges Inn Med 35:296–299Google Scholar

EH

  1. 1.
    Cohen E in Ana 2, S. 174Google Scholar
  2. 2.
    Kadac B, Vejdelek ZJ (1977) Photometrie 1977, Verlag Chemie, Weinheim. Bd.2, S. 1.095Google Scholar
  3. 3.

Rh

  1. 1.
    Kaiser H (1987) Thieme, Stuttgart New YorkGoogle Scholar
  2. 2.
    Hochhaus F, Möllmann H, Barth J (1990) Akt Rheumatol 15:66–69Google Scholar
  3. 3.
    Rohdewald P, Möllmann HW, Hochhaus G (1984) Atemw Lungenkrkh 10:484–489Google Scholar
  4. 4.
    Miesfeld RL (1990) Am Rev Respir Dis 141 S2:11–17Google Scholar
  5. 5.
    Munck A, Mendel DB, Smith LI, Orti E (1990) Am Rev Respir Dis 141 S2:2–10Google Scholar
  6. 6.
    Hahn HL (1990) Wirkungsmechanismen der Glukokortikoide bei Asthma, bronchialer Entzündungsreaktion und Hyperreaktivität. In: Nolte D (Hrsg.) Glukokortikoide bei obstruktiven Atemwegserkrankungen, de Gruyter, Berlin New York, S. 23–56Google Scholar
  7. 7.
    Schleimer RP (1990) Am Rev Respir Dis 141 S2:59–69Google Scholar
  8. 8.
    Bowen DL, Fauci AS (1988) Adrenal Corticosteroids. In: Gallin JI, Goldstein M, Snyderman R (Hrsg.) Inflammation: basic principles and clinical correlates, Raven Press, New York, S. 877–896Google Scholar
  9. 9.
    Nichols T, Nugent CA, Tyler FH (1967) J Clin Endocrinol 27:549Google Scholar
  10. 10.
    Loew D, Schuster O, Graul EH (1985) Therapiewoche 35:1106–1113Google Scholar
  11. 11.
    Melby JC (1977) Ann Rev Pharmacol Toxicol 17:511–527Google Scholar
  12. 12.
    Möllmann HW, Barth J, Schott D, Ulmer WT, Derendorf H, Hochhaus G (1989) Intensivmed 26:2–15Google Scholar
  13. 13.
    Hwang DG, Stern WH, Hwang PH, MacGowan-Smith LA (1989) Arch Ophthalmol 107:1375–1380PubMedGoogle Scholar
  14. 14.
    Watson D, Noble MJ, Dutton GN, Midgley JM, Healey TM (1988) Arch Ophthalmol 106:686–687PubMedGoogle Scholar
  15. 15.
    Kaiser H (1988) Akt Rheumatol 13:27–30Google Scholar
  16. 16.
    Tsuei SE, Moore RG, Ashley JJ, McBride WG (1979) J Pharm Biopharm 7:249–264Google Scholar
  17. 17.
    Laasko L (1981) Curr Ther Res 30:19Google Scholar
  18. 18.
    Miyabo S, Nakamura T, Kuwazima S, Kishida S (1981) Eur J Clin Pharmacol 20:277–282PubMedGoogle Scholar
  19. 19.
    Hornke I, Cavagna F, Christ O, Fehlhaber HW, Kellner HM, Sandow J (1980) Arzneim Forsch 30:47–51Google Scholar
  20. 20.
    Straub W (1987) Augenkrankheiten. In: Kaiser H (Hrsg.) Cortisonderivate in Klinik und Praxis, Thieme, Stuttgart New York, S. 216–225Google Scholar
  21. 21.
    Ortega E, Rodriguez C, Strand LJ, Segre E (1976) J Int Med Res 4:326–337PubMedGoogle Scholar
  22. 22.
    Fiegel G (1981) Med Welt 32:130–134PubMedGoogle Scholar
  23. 23.
    Karl HJ (1980) Muench Med Wochenschr 122:1191–1194Google Scholar
  24. 24.
    Jubiz W, Meikle AW (1979) Drugs 18:113–121PubMedGoogle Scholar

GM

  1. 1.
    Melby JC (1977) Ann Rev Pharmacol Toxicol 17:511–527Google Scholar
  2. 2.
    Kaiser H (1988) Akt Rheumatol 13:27–30Google Scholar
  3. 3.
    Clark JE, Lee HJ (1982) Curr Ther Res 32:761–781Google Scholar
  4. 4.
    Müller W (1981) Therapiewoche 31:6258–6265Google Scholar

GM/vB

  1. 1.
    Fresenius’ Z Anal Chem (1988) 389:778–780Google Scholar

Rh

  1. 1.
    Möllmann HW, Barth J, Schott D, Ulmer WT, Derendorf H, Hochhaus G (1989) Intensivmed 26:2–15Google Scholar
  2. 2.
    Jack D (1975) Atemw Lungenkrkh 1:S. 13–20Google Scholar

GM/vB

  1. 1.
    Möllmann HW, Barth J, Schott D, Ulmer WT, Derendorf H, Hochhaus G (1989) Intensivmed 26:2–15Google Scholar
  2. 2.
    Tsuei SE, Moore RG, Ashley JJ, McBride WG (1979) J Pharm Biopharm 7:249–264Google Scholar
  3. 3.
    Melby JC (1977) Ann Rev Pharmacol Toxicol 17:511–527Google Scholar

GM/vB

  1. 1.
    Harfst G, Katzung K, Sahihi A (1991) Rauschgift-Szene-Jargon von A-Z, Holger Harfst Verlag, WürzburgGoogle Scholar
  2. 2.
    Karrer P, Portmann P, Suter M (1948) Helv Chim Acta 31:1617–1623Google Scholar
  3. 3.
    Karrer P, Ehrhardt K (1951) Helv Chim Acta 34:2202–2210Google Scholar
  4. 4.
    Johns I B, Burch J M (1938) J Am Chem Soc 60:919–920Google Scholar
  5. 5.
    v Braun J, Friehmelt E (1933) Chem Ber 66:684–685Google Scholar
  6. 6.
    Wallis E S, Nagel S C (1931) J Am Chem Soc 53:2787–2791Google Scholar
  7. 7.
    Leithe W (1932) Chem Ber 65:660–666Google Scholar
  8. 8.
    Temmler (1939) Brit 508757Google Scholar
  9. 9.
    Magidson, Garkusha (1941) J Gen Chem (USSR) 11:339Google Scholar
  10. 10.
    Firmenschrift Knoll AG (1977): Pharma ChemikalienGoogle Scholar

NE

  1. 1.
    Dring LG, Smith RL, Williams RT (1970) Biochem J 116:425–435PubMedGoogle Scholar
  2. 2.
    Campbell DB (1969) Pharm Pharmac 21:129–130Google Scholar
  3. 3.
    Axelrod J (1970) Amphetamine: metabolism, physiological disposition and its effects on catecholamine storage. In: Costa E, Garattini S (Hrsg.) Amphetamines and related compounds, Raven Press, New York, S. 207–216 (enthält noch andere Artikel zu diesem Thema)Google Scholar
  4. 4.
    Lange KW (1990) Dtsch Med Wochenschr 115:1.244–1.250Google Scholar
  5. 5.
    Warneke L (1990) Can J Psychiat 35:3–10Google Scholar

hr

  1. 1.
    Harfst G, Katzung K, Sahihi A (1991) Rauschgift-Szene-Jargon von A-Z, Holger Harfst Verlag, WürzburgGoogle Scholar
  2. 2.
    Temmler (1939) Brit 508757Google Scholar
  3. 3.
    Magidson, Garkusha (1941) J Gen Chem (USSR) 11: 339Google Scholar
  4. 4.
    Firmenschrift Knoll AG (1977) Pharma ChemikalienGoogle Scholar
  5. 5.
    Moffat AC, Jackson JV, Moss MS, Widdop B (Hrsg) (1986) Clarke’s Isolation and Identification of Drugs, 2. Aufl., The Pharmaceutical Press, LondonGoogle Scholar
  6. 6.
    Kovar KA, Noy M, Pieper R (1982) Dtsch Apoth Ztg 122:3–22Google Scholar

NE

  1. 1.
    Walter LA, US Pat 3030371, zit. nach CA (1962) 57:9822i; Walter LA, US Pat 3061517, zit. nach CA (1963) 58:6744cGoogle Scholar
  2. 2.
    Beil Erg. Werk 5, Bd. 22, Teil 10, S.490Google Scholar

MP

  1. 1.
    Moffat AC, Jackson JV, Moss MS, Widdop B (1986) Clarke’s Isolation and Identification of Drugs (1986) The Pharmaceutical Press, LondonGoogle Scholar

MP

  1. 1.
    Walter LA, US Pat 3030371, zit. nach CA (1962) 57:9822i Walter LA, US Pat 3061517, zit. nach CA (1963) 58:6744cGoogle Scholar
  2. 2.
    Beil Erg. Werk 3/4, Bd. 22, Teil 6, S.4921.Brittain RT, D’Arcy PF, Hunt JH (1959) Nature 183:734–735Google Scholar
  3. 3.
    Fricke FL (1972) J Assoc Off Anal Chem 55:1162–1167PubMedGoogle Scholar

MP

  1. 1.
    Moffat AC, Jackson JV, Moss MS, Widdop B (1986) Clarke’s Isolation and Identification of Drugs, The Pharmaceutical Press, LondonGoogle Scholar

MP

  1. 1.
    Mar 29, S.530Google Scholar

vB

  1. 1.
    Beregi Fr Pat M1658 (1963 an Science-Union, Anm. 04.04.1961), zit. nach CA (1963) 59:3831gGoogle Scholar
  2. 2.
    Wieduwilt H, Haendel KH, Jassmann E (1974) Ger (East) 108971 (12.10.74, Appl 172919 16.08.73), zit. nach CA (1975) 83(13):113915]Google Scholar
  3. 3.
    Beregi L, Hugon P, Le Douarec JC, Schmitt H (1965) USP 3198 834 (03.08.65, Appl 27.07.64 an Science Union), zit. nach CA (1965) 63:11425Google Scholar

NE

  1. 1.
    Mar 29, S.1.441Google Scholar

vB

  1. 1.
    Brit. Pat. 582156, zit. nach CA 41:2432iGoogle Scholar
  2. 2.
    DDR Pat. 45705, zit. nach CA 65:3757fGoogle Scholar
  3. 3.
    Beil Erg. Werk 4, Bd.4, Teil 1, S. 1652Google Scholar
  4. 4.
    Prosser AR, Sheppard AJ (1971) J Pharm Sci 60:909PubMedGoogle Scholar
  5. 5.
    Umagat H, Tscherne R (1980) Anal Chem 52:1368–1370PubMedGoogle Scholar

hh

  1. 1.
    Bäßler KH, Grühn E, Loew D, Pietrzik K (1992) Vitamin-Lexikon, Gustav Fischer Verlag, Stuttgart, New YorkGoogle Scholar
  2. 2.
    Buddecke E (1984) Grundriß der Biochemie, 7. Aufl., Gruyter Verlag, Berlin New YorkGoogle Scholar
  3. 3.
    Stryer L (1985) Biochemie, 3. Aufl., Friedrich Viehweg & Sohn, Braunschweig WiesbadenGoogle Scholar
  4. 4.
    Friedrich W (1987) Pantothensäure. In: Friedrich W (Hrsg.) Handbuch der Vitamine, Urban und Schwarzenberg, München Wien BaltimoreGoogle Scholar
  5. 5.
    Lang K (1976) Biochemie der Ernährung, Steinkopf Verlag, DarmstadtGoogle Scholar
  6. 6.
    Pietrzik K, Hornig D (1980) Int J Vit Nutr Res 50:283–293Google Scholar
  7. 7.
    Bamji MS (1981) Laboratory tests for the assessment of vitamin nutritional status. In: Briggs M (Hrsg.) Vitamin in Human Biology, CRC Press, Boca RatonGoogle Scholar
  8. 8.
    Fox HM (1984) Pantothenic Acid. In: Machlin LJ (Hrsg.) Handbook of Vitamins, Marcel Dekker, Inc., New YorkGoogle Scholar
  9. 9.
    Sauberlich HE, Skala JH, Dowdy RP (1974) The assessment of nutritional status, CRS Press, Inc., Cleveland, OhioGoogle Scholar
  10. 10.
    Hanck A (1986) Pantothensäure. In: Spektrum Vitamine, Arzneimitteltherapie heute, Bd. 42, Aesopus Verlag, Zug, S. 97–102Google Scholar
  11. 11.
    Höhne E (1985) Pantothensäure/Panthenol. In: Vitamine, 2. Aufl., Otto Hoffmans Verlag GmbH, MünchenGoogle Scholar
  12. 12.
    Spector R (1986) Fed Proc 45:37–39Google Scholar
  13. 13.
    Wagner M, Schubert V, Hötzel D (1972) Med Ernährung 13:25–29Google Scholar
  14. 14.
    Monographie Dexpanthenol, BAz (in Vorbereitung)Google Scholar

KP

  1. 1.
    Gloor M (1982) Pharmakologie dermatologischer Externa, Springer, Berlin Heidelberg New York, S. 27–28Google Scholar
  2. 2.
    Lochbühler H, Kaufmann W, Storz WL (1978) Therapiewoche 28:2665Google Scholar
  3. 3.
    Petzoldt D, Henkel W (1979) Ext Derm 3 (Suppl 1):29–34Google Scholar
  4. 4.
    Jacobsson S, Rothman U, Arturson G (1976) Scand J Plast Reconstr Surg 10:65–72PubMedGoogle Scholar
  5. 5.
    Paavolainen P, Sundell B (1976) Ann Chir Gynaec Fenn 65:313–317Google Scholar
  6. 6.
    Lassus A, Karvonen J, Juvakoski T (1977) Acta Derm Venerol 57:361–363PubMedGoogle Scholar
  7. 7.
    Matthews RW (1982) Brit Dent J 152:157–159PubMedGoogle Scholar

Gs

  1. 1.
    Handbook of Pharmaceutical Excipients (1986), American Pharmaceutical Association, Washington, USA, S. 93–94Google Scholar

BK

  1. 1.
    Fr. M 3683 (1965), zit. nach CA (1967) 66:55204nGoogle Scholar
  2. 2.
    Brit. 1,076,174, zit. nach CA (1966) 65:21691vGoogle Scholar
  3. 3.
    Schmitt J, Comoy P, Boitard J, Meingan JP, Le Meur J, Briot M (1966) Chim Therap 71–77, zit. nach CA (1966) 65:15255Google Scholar
  4. 4.
    Neth Appl 6:407,309, zit. nach CA(1965) 63:535Google Scholar

GU

  1. 1.
    Mar 29, S. 1.609Google Scholar

vB

  1. 1.
    Fr M3683 (1965), CA 66 (1967) 55204nGoogle Scholar
  2. 2.
    Brit 1,076,174, CA 68 (1968) 21691vGoogle Scholar
  3. 3.
    Schmitt J, Comoy P, Boitard J, Meingan JP, LeMeur J, Briot M (1966) Chim Ther 71–77; CA 65 (1966) 15255Google Scholar
  4. 4.
    Neth Appl 6,407,309, CA63 (1965) 535Google Scholar
  5. 5.
    Schnider O, Hellerbach J (1950) Helv Chim Acta 33:1437–1448Google Scholar
  6. 6.
    Schnider O, Grüssner A (1951) Helv Chim Acta 34:2211–2213Google Scholar
  7. 7.
    Weiss U, Rüll Th (1965) Bull Soc Chim France 12:3707–3714Google Scholar
  8. 8.
    Terui Y, Tori K, Maeda S, Sawa YK (1975) Tettrahedron Lett 33:2853–2856Google Scholar
  9. 9.
    Wainer IW, Tischler MA, Sheinin EB (1980) J Pharm Sci 69:459–461PubMedGoogle Scholar
  10. 10.
    Achari RG, Theimer EE (1977) J Chromatogr Sci 15:320–321PubMedGoogle Scholar
  11. 11.
    Park YH, Kuliberg MP, Hinsvark ON (1980) J Pharm Sci 73:24–29Google Scholar
  12. 12.
    Furlanut M, Cima L, Benetello P, Giusti P (1977) J Chromatogr 140:270–274PubMedGoogle Scholar
  13. 13.
    Barnhart JW, Massad EN (1979) J Chromatogr 163:390–395PubMedGoogle Scholar
  14. 10.
    Noirfalise A (1974) J Chromatogr 90:392–393PubMedGoogle Scholar
  15. 11.
    Häfliger O, Brossi A, Chopard-dit-Jean LH, Walter M, Schnider O (1956) Helv Chim Acta 39:2053–2061Google Scholar

KU

  1. 1.
    Marks W (1987) Pharmazeut Ztg 132:426–428Google Scholar
  2. 2.
    Benson WM, Stefko PL, Randell LO (1953) J Pharmacol Exp Ther 109:189–200PubMedGoogle Scholar
  3. 3.
    Eddy NB, Friebel H, Hahn KJ, Halbach H (1970) Bull WHO 40:169–178Google Scholar
  4. 4.
    Mortimer Ö, Lindström B, Laurell H, Bergmann U, Rane A (1989)-demethylated and didemethylated metabolites in man, Br J clin Pharmac 27:223–227Google Scholar
  5. 5.
    Silvasti M, Karttunen P, Tukiainen H, Kokkonen P, Hänninen U, Nykänen S (1987) Int J Clin Pharmacol Ther Tox 25:493–497Google Scholar
  6. 6.
    Hildebrand M, Seifert W, Reichenberger A (1989) Eur J Clin Pharmacol 36:315–318PubMedGoogle Scholar
  7. 7.
    Matthys H, Bleicher B, Bleicher U (1983) J Int Med Res 11:92–100PubMedGoogle Scholar
  8. 8.
    Matthys H, Erhard J, Rühle KH (1985) Schweiz Med Wschr 115:307–311PubMedGoogle Scholar
  9. 9.
    Flemming PhA (1986) Br J Med 293:597Google Scholar
  10. 10.
    Dodds A, Revai E (1967) Med J Aust 2:231Google Scholar
  11. 1.
    Schnider O, Grüssner A (1954) US Pat. 2676177; CA (1955) 49:6325aGoogle Scholar
  12. 2.
    Moffat AC, Jackson JV, Moss MS, Widdop B (Hrsg.) (1986) Clarke’s Isolation and Identification of Drugs, 2. Aufl., The Pharmaantical Press, LondonGoogle Scholar
  13. 3.
    Farbegas JL, Margalet A (1975) J Pharm Sci 64:1005–1006Google Scholar
  14. 4.
    Barnhart JW, Massad EN (1979) J Chromatogr 163:390–395PubMedGoogle Scholar
  15. 5.
    Noirfalise A (1974) J Chromatogr 90:392–393PubMedGoogle Scholar
  16. 6.
    Park JH, Kuliberg MP, Hinsvark ON (1984) J Pharm Sci 73:24–29PubMedGoogle Scholar

KU

  1. 1.
    Janssen P A J (1956) J Am Chem Soc 78:3862Google Scholar
  2. 2.
    Kovar K A, Noy M, Pieper R (1982) Dtsch Apoth Ztg 122:3Google Scholar
  3. 3.
    Caddy B, Idowu R (1979) Analyst (London) 104:328Google Scholar

Rh

  1. 1.
    Arzneistoff-Profile: Basisinformation über arzneiliche Wirkstoffe (1990) Govi-Verlag, Frankfurt a. M.Google Scholar
  2. 2.
    Ghodse AH, Sheehan M, Taylor C, Edwards G (1985) Br Med J 290:425–428Google Scholar
  3. 3.
    Jurand A, Martin LV (1990) Teratology 42:45–54PubMedGoogle Scholar
  4. 4.
    Kintz P, Mangin P, Lugnier AA, Chaumont AJ (1990) J Anal Toxicol 14 (4):252–253PubMedGoogle Scholar
  5. 5.
    Kintz P, Tracqui A, Mangin P, Lugnier AA, Chaumont AJ (1989) J Anal Toxicol 13 (4):238–239PubMedGoogle Scholar
  6. 6.
    Lançon JP, Pechinot A, Athis PD, Pechinot M, Pointaire P, Obadia JF, Caillard B (1989) Ann Fr Anesth Réanim 8:488–492PubMedGoogle Scholar
  7. 7.
    Meignier M, Zaouter M, Ricard P, Charles-Guillard S, Heloury Y, Rogez JM, Pannier M (1990) Chir Pédiatr 31:341–344PubMedGoogle Scholar
  8. 8.
    Pagani I, Barzaghi N, Crema F, Perucca E, Ego D, Rovei V (1989) Fundam Clin Pharmacol 3 (l):27–35PubMedGoogle Scholar

KG

  1. 1.
    Anon (1972) Med Lett Drug Ther 14 (ll):37–40Google Scholar
  2. 2.
    Baratta RR (1976) Curr Ther Res 20:233–240PubMedGoogle Scholar
  3. 3.
    Bassendine MF, Woodhouse KW, Bennett M, James OF (1986) Gut 27 (4):444–449PubMedGoogle Scholar
  4. 4.
    Beaver WT (1984) Hum Toxicol 3 Suppl.:191S–220SPubMedGoogle Scholar
  5. 5.
    Bellville JW,Seed JC (1968) Clin Pharmacol Ther 9:428–434PubMedGoogle Scholar
  6. 6.
    Briggs GG, Freeman RK, Yaffe SJ (1986) Drugs in Pregnancy and Lactation, 2. Aufl., Williams, Wilkins, Baltimore, 537S.Google Scholar
  7. 7.
    Brosen K, Gram LF, Schou J, Larsen NE, Thayssen P (1985) Eur J Clin Pharmacol 29 (l):79–84PubMedGoogle Scholar
  8. 8.
    Claghorn JL, Schoolar JC (1966) JAMA 196:1.089–1.091Google Scholar
  9. 9.
    Daftery AV (1974) N Engl J Med 291:979–980PubMedGoogle Scholar
  10. 10.
    Flanagan RJ, Johnston A, White AST, Crome P (1989) Br J Clin Pharmacol 28:463–469PubMedGoogle Scholar
  11. 11.
    Ford JF, Kellett RJ (1977) Br Med J 2:674PubMedGoogle Scholar
  12. 12.
    Giacomini KM, Giacomini JC, Gibson TP, Levy G (1980) Clin Pharmacol Ther 28(3):417–424PubMedGoogle Scholar
  13. 13.
    Hansten PD, Horn JR (1990) Drug Interactions & Updates, 6. Aufl., Lea & Febiger, Philadelphia, London, 620S.Google Scholar
  14. 14.
    Jaffe JH, Martin WR (1990) Opioid Analgesics and Antagonists. In: Gilman AG, Rall TW, Nies AS, Taylor P (Hrsg.) The Pharmacological Basis of Therapeutics, Pergamon Press, New York, S. 485–521Google Scholar
  15. 15.
    Kunka RL, Venkataramanan R, Stern RM, Ladik CF (1984) Clin Pharm Ther 35:675–680Google Scholar
  16. 16.
    Kurz-Müller K, Zenz M (1991) Schmerz 5:233–242PubMedGoogle Scholar
  17. 17.
    Lee TH, Rees PJ (1977) Br Med J 2:296PubMedGoogle Scholar
  18. 18.
    Lupin AJ, Harley CH (1976) Can Med Assoc J 114:596PubMedGoogle Scholar
  19. 19.
    Musa MN, Lyons LL (1976) Curr Ther Res 19 (6):669–674PubMedGoogle Scholar
  20. 20.
    Owen M, Hillis LJ (1980) Med J Aust 1:617–618PubMedGoogle Scholar
  21. 21.
    Sewester CS (1990) Drug: Fact and comparison, Lippincott, PhiladelphiaGoogle Scholar
  22. 22.
    Tennant FS (1973) Arch Intern Med 132:191–194PubMedGoogle Scholar
  23. 23.
    Tyson HK (1974) J Pediatr 85 (5):684–685PubMedGoogle Scholar
  24. 24.
    Verebely K, Inturrisi CE (1974) Clin Pharmacol Ther 15:302–309PubMedGoogle Scholar
  25. 25.
    Wagner JG, Welling PG, Sedmann AJ (1972) Int J Clin Pharmacol 5:381–388Google Scholar
  26. 26.
    Waife SO, Gruber CM, Rodda BE, Nash JF (1976) Int J Clin Pharmacol Biopharm 13:177–181PubMedGoogle Scholar
  27. 27.
    Welling PG, Lyons LL, Tse FLS, Craig WA (1976) Clin Pharmacol Ther 19:559–565PubMedGoogle Scholar
  28. 28.
    Wiederholt IC, Genco M, Foley JM (1967) Neurology 17:703PubMedGoogle Scholar
  29. 29.
    McMahon RE, Shader RI (1973) Life Sci (II) 12:463–473Google Scholar
  30. 30.
    Abernethy DR, Greenblatt DJ, Steel K, Sullivan HR, Due SL, Marshall FJ (1982) Ann Intern Med 97:223–224PubMedGoogle Scholar

KG

  1. 1.
    Schnider O, Grüssner A (1951) Helv Chim Acta 34:2211–2217Google Scholar
  2. 2.
    Meyers AI, Bailey TR (1985) J Org Chem 51:872–875Google Scholar
  3. 3.
    Moffat AC, Jackson JV, Moss MS, Widdop B (Hrsg.) (1986) Clarke’s Isolation and Identification of Drugs, 2. Aufl., The Pharmaceutical Press, LondonGoogle Scholar
  4. 4.
    Jane I, McKinnon A, Flanagan RJ (1985) J Chromatogr323(2):191–225PubMedGoogle Scholar
  5. 5.
    Furlanut M, Cima L, Benetello G, Giusti P (1977) J Chromatogr 140 (3):270–274PubMedGoogle Scholar

KU

  1. 1.
    Nahm H, Siedel W (1963) Chem Ber 96:1–9Google Scholar
  2. 2.
    In: Pouchert CJ (Hrsg.) (1989) The Aldrich Library of FT-IR-Spectra, Bd. 1, Aldrich Chemical Co., Milwaukee, S. 254Google Scholar
  3. 3.
    In: Hansch C, Sammes PG, Taylor JB (Hrsg.) (1990) Comprehensive Medicinal Chemistry, Bd. 6, Pergamon Press Oxford, S. 438Google Scholar

Ba

  1. 1.
    Schwindler H (1968) Wien Med Wochenschr 118:98–100Google Scholar
  2. 2.
    Myant NB (1964) The thyroid and lipid metabolism. In: Paoletti R (Hrsg.) Lipid Pharmacology, Academic Press Inc, New York, S. 299–323Google Scholar
  3. 3.
    Kuschinsky G, Lüllmann H (1981) Kurzes Lehrbuch der Pharmakologie und Toxikologie, Georg Thieme Verlag, Stuttgart New York, S. 155Google Scholar
  4. 4.
    The Coronary Drug Project (1972) J Am Med Assoc 220:996–1.008Google Scholar
  5. 5.
    The Coronay Drug Project Research Group (1975) J Am Med Assoc 231:360–381Google Scholar
  6. 6.
    Tapley DF, Davidoff FF, Hatfield WB, Ross JE (1959) Am J Physiol 197:1.021–1.025Google Scholar
  7. 7.
    Klotz U (1984) Klinische Pharmakokinetik, Gustav Fischer Verlag, Stuttgart New York, S. 120Google Scholar
  8. 8.
    Weser JK, Sellers E (1971) N Engl J Med 285:547–558PubMedGoogle Scholar

Bj

  1. 1.
    Neudecker H, Scheiffele E (1971) Arzneim Forsch 21:432Google Scholar
  2. 2.
    HeintzB, Hamacher H (1983) Dtsch Apoth 123:417–420Google Scholar
  3. 3.
    Gübitz G, Juffmann F (1987) J Chromatogr 404:391–393PubMedGoogle Scholar
  4. 4.
    Richheimer SL, Schacher MS (1983) J Pharm Sci 72: 822–823PubMedGoogle Scholar
  5. 5.
    Wachholz E, Pfeifer S (1972) Pharmazie 27:43–46PubMedGoogle Scholar
  6. 6.
    Wachholz E, Pfeifer S (1972) Pharmazie 27:97–106PubMedGoogle Scholar
  7. 7.
    Hay ID, Annesley TM, Jiang NS, Gorman CA (1981) J Chromatogr 226:383–390PubMedGoogle Scholar
  8. 8.
    DAB 10, Monographie Levothyroxin-NatriumGoogle Scholar

Ba

  1. 1.
    Cohen MS (1987) Special aspects of perinatal and pediatric pharmacology. In: Katzung BG (Hrsg.) Basic and clinical pharmacology, Norwalk, Appleton Lange, S. 749–755Google Scholar
  2. 2.
    Inturrisi CE, Max MB, Foley KM, Schultz M, Shin SU, Houde RW (1984) N Engl J Med 310:1.213–1.217Google Scholar
  3. 3.
    Jamous MA, Hand CW, Moore RA, Teddy PJ, McQuay HJ (1986) Anesth Analg 65:1.290–1.294Google Scholar
  4. 4.
    Kaiko RF, Wallenstein SL, Rogers AG, Grabinski PY, Houde RW (1981) N Eng J Med 304:1.501–1.505Google Scholar
  5. 5.
    Kotob HI, Hand CW, Moore RA, Evans PJ, Wells J, Rubin AP, McQuay HJ (1986) Anesth Analg 65:718–722PubMedGoogle Scholar
  6. 6.
    Lee A, McKeown D, Brockway M, Bannister J, Wildsmith JA (1991) Anaesthesia 46 (6):447–450PubMedGoogle Scholar
  7. 7.
    Levine MN, Sackett DL, Bush H (1986) Arch Intern Med 146:353–356PubMedGoogle Scholar
  8. 8.
    McGrady EM, Brownhill DK, Davis AG (1989) Anaesthesia 44:400–403PubMedGoogle Scholar
  9. 9.
    Moore A, Bullingham R, McQuay H, Allen M, Baldwin D, Cole A (1984) Clin Pharmacol Ther 35:40–45PubMedGoogle Scholar
  10. 10.
    Product Information-Diamorphine hydrochloride BP for injection® (1989)Google Scholar
  11. 11.
    Robinson SL, Rowbotham DJ, Smith G (1991) Anaesthesia 46 (7):538–540PubMedGoogle Scholar
  12. 12.
    Sawynok J (1986) Can J Physiol Pharmacol 64:1–6PubMedGoogle Scholar
  13. 13.
    Smith ID, Klubien KE, Wood ML, Macrae DJ, Carli F (1991) Anaesthesia 46 (11):970–973PubMedGoogle Scholar
  14. 14.
    Stevens JD, Braithwaite P, Corke CF, Madej TH, Wheatley RG (1991) Anaesthesia 46 (4):256–259PubMedGoogle Scholar
  15. 15.
    Wallenstein SL, Houde RW, Portenoy R, Lapin J, Rogers A, Foley KM (1990) Pain 41 (1):5–13PubMedGoogle Scholar
  16. 16.
    Way WL, Way EL (1987) Opioid Analgesics and Antagonists. In: Katzung BG (Hrsg.) Basic and clinical pharmacology, Norwalk, Appleton Lange, S. 749–755Google Scholar

KG

  1. 1.
    Poochikian GK, Cradock JC, Davignon JP (1983) Int J Pharm 13:219Google Scholar
  2. 2.
    Beaumont I, Deeks T (1982) J Chromatogr 238:520PubMedGoogle Scholar
  3. 3.
    Wyatt DK, Grady LT (1982) in Florey K Anal Profiles of Drug Substances 10:357Google Scholar
  4. 4.
    Bernhauer D, Fuchs E, Neumann H (1983) Fresenius Z Anal Chem 316:357Google Scholar
  5. 5.
    Rogers GC, Davies MB, Allwood MC (1991) International Pharmacy Journal 5(2):70Google Scholar

Am

  1. 1.
    Sternbach LH (1978) Progr. Drug Res 22:229–266Google Scholar
  2. 2.
    Schütz H (1982) Benzodiazepines, Springer, Berlin Heidelberg New YorkGoogle Scholar

  1. 1.
    Haefely W, Pieri L, Polc P, Schaffner R (1981) General pharmacology and neuropharmacology of benzodiazepine derivatives. In: Hoffmeister F, Stille G (Hrsg.) Handbook of experimental pharmacology, Bd. 55/II, Springer-Verlag, Berlin, S. 13–262Google Scholar
  2. 2.
    Haefely W, Kyburz E, Gerecke M, Möhler H (1985) Adv in Drug Res 14:165–322Google Scholar
  3. 3.
    Müller WE (1987) The benzodiazepine receptor: drug only or a physiologically relevant part of our central nervous system? Cambridge University Press, CambridgeGoogle Scholar
  4. 4.
    Klotz U, Kanto J (1988) Clin Pharmacokin 14:1–12Google Scholar
  5. 5.
    O’Sullivan GF, Wade DN (1987) Clin Pharmacol Ther 42:254–259PubMedGoogle Scholar
  6. 6.
    Mandelli M, Tognoni G, Garattini S (1978) Clin Pharmacokin 3:72–91Google Scholar
  7. 7.
    Greenblatt DJ, Allen MD, Harmatz JS, Shader RI (1980) Clin Pharmacol Ther 27:301–312PubMedGoogle Scholar
  8. 8.
    Klotz U, Avant GR, Hoyumpa A, Schenker S, Wilkinson GR (1975) J Clin Invest 55:347–359PubMedGoogle Scholar
  9. 9.
    Greenblatt DJ, Shader RI (1974) Benzodiazepines in clinical practice, Raven-Press, New YorkGoogle Scholar
  10. 10.
    Müller WE (1990) Therapiewoche 40:3.170–3.175, 3.635–3.641Google Scholar
  11. 11.
    Stoeckel H, Lauven PM, Schwilden H, Murday H (1986) Benzodiazepine als Supplement in der Allgemeinanästhesie. In: Hippius H, Engel RR, Laakmann G (Hrsg.) Benzodiazepine, Rückblick und Ausblick, Springer-Verlag, Berlin Heidelberg New York, S.214–223Google Scholar
  12. 12.
    Kugler J, Leutner V (Hrsg.) (1987) Benzodiazepine in der Neurologie, Editiones Roche, GrenzachGoogle Scholar
  13. 13.
    Nathan PW (1970) J Neurol Sci 10:33–50PubMedGoogle Scholar
  14. 14.
    Woods JH, Katz JL, Winger G (1987) Pharmacol Rev 39:251–419PubMedGoogle Scholar
  15. 15.
    Winokur A, Rickels K, Greenblatt DJ, Snyder PJ, Schatz NJ (1980) Arch Gen Psychiatry 37:101–105PubMedGoogle Scholar
  16. 16.
    Tyrer P, Owen R, Dawling S (1983) Lancet 25:1.402–1.406Google Scholar
  17. 17.
    Klotz U (1984) Progr Clin Biochem Med 1:117–167Google Scholar

Wm

  1. 1.
  2. 2.
    Sittig M (1988) Pharmaceutical Manufacturing Encyclopedia 2. Aufl., Noyes Publications, Park Ridge, New Jersey USA, S. 467Google Scholar
  3. 3.
    ToplissJG, Sperber N, Rubin AA (1967) US Pat 3.345.365; zit. nach CA (1968) 68:78.318hGoogle Scholar
  4. 4.
    Ebel S (1977) Handbuch der Arzneimittelanalytik,Verlag Chemie Weinheim-New York, S.226Google Scholar
  5. 5.
    JakobsenP, Treppendahl S (1979) Tetrahedron 35:2151Google Scholar
  6. 6.
    Mannhold R, Rodenkirchen R, Bayer R, Haas W (1984) Arzneim Forsch 34:407Google Scholar
  7. 7.
    DaldrupT, Susanto F, Michalke P (1981) Fresenius Z Anal Chem 308:413Google Scholar

RE

  1. 1.
    Rubin AA, Roth FE, Taylor RM, Rosenkilde H (1962) J Pharmacol Exp Ther 136:344–352PubMedGoogle Scholar
  2. 2.
    Topliss JG, Konzelman LM, Shapiro EP, Sperber N, Roth FE (1964) J Med Chem 7:269–273PubMedGoogle Scholar
  3. 3.
    Topliss JG, Sherlock MH, Reimann H, Konzelman LM, Shapiro EP, Petterson BW, Schneider H, Sperber N (1963) J Med Chem 6:122–127PubMedGoogle Scholar
  4. 4.
    Koch-Weser K (1976) N Engl J Med 294:1.271–1.274Google Scholar
  5. 5.
    Scriabine A (1980) Diazoxide. In: Scriabine A (Hrsg.) Pharmacology of antihypertensive drugs, Raven Press, New York, S. 397–406Google Scholar
  6. 6.
    McMahon FG (1984) Diazoxide (Hyperstat). In: McMahon FG (Hrsg.) Management of essential Hypertension: The new low dose era. Futura Publishing Company, Inc, Mount Kisco New York, S. 506–522Google Scholar
  7. 7.
    Küchel O, Fishman ML, Liddle GW, Michelakis A (1967) An Intern Med 67:791–799Google Scholar
  8. 8.
    Finnerty FA (1974) Am Heart J 88:265–268PubMedGoogle Scholar
  9. 9.
    Dollery CT, Pentecost BL, Samaan NA (1962) Lancet II:735–737Google Scholar
  10. 10.
    Fang P, Macdonald I, Laver M, Hua A, Kincaid-Smitth P (1974) Med J Aust 2:621–624PubMedGoogle Scholar
  11. 11.
    Wohl AJ, Hausier LM, Roth FE (1968) Life Sci 7:381–387PubMedGoogle Scholar
  12. 12.
    Maxwell GM (1971) Nature 233:250Google Scholar
  13. 13.
    Quast U, Cook NS (1989) J Pharmacol Exp Ther 250:261–271PubMedGoogle Scholar
  14. 14.
    Taylor J, Green RG (1970) Europ J Pharmacol 12:385–387Google Scholar
  15. 15.
    Thirlwell MP, Green RD (1972) Am Heart J 83:512–517Google Scholar
  16. 16.
    Lang RE (1985) Vasodilatantien. In: Ganten D, Ritz E (Hrsg.) Lehrbuch der Hypertonie, Schattauer-Verlag, Stuttgart New York, S. 677–685Google Scholar
  17. 17.
    Sellers EM, Koch-Weser J (1973) Ann NY Acad Sci 226:319–332PubMedGoogle Scholar
  18. 18.
    Dayton PG, Pruitt AW, Faraj BA, Israili ZH (1975) Drug Metab Dispos 3:226–229PubMedGoogle Scholar
  19. 19.
    Pearson RM (1977) Clin Pharmacokin 2:198–204Google Scholar
  20. 20.
    Pruitt AW, Faraj BA, Dayton PG (1974) J Pharmacol Exp Ther 188:248–256PubMedGoogle Scholar
  21. 21.
    Finnerty FA, Kakaviatos N, Tuckman J (1963) Circulation 28:203–208PubMedGoogle Scholar
  22. 22.
    Black J (1968) Ann NY Acad Sci 150:194–203PubMedGoogle Scholar
  23. 23.
    Morris JA, Arce JJ et al (1977) Obstet Gynecol 49:675–680PubMedGoogle Scholar
  24. 24.
    Kumar GK, Dastoor FC, Robayo JR, Razzaque MA (1976) J Amer Med Ass 235:275–276Google Scholar
  25. 25.
    Combs JT, Grunt JA, Brande IK (1967) Pediatrics 40:90–92PubMedGoogle Scholar
  26. 26.
    Wales JK, Wolff F (1967) Lancet I:53–54Google Scholar
  27. 27.
    Lockwood CH, Nicholls DM, Troop VL, Lewis JA (1963) Am J Med Sci 246:312–318PubMedGoogle Scholar
  28. 28.
    Okun R, Russel RP, Wilson WR (1963) Arch Intern Med 112:120–126Google Scholar
  29. 29.
    Milner RDG, Chouksey SK (1972) Arch Dis Child 47:537–543PubMedGoogle Scholar
  30. 30.
    Huysmans FTM, Thien TA, Koene RAP (1982) Am Heart J 103:395–400PubMedGoogle Scholar
  31. 31.
    Aynsley-Green A, Illig R (1975) Lancet II:658–659Google Scholar
  32. 32.
    Sellers EM, Koch-Weser J (1970) Clin Pharmacol Ther 11:524–529PubMedGoogle Scholar

GW

  1. 1.
    Angaben der Fa. PfizerGoogle Scholar

Gg

  1. 1.
    l.Noone P (1984) Drugs 27:548–578PubMedGoogle Scholar
  2. 2.
    Walther H, Meyer FP (1987) Klinische Pharmakologie antibakterieller Arzneimittel, Urban & Schwarzenberg, München Wien Baltimore, S.306Google Scholar
  3. 3.
    Rimoldi R, Curcio L, Sanfilippo A (1978) Pharmacokinetic study of dibekacin in humans. Current chemotherapy. Proc 10th Congr Chemother, Zürich 1977, Vol.2, S. 928Google Scholar
  4. 4.
    Bégué P, Safran C, Quiniou F, Michel P, Laget P (1984) Dev Pharmacol Ther 7 (Suppl. 1):116–120PubMedGoogle Scholar
  5. 5.
    Autret E, Borderon JC, Saliba E, Koki P, Ployet MJ, Gold F, Breteau M, Laugier J (1984) Dev Pharmacol Ther 7 (Suppl. 1):121–124PubMedGoogle Scholar
  6. 6.
    Furlanut M, D’Elia R, Granati B, Bruno R, Mainardi G, Tamassia V (1981) Pharmacokinetic study of dibekacin in full-term newborn infants. Current chemotherapy and immunotherapy. Proc 12th Congr Chemother, Florence 1981, Vol. 12, S. 813–814Google Scholar
  7. 7.
    Arancibia A, Chávez J, Ibarra R, Ruiz I, Icarte A, Thambo S, Chávez H (1987) Int J Clin Pharmacol Ther Toxicol 25:38–43PubMedGoogle Scholar
  8. 8.
    Campillo JA, Lanoa JM, Dominguez-Gil A, Rubio F, Martin A (1980) Eur J Clin Pharmacol 18:347–350PubMedGoogle Scholar

fm

  1. 1.
    Mar 29, S. 1.352Google Scholar

vB

  1. 1.
    Spezifikation der Fa. Luitpold-Pharma, MünchenGoogle Scholar

FB

  1. 1.
    Wallhäußer KH (1988) Praxis der Sterilisation Desinfektion-Konservierung, 4. Aufl., Thieme Verlag, Stuttgart New York, S. 514Google Scholar
  2. 2.
    Beilfuß W, Bücklers L, Eigener U, Harke HP, Sturm U (1987) Phenole. In: Kramer A, Weuffen W, Krasilnikow AP, Gröschel D, Bulka E, Rehn D (Hrsg.) Handbuch der Antiseptik, Bd.II/3 Antibakterielle, antifungielle und antivirale Antiseptik-ausgewählte Wirkstoffe, Volk und Gesundheit, Berlin, S.292–293Google Scholar
  3. 3.
    Kramer A, Zbinden G, Stephan U, Koch St, Koch D, Junghans A (1985) Akute Toxizität von Antiseptika. In: Kramer A, Berencsi G, Weuffen W (Hrsg.) Handbuch der Antiseptik, Bd. I/5, Toxische und allergische Nebenwirkungen von Antiseptika, Volk und Gesundheit, Berlin, S. 113–210Google Scholar
  4. 4.
    Beilfuß W, Bücklers L, Eigener U, Harke HP, Sturm U (1987) Phenole. In: Kramer A, Weuffen W, Krasilnikow AP, Gröschel D, Bulka E, Rehn D (Hrsg.) Handbuch der Antiseptik, Bd.II/3, Antibakterielle, antifungielle und antivirale Antiseptik-ausgewählte Wirkstoffe, Volk und Gesundheit, Berlin, S. 320Google Scholar

ak

  1. 1.
    Todd A, Sorkin EM (1988) Drugs 35:244–285PubMedGoogle Scholar
  2. 2.
    Skoutakis VA, Carter CA, Mickle TR, Smith VH, Arkin CR, Alissandratos J, Petty DE (1988) Drug Intell Clin Pharm 22:850–859PubMedGoogle Scholar
  3. 3.
    Ku EC, Lee W, Kothari HV, Kimble EF, Liauw L, Tjan J (1985) Semin Arthritis Rheum 15 (Suppl 1):36–41PubMedGoogle Scholar
  4. 4.
    Ku EC, Lee W, Kothari HV, Scholer DW (1986) Am J Med 80 (Suppl4B):18–23PubMedGoogle Scholar
  5. 5.
    Vane JR (1987) Drugs 33 (Suppl1): 18–27PubMedGoogle Scholar
  6. 6.
    Brogden RN, Heel RC, Pakes GE, Speight TM, Avery GS(1980) Drugs 20:24–48PubMedGoogle Scholar
  7. 7.
    Burkhardt D, Ghosh P (1987) Semin Arthritis Rheum 17(Suppll):3–34PubMedGoogle Scholar
  8. 8.
    Martel-Pelletier J, Pelletier JP, Cloutier JM, Howell DS, Ghandur-Mnaymneh L, Woessner JF (1984) Arthritis Rheum 27:304–312Google Scholar
  9. 9.
    Woessner JF, Seize MG (1984) J Biol Chem 259:3.633–3.638Google Scholar
  10. 10.
    Walton EA, Upfold LI, Stephens RW, Ghosh P, Taylor TKF (1981) Semin Arthritis Rheum 11:73–74Google Scholar
  11. 11.
    Kruze D, Fehr K, Menninger H, Böni A (1976) Z Rheumatol 35:337–346PubMedGoogle Scholar
  12. 12.
    Minta JO, Williams MD (1985) J Rheumatol 12:751–757PubMedGoogle Scholar
  13. 13.
    Kalbhen DA (1984) Biochemically induced osteoarthritis in the chicken and rat. In: Munthe E, Bjelle A (Hrsg.) Effects of drugs on osteoarthritis, Huber-Verlag, Bern Stuttgart Vienna, S. 48–68Google Scholar
  14. 14.
    Hoedt-Schmidt S, Scheid A, Kalbhen DA (1989) Arzneim Forsch 39:1.212–1.219Google Scholar
  15. 15.
    McKenzie LS, Horsburgh BA, Ghosh P, Taylor TKF (1977) Ann Rheum Dis 36:369–373PubMedGoogle Scholar
  16. 16.
    John VA (1979) Rheumatol Rehabil (Suppl2):22–35Google Scholar
  17. 17.
    Kendall MJ, Thornhill DP, Willis JV (1979) Rheumatol Rehabil (Suppl2):38–45Google Scholar
  18. 18.
    Riess W, Stierlin H, Degen P, Faigle JW, Gérardin A, Moppert J, Sallmann A, Schmid K, Schweizer A, Theobald W, Wagner J (1978) Scand J Rheumatol 22 (Suppl):17–29Google Scholar
  19. 19.
    Morimoto K, Iwamoto Y, Katashima T, Takeeda T, Nakamoto Y, Morisaka K (1985) Pharm Res 4:166–170Google Scholar
  20. 20.
    Willis JV, Kendall MJ, Jack DB (1981) Eur J Clin Pharmacol 19:33–37PubMedGoogle Scholar
  21. 21.
  22. 22.
    Riess W, Schmid K, Botta L, Kobayashi K, Moppert J, Schneider W, Sioufi A, Strusberg A, Tomasi M (1986) Arzneim Forsch 36:1.092–1.096Google Scholar
  23. 23.
    Willis JV, Kendall MJ, Flinn RM, Thornhill DP, Welling PG (1979) Eur J Clin Pharmacol 16:405–410PubMedGoogle Scholar
  24. 24.
    Willis JV, Kendall MJ, Jack DB (1980) Eur J Clin Pharmacol 18:415–418PubMedGoogle Scholar
  25. 25.
    Chamouard JM, Barce J, Urien S, Houin G, Tillement JP (1985) Biochem Pharmacol 34:1.675–1.700Google Scholar
  26. 26.
    Brune K, Dietzel K, Nürnberg B, Schneider HT (1987) Scand J Rheumatol 65 (Suppl): 135–140Google Scholar
  27. 27.
    Benson MD, Aldo-Benson M, Brandt KD (1985) Semin Arthritis Rheum 15 (Suppl 1):65–67PubMedGoogle Scholar
  28. 28.
    Stierlin H, Faigle JW, Colombi A (1978) Scand J Rheumatol 22 (Suppl) :30–35Google Scholar
  29. 29.
    Zimmerer J, Tittor W, Degen P (1982) Fortschr Med 100:683–688Google Scholar
  30. 30.
    Willis JV, Kendall MJ (1978) Scand J Rheumatol 22 (Suppl):36–41Google Scholar
  31. 31.
    Borghi C, Corno C, Palummeri E, Giorgi D (1986) Acta Pharmacol Toxicol 59 (Suppl5):101Google Scholar
  32. 32.
    Rainsford KD (1984) Trends Pharmacol Sci 5:156–159Google Scholar
  33. 33.
    O’Brien WM, Bagdy GF (1985) J Rheumatol 12:13–20, 347–353, 562–567, 785–790PubMedGoogle Scholar
  34. 34.
    Rainsford KD, Velo GP (Hrsg.) (1987) Side effects of anti-inflammatory drugs, Bd. I und II, MTP Press, LancasterGoogle Scholar
  35. 35.
    Rainsford KD (1988) J Rheumatol 15 (Suppl 17):63–70Google Scholar
  36. 36.
    Small RE (1989) Clin Pharm 8:545–548PubMedGoogle Scholar
  37. 37.
    Fowler PD (1979) Rheumatol Rehabil 2:60–68PubMedGoogle Scholar
  38. 38.
    Koopmans PP, Thien T, Gribnau FWJ (1987) Eur J Clin Pharmacol 31:553–557PubMedGoogle Scholar
  39. 39.
    Kuhlmann J (1982) Akt Rheumatol 7:38–43Google Scholar
  40. 40.
    Reimann IW, Frölich JC (1981) Clin Pharmacol Ther 30:348–352PubMedGoogle Scholar
  41. 41.
    Danion JM, Schmidt M, Welsch M, Imbs JL, Singer L (1987) Encephale 13:255–260PubMedGoogle Scholar
  42. 42.
    Gabrielli A, Leoni P, Danieli G (1987) Br Med J 294:776Google Scholar
  43. 43.
    Daly HM, Boyle J, Roberts CJC, Scott GL (1986) Lancet 1:557PubMedGoogle Scholar
  44. 44.
    Harima Y, Maekawa T, Miyauchi Y, Tsutsui T, Sakabe T, Koshiro A (1987) Intensive Care Med 13:361–362PubMedGoogle Scholar
  45. 45.
    Netter P, Lambert H, Larcan A, Godbillon J, Gosset J (1984) Eur J Clin Pharmacol 26:535–536PubMedGoogle Scholar

Hs/KA

  1. 1.
    Moffat AC (1986) Clarke’s Isolation and Identification of Drugs, 2. Aufl., The Pharmaceutical Press, London, S. 532–533Google Scholar
  2. 2.
    Schmitt C, Vandenheuvel WJA, Walker RW, Plazonnet B (1979) J Pharm Sci 68:381–383PubMedGoogle Scholar

WE

  1. 1.
    Novello FC, Bell SC, Abrams ELA, Ziegler J, Sprague JM (1960) J Org Chem 25:965–970Google Scholar
  2. 2.
    Boissier JR, Dumont C, Lesbros J (1966) Therapie 21:331–340PubMedGoogle Scholar
  3. 3.
    Mar 29, S.985Google Scholar

  1. 1.
    Gloxhuber C, Offe HA, Rauenbusch E, Scholtan W, Schmid J (1965) Arzneim Forsch 15:322–330Google Scholar
  2. 2.
    Knott T, Lange A, Volkening R (1965) Arzneim Forsch 15:331–340Google Scholar
  3. 3.
    Sutherland R, Croydon EAP, Rolinson GN (1970/4) Br Med J:455–460Google Scholar
  4. 4.
    Gravenkemper CF, Bennett JV, Brodie JL, Kirby WMM (1965) Arch Intern Med 116:340–345PubMedGoogle Scholar
  5. 5.
    Thijssen HHW, Mattie H (1976) Antimicrob Agents Chemother 10:441–446PubMedGoogle Scholar
  6. 6.
    Thijssen HHW (1980) J Chromatog 183:339–345Google Scholar
  7. 7.
    Thijssen HHW (1979) J Antibiotics 32:1.033–1.037Google Scholar
  8. 8.
    Cole M, Kenig MD, Hewitt VA (1973) Antimicrob Agents Chemother 3:463–468PubMedGoogle Scholar
  9. 9.
    Onorato JM, Axelrod JL (1978) Arch Intern Med 89:497–500Google Scholar
  10. 10.
    Deboever G (1987) Amer J Gastroenterol 82:483Google Scholar
  11. 11.
    Tauris P, Jorgensen NF, Petersen CM, Albertsen K (1985) Acta Med Scand 217:567–569PubMedGoogle Scholar
  12. 12.
    Nauta EH, Mattie H (1976) Clin Pharmacol Ther 19:98–108Google Scholar
  13. 13.
    Daten der Firma Bayer (s. Fachinfo zu Dichlor-Stapenor®)Google Scholar
  14. 14.
    Barza M, Weinstein L (1976) Clin Pharamcokinet 1:297–308Google Scholar
  15. 15.
    Olsson R, Wiholm BE, Sand C, Zettergren L, Hultcrantz R, Myrhed M (1992) J Hepatol 15:154–161PubMedGoogle Scholar

CW

  1. 1.
    Gloxhuber C, Offe HA, Rauenbusch E, Scholtan W, Schmid J (1965) Arzneim Forsch 15:322Google Scholar
  2. 2.
    Dibbern HW (1978) UV-und IR-Spektren wichtiger pharmazeutischer Stoffe, Editio Cantor, AulendorfGoogle Scholar
  3. 3.
    MuraiY, Nakagawa T, Okumura K, Uno T (1984) Chem Pharm Bull 32:3277–3280Google Scholar

GU

  1. 1.
    Link KP (1959) Circulation 19:97–109PubMedGoogle Scholar
  2. 2.
    Suttie JW (1987) Adv Exp Med Biol 214:3–16PubMedGoogle Scholar
  3. 3.
    Preusch PC, Smalley DM (1990) Free Radic Res Commun 8:401–415PubMedGoogle Scholar
  4. 4.
    Myszka DG, Swenson RP (1991) J Biol Chem 266:4.789–4.797Google Scholar
  5. 5.
    Liska DJ, Suttie JW (1988) Biochemistry 27:8.636–8.641Google Scholar
  6. 6.
    Rockwell S, Keyes SR, Sartorelli AC (1989) Cancer Chemother Pharmacol 24:349–353PubMedGoogle Scholar
  7. 7.
    Sartorelli AC (1988) Cancer Res 48:775–778PubMedGoogle Scholar
  8. 8.
    Mar 29, Anticoagulants, S. 338–349Google Scholar
  9. 9.
    Otagiri M, Miyoshi T, Yamamichi R, Maruyama T, Perrin JH (1991) Biochem Pharmacol 42:729–733PubMedGoogle Scholar
  10. 10.
    Majerus PW, Broze GJ, Miletich JP, Tollefsen DM (1990) Anticoagulant, Thrombolytic, and Antiplatelet Drugs. In: Goodman-Gilman A, Rall W, Nies AS, Tay lor P (Hrsg.) The Pharmacological Basis of Theapeutics, 8. Aufl., Pergamon Press, New York, S. 1.311–1.331Google Scholar
  11. 11.
    American College of Chest Physicians and the National Heart. Lung, Blood Institute. National Conference on antithrombotic therapy (1986) Chest 89 Suppl:1s-106sGoogle Scholar
  12. 12.
    Arfvidsson B, Lundgren F, Drott C, Schersten T, Lundholm K (1990) Am J Surg 159:556–560PubMedGoogle Scholar
  13. 13.
    Kretschmer G, Wenzl E, Huk I, Polterauer P, Ehringer H, Minar E, Schemper M (1987) Wien Klin Wochenschr 99:591–595PubMedGoogle Scholar
  14. 14.
    Levine MN, Hirsh J (1986) Semin Thromb Hemost 12:39–57PubMedGoogle Scholar
  15. 15.
    Griffin JP, D’Arcy PF, Speirs CJ (1988) Anticoagulants. In: A Manual of Adverse Drug Interactions. 4. Aufl., John Wright, London, S. 137–158Google Scholar

EH

  1. 1.
    Bohlmann F, Herbst P, Arndt C, Schönowsky H, Gleinig H (1961) Chem Ber 94:3193–3212Google Scholar
  2. 2.
    Bohlmann F, Mönch H, Blaskiewicz P (1967) Chem Ber 100:611–617PubMedGoogle Scholar
  3. 3.
    Breinlich J, Scharnagel K (1968) Arzneim Forsch 18:429–431Google Scholar
  4. 4.
    Mitteilung der Asta Pharma (1991) FrankfurtGoogle Scholar

  1. 1.
    Bohlmann F, Herbst P, Arndt C, Schönowski H, Gleinig H (1961) Chem Ber 94:3193–3212Google Scholar
  2. 2.
    Bohlmann F, Mönch H, Blaskiewicz P (1967) Chem Ber 100:611–617PubMedGoogle Scholar
  3. 3.
    Mitteilung der Asta Pharma (1991), FrankfurtGoogle Scholar

  1. 1.
    Tilford M et al (1947) J Am Chem Soc 69:2903–2905Google Scholar
  2. 2.
    Kopp M, Tchouber B (1952) Bull Soc Chim France 1952:84–89Google Scholar
  3. 3.
    Yoshida Y, Iwashige M (1955) Pharm Bull (Tokyo) 3:417–425Google Scholar
  4. 4.
    Verrier M (1959) Bull Soc Chim France 1959:1863–1865Google Scholar
  5. 5.
    Mills III T, Roberson J C (1987) Instrumental Data for Drug Analysis, 2. Aufl., Bd. 1 Elsevier, New York-Amsterdam-London, S.654–655Google Scholar
  6. 6.
    Meffin P J, Moore G, Thomas J (1973) Anal Chem 45:1964–1966PubMedGoogle Scholar

Gb

  1. 1.
    Kilbinger H, Stein A (1988) B J Pharmacol 94:1.270–1.274Google Scholar
  2. 2.
    Nilvebrant L, Sparf B (1986) Eur J Pharmacol 123:133–143PubMedGoogle Scholar
  3. 3.
    Freedman SB, Beer MS, Harley EA (1988) Eur J Pharmacol 156:133–142PubMedGoogle Scholar
  4. 4.
    Delmendo RE, Michel AD, Whiting RL (1989) Br J Pharmacol 96:457–464PubMedGoogle Scholar
  5. 5.
    Anticholinergics/Spasmodics. In: Drug Information for the health care professional (USPDI) (1990) Bd. IA, The United States Pharmacopeial Convention, Rockville Maryland (USA), S. 312–332Google Scholar
  6. 6.
    Smith JM (1980) J Cln Psychiatry 41:351–354Google Scholar
  7. 7.
    Greenblatt DJ, Shrader RI (1973) N Engl J Med 288:1.215–1.219Google Scholar
  8. 8.
    Mar 29, S. 530Google Scholar
  9. 9.
    Noronha-Blob L, Lowe VC, Peterson JS, Hanson RC (1989) J Pharmac Exp Ther 249:843–851Google Scholar

RJ

  1. 1.
    Dibbern HW, Wirlitzki E (1978) UV-und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Editio Cantor, AulendorfGoogle Scholar
  2. 2.
    Moffat AC, Jackson JV, Moss MS, Widdop B (1986) Clarke’s Isolation and Identification of Drugs, The Pharmaceutical Press, LondonGoogle Scholar
  3. 3.
    Mills III T, Roberson IC (1987) Instrumental Data for Drug Analysis, 2. Aufl., Bd. 1, Elsevier, New York Amsterdam LondonGoogle Scholar
  4. 4.
    SchmidtF (1968) Arch Pharm (Weinheim) 301:940–942Google Scholar
  5. 5.
    MeffinPJ, Moore G, Thomas J (1973) Anal Chem 45:1964–1966PubMedGoogle Scholar
  6. 6.
    Oza SP, Dave MP, Vakil HN (1991) Indian Drugs 28:198–200Google Scholar
  7. 7.
    Shingbal DM, Barad UG (1985) Indian Drugs 22:609–610Google Scholar
  8. 8.
    Raggi MA, Cavrini V, Di Pietra AM (1985) J Pharm Biomed Anal 3:287–291PubMedGoogle Scholar
  9. 9.
    Hanna GM (1984) J Assoc Off Anal Chem 67:222–224PubMedGoogle Scholar
  10. 10.
    Jane I, Mc Kinnon A, Flanagan RJ (1985) J Chromatogr 323:191–225PubMedGoogle Scholar

Gb

  1. 1.
    Hübner M, Ponsold K, Oettel M, Freund R (1980) Arzneimittelforschung/Drug Res 30:401–406Google Scholar
  2. 2.
    OettelM,Kurischko A (1980) Contraception 21:61–75Google Scholar
  3. 3.
    Oettel M, Komor A, Goncharov NP, Kurischko A, Strecke J, Schubert K (1980) Contraception 21:537–549PubMedGoogle Scholar
  4. 4.
    Freund H, Hesse G, Oettel M (1980) Contraception 21:641–650PubMedGoogle Scholar
  5. 5.
    Majumdar SS, Chaudhary J, Sharma RK, Das RP (1990) Contraception 41:641–649PubMedGoogle Scholar
  6. 6.
    Hobe G, Hillesheim HG, Schumann W, Ritter P, Claussen C (1983) Exper Clin Endocrinol 81:158–167Google Scholar
  7. 7.
    Hobe G, Klinger G, Reddersen G, Erdmann A, Klinger G (1986) Pharmazie 41:772–774PubMedGoogle Scholar
  8. 8.
    Klinger G, Carol W (1985) Wiss. Beiträge der Friedrich-Schiller-Universität, Jena, IV. Jenaer Symp. Horm. Kontrazeption, S. 125–141Google Scholar
  9. 9.
    Klinger G, Carol W (1989) Wiss. Beiträge der Friedrich-Schiller-Universität, Jena, IV. Jenaer Symp. Horm. Kontrazeption, S. 30–51Google Scholar
  10. 10.
    Klinger G (1989) Wiss. Beiträge der Friedrich-Schiller-Universität, Jena, IV Jenaer Symp. Horm. Kontrazeption, S. 141–144Google Scholar
  11. 11.
    Hillesheim HG, Hoffmann H (1983) Exper Clin Endocrinol 81:175–178Google Scholar
  12. 12.
    Hoffmann H, Hillesheim HG, Güttner J, Stade K, Merbt EM, Holle K (1983) Exper Clin Endocrinol 81:179–196Google Scholar

OM

  1. 1.
    Clarke CGC (Hrsg.) (1969/1975) Isolation and Identification of Drugs, Pharmaceutical Press, LondonGoogle Scholar
  2. 2.
    Moffat AC, Jackson JV, Moss MS, Widdop B (1986) Clarke’s Isolation and Identification of Drugs, Pharmaceutical Press, LondonGoogle Scholar

PA

  1. 1.
    Testa E, Fontanella L, Christiani G, Gallo G (1959), J Org Chem 24:1928–1936Google Scholar

NE

  1. 1.
    Mar 29, S.531Google Scholar

vB

  1. 1.
    Charpentier P (Rhone Poulenc) Fr Pat 986, 718 (ert. 1951); CA50:7880d (1956)Google Scholar
  2. 2.
    Clarke CGC (1969/1975), Isolation and Identification of Drugs, Pharmaceutical Press, LondonGoogle Scholar
  3. 3.
    Moffat AC, Jackson JV, Moss MS, Widdop B (1986) Clarke’s Isolation and Identification of Drugs, Pharmaceutical Press, LondonGoogle Scholar

PA

  1. 1.
    Maxim R (1929) Bull Soc Chim Romania 11:29–32Google Scholar
  2. 2.
    Mc Cabe ET et al. (1954) J Org Chem 19:493–496Google Scholar
  3. 3.
    Moffat AC (hrsg.) (1986) Clarke’s Isolation and Identification of Drugs, Pharmaceutical Press, LondonGoogle Scholar
  4. 4.
    eigene MessungenGoogle Scholar
  5. 5.
    Wu A et al. (1979) J High Resolut Chromat Commun 2:558–562Google Scholar

QO

  1. 1.
    Kushner S et al (1948) J Org Chem 13:144PubMedGoogle Scholar

sb/Ni

  1. 1.
    Denham DA (1986) Nematode infections in man, extraintestinal infections. In: Campbell WC, Rew RS (Eds.) Chemotherapy of parasitic diseases, Plenum Press, New York London, p. 277–286Google Scholar
  2. 2.
    Bossche H van den (1981) Ann Soc Belg Med Trop 61:287–296PubMedGoogle Scholar
  3. 3.
    Hawking F, Sewell P, Thruston JP (1950) Br J Pharmacol 5:217–238Google Scholar
  4. 4.
    Mehlhorn H, Steinhorst U, Lindenblatt B, Grüntzig J, Thomas H (1981) Zentralbl Bakteriol Hyg I Abb Orig A 251:263–272Google Scholar
  5. 5.
    Kobayashi J, Matsuda H, Fujita K, Sakai T, Shinoda K (1969) Jpn J Parasitol 18:563–574Google Scholar
  6. 6.
    Piessens WF, Beldekas M (1979) Nature 282:845–847PubMedGoogle Scholar
  7. 7.
    Beckenridge A, Awadzi K, Back DJ, Edwards G, Gilles H, Orme M, Ward S (1984) Biochem Soc Trans 12:90–95Google Scholar
  8. 8.
    Roberson EL (1988) Chemotherapy of parasitic diseases. In: Booth NH, McDonald LE (Eds.) Veterinary Pharmacology and Therapeutics, Iowa State University Press, Ames, S. 877–968Google Scholar
  9. 9.
    Adam D, Christ W (1987) Antiinfektiöse Therapie. In: Forth W, Henschler D, Rummel W (Hrsg.) Allgemeine und spezielle Pharmakologie und Toxikologie, Wissenschaftsverlag, Mannheim Wien Zürich, S. 580–715Google Scholar
  10. 10.
    Rote Liste (1989)Google Scholar
  11. 11.
    Andrews P (1985) Anthelmintics, Ullmanns’s encyclopedia of industrial chemistry, VCH Verlagsgesellschaft 2:329–342Google Scholar

ha

  1. 1.
    Baveja SK, Rao KVR (1981) Analyst 106:726Google Scholar
  2. 2.
    Allen GD, Goodchild TH, Weatherly BC (1979) J Chromatogr 164:521PubMedGoogle Scholar
  3. 3.
    BulbuleMV, Kasture A, Wadodkar SG (1981) Indian Drugs 19:27, zit. nach CA (1982) 96:129.876bGoogle Scholar

sb/Ni

  1. 1.
    Handbook of Pharmaceutical Excipients (1986), American Pharmaceutical Association, Washington, USA, S.105Google Scholar

BK

  1. 1.
    Korn 2, S. 1.442Google Scholar

Eb/kp

  1. 1.
    Westerholm B (1980) Pharmac Ther 10:337–349Google Scholar
  2. 2.
    Beral V,Colwell L(1980) Br Med J 281:1.098–1.106Google Scholar
  3. 3.
    Fachinformation Merbentul, Merrel Dow Pharma GmbH, Juni 1990Google Scholar
  4. 4.
    Haspels AA (1972) IPFF med Bull 6:3–7Google Scholar
  5. 5.
    Oettel M (1975) Pharmazie 30:42–47PubMedGoogle Scholar
  6. 6.
    Konturri M, Sotaniemi E, Ahlqvist J (1972) Scand J Urol Nephrol 6:289–294Google Scholar
  7. 7.
    Herbst AL, Cole P, Colton T, Robboy SJ, Scully RE (1977) Am J Obstet Gynec 119:713–720Google Scholar
  8. 8.
    Oelschläger H, Rothley D, Dunzendorfer U (1984) Arzneim Forsch/Drug Res 34:1.333–1.336Google Scholar
  9. 9.
    Mar 29, S. 1.433–1.435Google Scholar
  10. 10.
    Brandes LJ, Hermonat MW (1983) Cancer Res 43:2.831–2.835Google Scholar
  11. 11.
    Griffiths K, Peeling WB, Harper ME, D Avies P, PierrePoint CG (1981) Prostatic cancer: rational for hormonal therapy. in: Stoll BA (Hrsg.) Hormonal management of endocrine-related cancer, Lloyd-Luke, London, S. 131–147Google Scholar
  12. 12.
    Schneider MR, Humm A, Graf AH (1990) J Cancer Res Clin Oncol 116:159–167PubMedGoogle Scholar
  13. 13.
    Forth W, Henschler D, Rummel W (1987) Allgemeine und spezielle Pharmakologie und Toxikologie, 5. Aufl., Bibliographisches Institut & FA. Brockhaus AG, S.416Google Scholar
  14. 14.
    Oettel M (1971) Mh Vet med 26:670–672Google Scholar
  15. 15.
    Vangils APG, Tham RTO, Falke THM, Peters AAW (1990) Am J Roentgenol 153:1.235–1.238Google Scholar
  16. 16.
    Sharp GB, Cole P (1990) Am J Obstet Gynecol 162:994–999PubMedGoogle Scholar
  17. 17.
    Thorp JM, Fowler WC, Donehoo R, Sawicki C, Bowes WA (1990) Obstet Gynecol 76:828–832PubMedGoogle Scholar
  18. 18.
    Liehr JG (1990) Mut Res 238:269–276Google Scholar
  19. 19.
    Hailing A, Forsberg JG (1990) J Reprod Fert 88:399–405Google Scholar
  20. 20.
    Sharp GB, Cole P (1990) Am J Obstet Gynecol 162:994–1.001PubMedGoogle Scholar
  21. 21.
    De Sario A, Vagnarelli P, De Carli L (1990) Mut Res 243:127–131Google Scholar
  22. 22.
    Walker BE (1990) J Natl Cancer Inst 82:50–54PubMedGoogle Scholar
  23. 23.
    Bergsjo P, Brodtkorb C (1974) Acta Obstet Gynec Scand 53:77–80PubMedGoogle Scholar

OM

  1. 1.
    Oda T, Murai T, Sato Y (1988) Chem Parm Bull 36:1534–1539Google Scholar
  2. 2.
    Inamori Y (1985) Chem Pharm Bull 33:4478–4483PubMedGoogle Scholar
  3. 3.
    McLachlan JA (1982) Cancer Res 42:3040–3045PubMedGoogle Scholar

JM/Mo/Wc

  1. 1.
    Kuznetsov SG, El’tsov AV (1962) Zh Obshch Khim 32:511–515, zit. nach CA (1963) 58:470bGoogle Scholar
  2. 2.
    Hoffmann C (1965) Fr M 3406, zit. nach CA (1965) 63:13163aGoogle Scholar

gs

  1. 1.
    Hoffmann C (1965) Fr M 3406, CA (1965) 63:1.3163aGoogle Scholar
  2. 2.
    Kuznetsov SG, El’tsov AV (1962) Zh Obshch Khim 32:511–515, CA (1963) 58:470bGoogle Scholar
  3. 1.
    van Wijngaarden I, Soujdin W (1972) Arzneim-Forsch 22:513–516Google Scholar
  4. 2.
    Eisner M, Ferrat E (1976) Arzneim-Forsch 26:1.642–1.644Google Scholar
  5. 3.
    van Nueten JM, Janssen PAJ (1972) Arzneim-Forsch 22:518–520Google Scholar
  6. 4.
    Bianchi C, Goi A (1977) Arzneim-Forsch 27:1.040–1.043Google Scholar
  7. 5.
    Niemegeers CJE, Lenaerts FM, Janssen PAJ (1972) Arzneim-Forsch 22:516–518Google Scholar
  8. 6.
    Stransky M, Schwarzenbach FH (1979) Therap Umschau 36:267–270Google Scholar
  9. 7.
    Schenker H (1976) Schweiz med Wschr 106:1.650–1.653Google Scholar
  10. 8.
    Rubens R, Verhaegen H, Brugmans J, Schuermans V (1972) Arzneim-Forsch 22:513–516Google Scholar
  11. 9.
    Awouters F, Niemegeers CJE, Janssen PAJ (1983) Ann Rev Pharmacol Toxicol 23:279–301Google Scholar
  12. 10.
    Mar 29, S. 1.087Google Scholar
  13. 11.
    Heykants J, Brugmans J, Verhaegen H (1972) Arzneim-Forsch 22:529–531Google Scholar
  14. 12.
    Heykants J, Lewi PJ, Janssen PAJ (1972) Arzneim-Forsch 22:520–526Google Scholar

PK

  1. 1.
    Janel, Mc Kinnon A, Flanagan RJ (1985) J Chromatogr 323(2):191–225Google Scholar

WP

  1. 1.
    Mar29,S.662Google Scholar

vB

  1. 1.
    Barquin A, Jose J (1982), S.31Google Scholar
  2. 2.
    Mitteilungen der Fa. Upjohn, 6148 HeppenheimGoogle Scholar
  3. 3.
    Van de Vaart FY, Hultshoff A, Indemans AWM (1983) Pharm Weekbl Sci Ed 5:113–118Google Scholar
  4. 4.
    Heintz B, Kalusa R (1978) Dtsch Apoth Ztg 118:1.000–1.006Google Scholar
  5. 5.
    Kirschmann Y, Poet R, Bush K, Petrie G (1980) J Chromatogr 190:481–485Google Scholar
  6. 6.
    Shaw MC, Van der Wielen AJ (1984) J Pharm Sci 73:1.606–1.608Google Scholar

As

  1. 1.
    Miller JA, Munro DD (1980) Drugs 19:119–134PubMedGoogle Scholar
  2. 2.
    Goa KL (1988) Drugs 36 S5:51–61PubMedGoogle Scholar
  3. 3.
    Pichl J, Schell H (1990) Z Hautkrankheiten 65:527–533Google Scholar
  4. 4.
    Tronnier H (1987) Aerztl Kosmetol 17:458–482Google Scholar
  5. 5.
    Leiferman KM, Schroeter A, Kirschner MK, Speisberg TC (1983) J Invest Dermatol 81:355–360PubMedGoogle Scholar
  6. 6.
    Munck A, Mendel DB, Smith LI, Orti E (1990) Am Rev Respir Dis 141 S2:S2–10PubMedGoogle Scholar
  7. 7.
    Bowen DL, Fauci AS (1988) Adrenal corticosteroids. In: Gallin JI, Goldstein IM, Snyderman R (Hrsg.) Inflammation: basic principles and clinical correlates, Raven Press, New York, S. 877–896Google Scholar
  8. 8.
    Bluefarb SM, Howard FJ, Leibsohn E, Schlagel CA (1976) J Int Med Res 454Google Scholar
  9. 9.
    Turi JS, Danielson D, Wolterson JW (1979) J Pharm Sci 68:375Google Scholar
  10. 10.
    Niedner R (1989) Dtsch Aerztebl 86:1798–1803Google Scholar
  11. 11.
    Teller E (1983) Dtsch Dermatol 31:56–62Google Scholar
  12. 12.
    Eichenberger-de Beer H (1982) Schweiz Rundsch Med 32:1266–1268Google Scholar
  13. 13.
    Chan MM, Hall JH, Kirschenbaum MB, Klein L, Leibsohn E, Peng VT, Roth H, Savin RC, Schlagel CA (1977) Curr Ther Res 22:297Google Scholar
  14. 14.
    Squires JP, Masson EL (1981) J Int Med Res 9:79PubMedGoogle Scholar

GM

  1. 1.
    Kapp JF, Koch H, Casals-Stenzel J, Töpert M, Gerhards E (1976) Arzneim Forsch 26:1.463–1.475Google Scholar
  2. 2.
    Reckers R, Wendt H (1976) Arzneim Forsch 26:1.499–1.504Google Scholar
  3. 3.
    Miller JA, Munro DD (1990) Drugs 19:119–134Google Scholar
  4. 4.
    Goa KL (1988) Drugs 36 S5:51–61PubMedGoogle Scholar
  5. 5.
    Pichl J, Schell H (1990) Z Hautkrankheiten 65:527–533Google Scholar
  6. 6.
    Tronnier H (1987) Aerztl Kosmetol 17:458–482Google Scholar
  7. 7.
    Leiferman KM, Schroeter A, Kirschner MK, Speisberg TC (1983) J Invest Dermatol 81:355–360PubMedGoogle Scholar
  8. 8.
    Munck A, Mendel DB, Smith LI, Orti E (1990) Am Rev Respir Dis 141 S2:S2–10PubMedGoogle Scholar
  9. 9.
    Lavker RM, Schechter NM, Lazarus GS (1986) Br J Dermatol 115 S31:101–107PubMedGoogle Scholar
  10. 10.
    Hahn HL (1990) Wirkungsmechanismen der Glukokortikoide bei Asthma, bronchialer Entzündungsreaktion und Hyperreaktivität. In: Nolte D (Hrsg.) Glukokortikoide bei obstruktiven Atemwegserkrankungen, de Gruyter, Berlin New York, S. 23–56Google Scholar
  11. 11.
    Schleimer RP (1990) Am Rev Respir Dis 141 S2:59–69Google Scholar
  12. 12.
    Täuber U (1976) Arzneim Forsch 26:1.479–1.483Google Scholar
  13. 13.
    Täuber U (1983) Arzneim Forsch 33:1.503–1.507Google Scholar
  14. 14.
    Täuber U, Amin M, Fuchs P, Speck U (1976) Arzneim Forsch 26:1.492–1.494Google Scholar
  15. 15.
    Täuber U, Toda T (1976) Arzneim Forsch 26:1.484–1.487Google Scholar
  16. 16.
    Mützel W (1976) Arzneim Forsch 26:1.487–1.492Google Scholar
  17. 17.
    Langen ML (1979) Clinical Ther 2:124–133Google Scholar
  18. 18.
    Kesczkes K, Teasdale P, Wiseman RA, Mugglestone CJM (1978) Br J Dermatol 99:417–420Google Scholar
  19. 19.
    Reckers R, Wendt H (1976) Arzneim Forsch 26:1.504–1.509Google Scholar
  20. 20.
    Takeda K, Arase S, Takahashi S (1988) Drugs 36 S5:15–23PubMedGoogle Scholar

GM

  1. 1.
    Cotton M, Hux R in Florey 14:491Google Scholar
  2. 2.
    Ruyle, William V, Sarett, Lewis H: Matzuk, Alexander S; African 67 01, 021Google Scholar

Rh

  1. 1.
    Stone CA, Van Arman CG, Lotti VJ, Minsker DH, Risley EA, Bagdon WZ, Bokelman DL, Zensen RD, Mendlowski B, Tak CL, Peck HM, Zwickey RE, McKinney SE (1977) Br J Clin Pharmacol 4:19S–29SPubMedGoogle Scholar
  2. 2.
    Forbes JA, Calderazzo JP, Bowser MW, Foor VM, Shackleford RW, Beaver WT (1982) Z Clin Pharmacol 22:89–96Google Scholar
  3. 3.
    Honig WJ, Van Ochten J (1986) J Clin Pharmacol 26:700–705PubMedGoogle Scholar
  4. 4.
    DeVroey P (1978) Curr Med Res Opin 5:544–547Google Scholar
  5. 5.
    Brodgen RN, Heel RC, Pakes GE, Speight TM, Avery GS (1980) Drugs 19:84–106Google Scholar
  6. 6.
    Majerus PW, Stanford N (1977) Br J Clin Pharmacol 4:15S–18SPubMedGoogle Scholar
  7. 7.
    Forrest M, Brooks PM (1988) Basilliére’s Clinical Rheumatology 2:275–294Google Scholar
  8. 8.
    Schultz P, Perrier CV, Ferber-Perret F, Vanden Heuvel WZA, Steelman SL (1979) J Int Med Res 7:61–68Google Scholar
  9. 9.
    Smit Sibinga CT, Tempero KF, Breault GO (1976) Effect of flunisal, a novel salicylate, on platelet function and blood coagulation. In: Grayson Z, Zingg W (ed.) Microcirculation. Vol.1, Plenum Press, London, New York, S. 211–212Google Scholar
  10. 10.
    Smit Sibinga CT (1977) Br J Clin Pharmacol 4:37S–38SGoogle Scholar
  11. 11.
    Green D, Davies RO, Holmes GI, Kohl H, Lee RB, Reynolds N, Schmid FR, Ts’ao C (1981) Clin Pharmacol Ther 30:378–384PubMedGoogle Scholar
  12. 12.
    Green D, Davies RO, Holmes GI, Kohl H, Lee RB, Reynolds N, Schmid FR, Ts’ao C (1983) Pharmacotherapy 3:65S–69SPubMedGoogle Scholar
  13. 13.
    Tempero KF, Cirillo VJ, Steelman SL (1977) Br J Clin Pharmacol 4:31 S-36SPubMedGoogle Scholar
  14. 14.
    Tempero KF, Cirillo VJ, Steelman SL (1978) The clinical pharmacology of diflunisal. In: Diflunisal in clinical practice. Proceedings of a special symposium at 14th Congress of Rheumatology, Futura Publishing, New York, S. 23–39Google Scholar
  15. 15.
    Dresse A, Gerard MK, Lays A, Tempero KF, Verhaest L(1978) Pharm Acta Helv 53:177–181PubMedGoogle Scholar
  16. 16.
    Nuernberg B, Koehler G, Brune K (1991) Clin Pharmacokin 20:81–89Google Scholar
  17. 17.
    Verbeeck R, Tjandramaga TB, Mullie A, Verbesselt R, DeSchepper PJ (1979) Br J Clin Pharmacol 7:519–522PubMedGoogle Scholar
  18. 18.
    Tobert JA, DeSchepper P, Tjandramaga TB, Mullie A, Buntiux AP, Meisinger MAP, Huber PB, Hall TLP, Yeh KC (1981) Clin Pharmacol Ther 30:385–389PubMedGoogle Scholar
  19. 19.
    Verbeeck R, Tjandramaga TB, Mullie A, Verbesselt R, Verbeckmoes R, DeSchepper PJ (1979a) Br J Clin Pharmacol 7:273–282PubMedGoogle Scholar
  20. 20.
    Tocco DJ, Breault GO, Zacchei AG, Steelman SL, Perrier CU (1975) Drug Metab Disposition 3:453–466Google Scholar
  21. 21.
    DeSchepper PJ, Mullie A, Tjandramaga TB, Verbeeck R, Verbeckmoes R (1977) Br J Clin Pharmacol 4:645PGoogle Scholar
  22. 22.
    Steelman SL, Breault GO, Tocco DJ, Besselaar GH, Tempero KF, Lutterbeck PM, Perrier CU, Gribman FW, Hinseimann M (1975) Clin Pharmacol Ther 17: 245Google Scholar
  23. 23.
    Buck ME, Paintin DB (1978) Curr Med Res Opin 5:548–549PubMedGoogle Scholar
  24. 24.
    Goutallier D, Dedeyre J, Bock F (1978) A doubleblind study comparing the efficacy and safety of diflunisal and of glafenine in the relief of postoperative pain. In: Diflunisal in clinical practice. Proceedings of a special symposium at 14th Congress of Rheumatology, Futura Publishing, New York, S. 119–129Google Scholar
  25. 25.
    Ackermann K, Braun HD (1978) Diflunisal in the treatment of postoperative pain in oral surgery. In: Diflunisal in clinical practice. Proceedings of a special symposium at 14th Congress of Rheumatology, Futura Publishing, New York, S. 143–148Google Scholar
  26. 26.
    Peterson JK (1979) Int J Oral Surgery 8:102–113Google Scholar
  27. 27.
    Peterson JK (1978) Diflunisal in the treatment of postoperative pain in oral surgery. In: Diflunisal in clinical practice. Proceedings of a special symposium at 14th Congress of Rheumatology, Futura Publishing, New York, S. 133–142Google Scholar
  28. 28.
    Jaegemann V (1979) Diflunisal compared with placebo in acute untreated lumbago. In: Diflunisal. Royal Society of Medicine, International Congress and Symposium Series, No 6, Academic Press/Royal Society of Medicine, London, S. 45–19Google Scholar
  29. 29.
    Cirillo VJ, Bahous I, Franchimont P, Baumgartner H, Van Gemert J, Lutterbeck PM, Hwang I, Tempero KF (1978) Clin Trials J 15:40–48Google Scholar
  30. 30.
    Bahous I, Lutterbeck PM, Tempero KF (1978) Clin Ther(SupplA)l:10–19Google Scholar
  31. 31.
    Lee P, Davis P, Prat A (1985) J Rheumatol 12:544–548PubMedGoogle Scholar
  32. 32.
    Poe TE, Limpert GH, Winkler GJ (1989) J Fam Pract 28:104–105PubMedGoogle Scholar
  33. 33.
    Huskisson EC (1979) Practitioner 222:415–418PubMedGoogle Scholar
  34. 34.
    McLean CA, Begley CG, Harris RA (1986) Aust NZ J Med 16:811–812Google Scholar
  35. 35.
    Rider JA (1983) Pharmacotherapy 3:61S–64SPubMedGoogle Scholar
  36. 36.
    O’Brien WM, Bagby GF (1985) J Rheumatol 12:785–790PubMedGoogle Scholar
  37. 37.
    Warren JS (1978) Br Med J 2:736–737PubMedGoogle Scholar
  38. 38.
    Chan LK, Winearls CG, Oliver DO, Dunnill MS (1980) Br Med J 1:84–85Google Scholar
  39. 39.
    Steelman SL, Cirillo VJ, Tempero KF (1978) Curr Med Res Opin 5:506–514PubMedGoogle Scholar
  40. 40.
    Serlin MJ, Mossman S, Sibeon RG, Breckenridge AM (1980) Clin Pharmacol Ther 28:493–498PubMedGoogle Scholar
  41. 41.
    Upadhayay HP, Gupta SK (1978) Br Med J 2:640Google Scholar

Me

  1. 1.
    Zeliha I, Türkan Y (1986) Planta Med 53:43–46Google Scholar
  2. 2.
    Kiliani H (1892) Arch Pharm 230:250Google Scholar
  3. 3.
    Rittel W, Hunger A, Reichstein T (1952) Helv Chim Acta 35:434Google Scholar

AG

  1. 1.
    Bloch R, Steimer C, Spach MO, Schwartz J (1978) Coeur Med Interne 17:403–409PubMedGoogle Scholar
  2. 2.
    Bloch R, Steimer C, Schwartz J (1981) Rev Med Interne 2:349–355PubMedGoogle Scholar
  3. 3.
    Chiche P, Baligadoo S, Lamelle P, Borgard JP (1976) Coeur Med Interne 15:249–262PubMedGoogle Scholar
  4. 4.
    Scholz H (1989) Herzinsuffizienz. In: Fülgraff G, Palm D (Hrsg.) Pharmakotherapie, Klinische Pharmakologie, 7. Aufl., Gustav Fischer Verlag, Stuttgart, S.42–57Google Scholar

  1. 1.
    Brown L, Cheung HTA, Thomas R, Watson TR, Nemorin JLE (1981) J Chem Soc Perkin Trans 1:1779–1781Google Scholar
  2. 2.
    Kedde DL (1947) Pharm Weekbl 82:741Google Scholar
  3. 3.
    Keller CC (1895) Ber Dtsch Pharm Ges 5:275Google Scholar
  4. 4.
    Kiliani H (1899) Arch Pharm 237:446Google Scholar

AG

  1. 1.
    Braunwald E, Bloodwell RD, Goldberg LJ (1961) J Clin Invest 40:52–60PubMedGoogle Scholar
  2. 2.
    Mason DT (1974) Ann Int Med 80:520–530PubMedGoogle Scholar
  3. 3.
    Covell JW, Braunwald E, Ross J Jr (1966) J Clin Invest 45:1.535–1.543Google Scholar
  4. 4.
    Bailey JC, Anderson GJ, Fisch C (1973) Am J Cardiol 32:202–208PubMedGoogle Scholar
  5. 5.
    Higgins CB, Vatner SF, Braunwald E (1973) Pharm Rev 25:119–155PubMedGoogle Scholar
  6. 6.
    Hordorf HJ, Spotnitz A, Mary-Rabine L, Edie RN, Rosen MR (1978) Circulation 57:223–229Google Scholar
  7. 7.
    Weidmann S (1974) Ann Rev Physiol 36:155–169Google Scholar
  8. 8.
    Ferguson DW, Berg WJ, Sanders JS, Roach PJ, Kempf JS, Kienzle MG (1989) Circulation 80:65–77PubMedGoogle Scholar
  9. 9.
    Haasis R, Larbig D (1975) Dtsch Med Wochenschr 100:1.768–1.773Google Scholar
  10. 10.
    Amelie JP, Storstein L, Heldaas O (1979) J Cardiovasc Pharmacol 1:529–540Google Scholar
  11. 11.
    Aronson JK (1983) Clin Sci 64:253–258PubMedGoogle Scholar
  12. 12.
    Scholz H (1984) J Am Coll Cardiol 4:389–397PubMedGoogle Scholar
  13. 13.
    Kim D, Cragoe EJ Jr, Smith TW (1987) Circ Res 60:185–193PubMedGoogle Scholar
  14. 14.
    Allen DG, Blinks JR (1978) Nature (London) 273:509–513Google Scholar
  15. 15.
    Eisner DA, Lederer WJ (1985) Am J Physiol 248:C189–C202PubMedGoogle Scholar
  16. 16.
    Fabiato A, Fabiato F (1975) J Physiol (London) 249:469–495Google Scholar
  17. 17.
    Smith TW, Butler VP Jr, Haber E (1982) N Engl J Med 307:1.357–1.362Google Scholar
  18. 18.
    Mulrow CD, Feussner JR, Velez R (1984) Ann Int Med 101:113–117PubMedGoogle Scholar
  19. 19.
    Parmly WW (1989) J Am Coll Cardiol 13:771–785Google Scholar
  20. 20.
    Chai CY, Hsu PL, Wana SC (1973) Neuropharmacol 12:1.187–1.193Google Scholar
  21. 21.
    Mooradian AD (1988) Clin Pharmacokinet 15:165–179PubMedGoogle Scholar
  22. 22.
    Belz GG,PfledererW (1975) Basic Res Cardiol 70:142PubMedGoogle Scholar
  23. 23.
    Kuemmerle HP (1989) Klinische Pharmakologie. Datenhandbuch für Klinik und Praxis, ecomed-verlagsgesellschaft mbH, Landsberg München ZürichGoogle Scholar

  1. 1.
    BAz, Nr. 22a vom 03.02.1988Google Scholar

GS

  1. 1.
    Brown L, Cheung HTA, Thomas R, Watson TR, Nemorin JLE (1981) J Chem Soc Perkin Trans 1:1.779–1.781Google Scholar
  2. 2.
    Kedde DL (1947) Pharm Weekbl 82:741Google Scholar
  3. 3.
    Keller CC (1895) Ber Dtsch Pharm Ges 5:275Google Scholar
  4. 3.
    Kiliani H (1899) Arch Pharm 237:446Google Scholar
  5. 4.
    Baljet H (1918) Schweiz Apoth Ztg 56:71,84Google Scholar

AG

  1. 1.
    Aronson JK,Gaham-Smith DG (1976) Br J Clin Pharmacol 3:639–648PubMedGoogle Scholar
  2. 2.
    Larbig D, Haasis R, Kochsiek K (1978) Die Glykosidkonzentration und ihre klinsche Bedeutung: Neue Erkenntnisse für die Digitalistherapie durch radioimmunologische Bestimmung von Lanata-Glykosiden, forum cardiologicum 15:Studienreihe Boehringer-MannheimGoogle Scholar
  3. 3.
    Mooradian AD (1988) Clin Pharmacokinet 15:165–179PubMedGoogle Scholar
  4. 4.
    Ferrer MJ, Conroy RJ, Harvey RM (1960) Circulation 21:372–385PubMedGoogle Scholar
  5. 5.
    Scholz H (1984) J Am Coll Cardiol 4:389–397PubMedGoogle Scholar
  6. 6.
    Buschauer A (1989) Pharm Ztg Wiss 134:3–16Google Scholar
  7. 7.
    Kuemmerle HP (1989) Klinische Pharmakologie, Datenhandbuch für Klinik und Praxis, ecomed-verlagsgesellschaft mbH, Landsberg München ZürichGoogle Scholar
  8. 8.
    Doherty JE, Parkins WH (1962) Am Heart J 63:528–536PubMedGoogle Scholar
  9. 9.
    Kuhlmann I, Rietbrock N, Schnieders B (1979) J Cardiovasc Pharmacol 1:219–234PubMedGoogle Scholar
  10. 10.
    Brurion PF, Morgan LM, Stevenson HM, Fletcher E (1969) Brit Heart J 31:633–640Google Scholar
  11. 11.
    Allonen H, Andersson KE, Gisalo E, Kanto I, Stomblad LG, Wettrell G (1977) Acta Pharmacol Toxicol (Kbh) 41:193–201Google Scholar
  12. 12.
    Peters U, Falk LC, Kaiman SM (1978) Arch Intern Med 138:1.074–1.076Google Scholar
  13. 13.
    Zilly W, Richter E, Rietbrock N (1975) Clin Pharmacol Ther 17:302–309PubMedGoogle Scholar
  14. 14.
    Aronson JK (1978) Brit J Clin Pharmacol 5:55–64Google Scholar
  15. 15.
    Johnston GD (1989) Drugs 37:577–582PubMedGoogle Scholar
  16. 16.
    Steiness E (1978) Clin Pharmacol Ther 23:511–514PubMedGoogle Scholar
  17. 17.
    Leahey EB jr, Reiffei JA, Heissenbuthe RH, Drusin RE, Lovejoy WP, Bigger T jr (1979) Arch Intern Med 139:519–521PubMedGoogle Scholar

  1. 1.
    Sharp ME (1986) Can Soc Forensic Sci J 19:83–101Google Scholar
  2. 1.
    Kopp M, Tchouber B (1952) Bull Soc Chim Fr :84–86Google Scholar

gs

  1. 1.
    Mar 29, S. 531Google Scholar

EH

  1. 1.
    Drew HDK, Hatt HH, J Chem Soc (1937) 16; Haworth RD, Robinson S, J Chem Soc (1948) 777; Ciba DBP 847.748 (1949) Zentralbl. (1953) 53 85, U.S.Pat. 2484 785 (1949) CA (1950) 44:2573iGoogle Scholar

hh

  1. 1.
    Tripod J, Meier R (1954) Arch int Pharmacodyn 99:104–125PubMedGoogle Scholar
  2. 2.
    Bein HJ, Gross F, Tripod J, Meier R (1953) Schweiz Med Wochenschr. 83:336–340PubMedGoogle Scholar
  3. 3.
    Kolloch R (1983) Vasodilatatoren. In: Stumpe KO (Hrsg.) Therapie mit Antihypertensiva, Springer-Verlag, Berlin Heidelberg New York Tokyo, S. 55–105Google Scholar
  4. 4.
    Esselier AF, Luscher W, Morandi L (1053) Schweiz Med Wochenschr 83:28–37Google Scholar
  5. 5.
    Schaub F, Nager F, Schrithin W, Völlm K, Hany A (1964) Schweiz Med Wochenschr 94:769–775PubMedGoogle Scholar
  6. 6.
    Van Zwieten PA (1968) Arzneim Forsch 18:79–84Google Scholar
  7. 7.
    Koch-Weser J (1974) Arch Int Med 133:1.017–1.027Google Scholar
  8. 8.
    Reimann IW, Ratge D, Wisser H, Fröhlich JC (1985) Clin Exp Pharmacol Physiol 12:79–89PubMedGoogle Scholar
  9. 9.
    Gross F (1977) Drugs acting on arteriolar smooth muscle (vasodilator drugs). In. Gross F (Hrsg.) Antihypertensive Agents, Springer-Verlag, Berlin Heidelberg New York, S. 397–476Google Scholar
  10. 10.
    Struyker-Boudier HAJ, Van Essen H, Smits JFM (1983) Eur J Pharmacol 95:151–159PubMedGoogle Scholar
  11. 11.
    Heidland A, Heidbreder E (1985) Therapie des hypertensiven Notfalls und der malignen Hypertonie. In: Ganten D, Ritz E (Hrsg.) Lehrbuch der Hypertonie, Schattauer Verlag, Stuttgart New York, S. 705–725Google Scholar
  12. 12.
    Schroeder T, Sillesen H (1987) Eur J Clin Invest 17(3):214–217PubMedGoogle Scholar
  13. 13.
    Reubi FC (1950) Proc Soc exp Biol (N.Y.) 73:102–103Google Scholar
  14. 14.
    Fries ED (1953) Circulation 8:199–204Google Scholar
  15. 15.
    Heidbreder E, Heidland A (1985) Behandlung der Hypertonie bei chronischer Niereninsuffizienz. In. Ganten D, Ritz E (Hrsg.) Lehrbuch der Hypertonie, Schattauer Verlag, Stuttgart New York, S. 726–742Google Scholar
  16. 16.
    Curtis JR (1979) Drugs 18(5):377–391PubMedGoogle Scholar
  17. 17.
    Shultz PJ, Raij L (1989) Br J Clin Pharmacol 28(2):151S–157SPubMedGoogle Scholar
  18. 18.
    Fachinformation Nepresol/Nepresol forte CIBA Pharma, Feb 1991, Editio Cantor Verlag, AulendorfGoogle Scholar
  19. 19.
    Schneider T, Siegmund W, Zschiesche M, Kallwellis R, Scherber A (1988) Pharmazie 43(1):33–36PubMedGoogle Scholar
  20. 20.
    Palm D, Hellenbrecht D (1987) Pharmakologie des noradrenergen und adrenergen Systems. In: Forth W, Henschler D, Rummel W (Hrsg.) Allgemeine und spezielle Pharmakologie und Toxikologie, BI Wissenschaftsverlag, Mannheim Wien Zürich, S. 124–168Google Scholar
  21. 21.
    Franke G, Pietsch P, Schneider T, Siegmund W, Grabow D, Schutz H (1986) Biol Res Pregnancy Perinatol 7(1)30–33PubMedGoogle Scholar
  22. 22.
    Ashe RG, Moodley J, Richards AM, Philpott RH (1987) S Afr Med J 71(6):354–356PubMedGoogle Scholar
  23. 23.
    Jamieson MJ, Shepherd AMM (1987) Vasodilators: first or second choice therapy? In: Drayer JIM, Lowenthal DT, Weber MA (Hrsg.) Drug Therapy in Hpertension, Marcel Dekker, Inc., New York Basel, S. 163–190Google Scholar
  24. 24.
    Salvadeo A, Villa G, Segagni S, Piazza W, Criscuolo D (1981) Int J Clin Pharmacol Ther Toxicol 19(8):372–376PubMedGoogle Scholar
  25. 25.
    Mauro F (1990) Listing of antihypertensive medications. In: Ganten D, Mulrow PJ (Hrsg.) Handbook of Experimental Pharmacology, Bd. 93, Pharmacology of Antihypertensive Therapeutics, Springer-Verlag, Berlin Heidelberg, S. 861–874Google Scholar
  26. 26.
    Pariente EA, Pessayre D, Bernuau J, Degott C, Benhamou JP (1983) Digestion 27:47–52PubMedGoogle Scholar
  27. 27.
    Baumgartner R, Siegmund W, Frengler JD (1988) Z Klin Med 43(2):87–89Google Scholar

GW

  1. 1.
    Hartke K, Mutschier E (Hrsg.) (1986) Kommentar zum Deutschen Arzneibuch 9.Ausg., Bd. 1 bis 3, Wissenschaftliche Verlagsgesellschaft, StuttgartGoogle Scholar
  2. 2.
    Skita A, Franck HH (1911) Chem Ber 44:2861–2865Google Scholar
  3. 3.
    Budĕšinský, Protiva A (1961) Synthetische Arzneimittel, Akademie Verlag, Berlin, S. 192Google Scholar
  4. 4.
    Stein A (1955) Pharmazie 10:180–186PubMedGoogle Scholar
  5. 5.
    Ehrhart G, Ruschig H (1972) Arzneimittel, 2. Aufl., Verlag Chemie, Weinheim, S. 118Google Scholar
  6. 6.
    Takagi Y, Ueda J (1936) J Pharm Soc Jpn 56:44–56Google Scholar
  7. 7.
    Bobbitt JM, Weiss U, Hanessian DD (1959) J Org Chem 24:1582–1584Google Scholar
  8. 8.
    Okuda S, Yamaguchi S, Kawazoe Y, Tsuda K (1964) Chem Pharm Bull 12:104–112PubMedGoogle Scholar
  9. 9.
    Caroll JI, Moreland ChG, Brine GA, Kepler JA (1976) J Org Chem 41:996–1001Google Scholar

Gb

  1. 1.
    Friebel H, Reichle C, Graevenitz A v (1955) Naunyn-Schmiedeberg’s Arch Exper Path Pharmak 224:384–400Google Scholar
  2. 2.
    Haas, H (1955) Dtsch Apoth Ztg 95:1143–1148; 1171–1175Google Scholar
  3. 3.
    Haas H (1955) Naunyn-Schmiedeberg’s Arch Exper Path Pharmak 225:442–452Google Scholar
  4. 4.
    Seymour RA, Rawlins MD, Rowell FJ (1982) Lancet 1:1425PubMedGoogle Scholar
  5. 5.
    Vaughan DP, Beckett AH (1973) J Pharm Pharmacol 25 (Suppl.):104P–108PPubMedGoogle Scholar
  6. 6.
    Johnson MA, Woodcock AA, Geddes DM (1983) Br Med J 286:675–677Google Scholar
  7. 7.
    Supinski G, Dimarco A, Bark H, Chapman K, Clary S, Altose M (1990) Am Rev Respir Dis 141:1516–1521PubMedGoogle Scholar
  8. 8.
    Rowell FJ, Seymour RA, Rawlins MD (1983) Eur J Clin Pharmacol 25:419–424PubMedGoogle Scholar
  9. 9.
    Marks P, Ashraf H, Root TR (1978) Brit Med J i:1594Google Scholar
  10. 10.
    Kurz H (1989) Antitussiva und Expektoranzien, Wissenschaftliche Verlagsgesellschaft, StuttgartGoogle Scholar

SZ

  1. 1.
    Wieland H, Koralek E (1923) Liebigs Ann Chem 433:267–271Google Scholar

Gb

  1. 1.
    Stein A, (1955) Pharmazie 10:180–186PubMedGoogle Scholar
  2. 2.
    Dibbern HW, Wirlitzki E (1978) UV-und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Editio Cantor, AulendorfGoogle Scholar
  3. 3.
    Crone TA, Purdie N (1981) Anal Chem 53:17–21Google Scholar
  4. 4.
    Okuda S, Yamaguchi S, Kawazoe Y, Tsuda K (1964) Chem Pharm Bull 12:104–112PubMedGoogle Scholar
  5. 5.
    Carroll FI, Moreland ChG, Brine GA, Kepler JA (1976) J Org Chem 41:996–1001PubMedGoogle Scholar
  6. 6.
    Pesez M (1935) J Pharm Chim 21:542–544Google Scholar
  7. 6a.
    Philippi I, Auterhoff H (1976) Dtsch Apoth Ztg 116:206–206Google Scholar
  8. 7.
    Böhme H, Hocke H (1960) Arch Pharm 293:342Google Scholar
  9. 8.
    Sakano I, Kokubo S (1989) Anal Sci 5:623–624Google Scholar
  10. 9.
    Jane I, McKinnon A, Flanagan RJ (1985) J Chromatogr 323:191–225PubMedGoogle Scholar

Gb

  1. 1.
    Goldstein M, Lew JY, Hata F, Liebermann A (1978) Gerontology (Basel) 24(Suppl. l):76–85Google Scholar
  2. 2.
    Markstein R (1983) Eur J Pharmacol 86:145–155Google Scholar
  3. 3.
    Weil C (1989) Hydergin-Pharmakologische und klinische Befunde, Springer-Verlag, Berlin Heidelberg New York, S. 137–147Google Scholar

KC

  1. 1.
    Stoll A, Hoffmann A (1943) Helv Chim Acta 26:2070–2081Google Scholar

SH

  1. 1.
    Markstein R (1983) Eur J Pharmcol 86:145–155Google Scholar
  2. 2.
    Müller-Schweinitzer E (1982) Naunyn-Schmiedebergs Arch Pharmacol 318:225–233PubMedGoogle Scholar
  3. 3.
    Rothlin E (1947) Bull Schweiz Akad Med Wiss 2:246–273Google Scholar
  4. 4.
    Spagnolis A, Tognoni G (1983) Drugs 26:44–69Google Scholar
  5. 5.
    Rachmann A, Kellmann L, Kriegelstein J (1984) J Cerebral Blood Flow Metab 4:610–614Google Scholar
  6. 6.
    Kiechel JR (1979) J Pharmacol (Paris) 10:533–565Google Scholar
  7. 7.
    Mailland F, Poli A, Zottino G (1984) Curr Ther Res 42:857–861Google Scholar

KC

  1. 1.
    Stoll A, Hoffmann A (1943), Helv 26:2070, 2080Google Scholar
  2. 2.
    Sandoz, USP 2507832 (1946)Google Scholar
  3. 3.
    Cousse H et al. (1972), Bull Soc Chim Fr, S.3131Google Scholar
  4. 4.
    Dibbern HW (1984), UV-und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Verlag Editio Cantor, AulendorfGoogle Scholar

SH

  1. 1.
    Stoll A, Hofmann A (1943) Helv Chim Acta 26:2070–2081Google Scholar
  2. 2.
    Yamatodani, Abe (1959) J Agri Chem Soc Japan 33:1036, zit. nach CA (1958) 52:2878Google Scholar

SH

  1. 1.
    Müller-Schweinitzer E, Weidmann H (1978) Basic pharmacological properties. In: Berde B, Schild HO (Hrsg.) Ergot Alkaloids and Realted Compounds, Handb Exp Pharmacol, Bd. 49, Springer-Verlag, Berlin Heidelberg New York, S. 87–232Google Scholar
  2. 2.
    Eckert H, Kiechel JR, Rosenthaler J, Schmidt R, Schreier B (1978) Biopharmaceutical aspects. Analytical methods, pharmacokinetics, metabolism and bioavailability. In: Berde B, Schild HO (Hrsg.) Ergot Alkaloids and Related Compounds, Handb Exp Pharmacol, Bd. 49, Springer-Verlag, Berlin Heidelberg New York, S. 719–803Google Scholar
  3. 3.
    Weil C (1989) Hydergin-Pharmakologische und klinische Befunde, Springer-Verlag, Berlin Heidelberg New York, S. 143–147Google Scholar

KC

  1. 1.
    Stoll A, Hoffmann A (1943), Helv Chim, Acta 26:2070 ff.Google Scholar

HÄ/pb

  1. 1.
    Rall TW (1990) Oxytocin, prostaglandins, ergot alkaloids and other drugs; tocolytic agents. In: Gilman AG, Rall TW, Nies AS, Taylor P (Hrsg.) The pharmacological basis of therapeutics, 8. Aufl., Pergamon Press, New York Oxford Beijing Frankfurt Sao Paulo Sydney Tokyo Toronto, S. 933–953Google Scholar
  2. 2.
    Glusa E, Markwardt F (1984) Pharmacology 29:336–342PubMedGoogle Scholar
  3. 3.
    Müller-Schweinitzer E (1984) Naunyn-Schmiedeberg’s Arch Pharmacol 327:299–303Google Scholar
  4. 4.
    Mellander S, Nordenfelt I (1970) Clin Sci 39:183–201PubMedGoogle Scholar
  5. 5.
    Andersen AR, Tfelt-Hansen P, Lassen NA (1987) Stroke 18:120–123PubMedGoogle Scholar
  6. 6.
    Nordenfelt I, Mellander S (1976) Cardiology 61(Suppl.l):316–321PubMedGoogle Scholar
  7. 7.
    Barthel W, Großmann K (1982) Int J Clin Pharmacol Ther Tox 20:458–464Google Scholar
  8. 8.
    Partsch H (1981) Med Welt 32:1.668–1.671Google Scholar
  9. 9.
    Eichlisberger R, Huber P, Jäger K (1989) Vasa 18:221–226PubMedGoogle Scholar
  10. 10.
    Barthel W (1984) Z Ges Inn Med 39:417–428PubMedGoogle Scholar
  11. 11.
    Müller-Schweinitzer E (1984) Int J Clin Pharmacol Ther Tox 22:677–682Google Scholar
  12. 12.
    Aeilig WH, Nüesch E (1977) Int J Clin Pharmacol Ther Tox 15:106–112Google Scholar
  13. 13.
    Bobik A, Jennings G, Skews H, Esler M, McLean A (1981) Clin Pharmacol Ther 30:673–679PubMedGoogle Scholar
  14. 14.
    Schran HF, Tse FLS (1985) Int J Clin Pharmacol Ther Tox 23:1–4Google Scholar
  15. 15.
    Little PJ, Jennings GL, Skews H, Bobik A (1982) Br J Clin Pharmacol 13:785–790PubMedGoogle Scholar
  16. 16.
    Olver IN, Jennings GL, Bobik A, Esler M (1980) Br Med J 2:275–276Google Scholar
  17. 17.
    Wyss PA, Rosenthaler J, Nüesch E, Aellig WH (1991) Eur J Clin Pharmacol 41:597–602PubMedGoogle Scholar
  18. 18.
    Hilke H, Kanto J, Kleimola T, Mäntylä R (1978) Int J Clin Pharmacol Ther Tox 16:277–278Google Scholar
  19. 19.
    Kanto J, Allonen H, Koski K, Koulu M, Lammintausta R, Mäntylä R, Kleimola T, Siirtola T (1981) Int J Clin Pharmacol Ther Tox 19:127–130Google Scholar
  20. 20.
    Hilke H, Kanto J, Mäntylä R, Kleimola T, Syvälahti E (1978) Acta Anaesthesiol Scand 22:215–220PubMedGoogle Scholar
  21. 21.
    Aellig WH (1984) Eur J Clin Pharmacol 26:239–242PubMedGoogle Scholar
  22. 22.
    Jennings G, Esler M, Holmes R (1979) Br Med J 2:307–308PubMedGoogle Scholar
  23. 23.
    de Marées H, Welzel D, de Marées A, Klotz U, Tiedjen KU, Knaup G (1986) Eur J Clin Pharmacol 30:685–689PubMedGoogle Scholar
  24. 24.
    Müller-Schweinitzer E (1984) Eur J Clin Pharmacol 26:699–705PubMedGoogle Scholar
  25. 25.
    Labayle D, Chalas J, Lavène D, Humbert M, Azria M, Lindenbaum A, Chaput JC (1982) Gastroenterol Clin Biol 6:129–134PubMedGoogle Scholar
  26. 26.
    Dumont M, De Couët G, Le Bigot JF, Erlinger S (1985) J Pharmacol Exp Ther 234:239–243PubMedGoogle Scholar
  27. 27.
    Heuser B, Middendorf E (1985) Fortschr Med 103:966–970PubMedGoogle Scholar
  28. 28.
    Wörz R (1986) Fortschr Med 104:838–842PubMedGoogle Scholar
  29. 29.
    Thulesius O, Berlin E (1986) Int J Clin Pharmacol Ther Tox 24:465–467Google Scholar
  30. 30.
    Goeschen K, Jäger A, Saling E (1984) Geburtshilfe Frauenheilkde 44:351–355Google Scholar
  31. 31.
    Comerota AJ, White JV (1986) Chest 89(Suppl.):389S–395SPubMedGoogle Scholar
  32. 32.
    Kakkar VV, Stamatakis JD, Bentley PG, Lawrence D, de Haas HA, Ward VP (1979) JAMA 241:39–41PubMedGoogle Scholar
  33. 33.
    Gent M, Roberts RS (1986) Chest 89(Suppl.):396S–400SPubMedGoogle Scholar
  34. 34.
    Wolf H, Welzel D, Kaiser H, Majer M, Schäfer D, Husfeldt KJ, Voigt J, Sunder-Plassmann L (1988) Arzneim Forsch 38:1.516–1.519Google Scholar
  35. 35.
    Emory CE, Cuddy PG (1987) Drug Intell Clin Pharm 21:427–431PubMedGoogle Scholar
  36. 36.
    Barthel W, Glusa E, Koth W (1987) Int J Clin Pharmacol Ther Tox 25:63–69Google Scholar

GE/BW

  1. 1.
    Dibbern H W (1978), UV-und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Editio Cantor, AulendorfGoogle Scholar
  2. 2.
    Ergebnisse der Firma Boehringer IngelheimGoogle Scholar

HÄ/pb

  1. 1.
    Mitteilung der Firma Boehringer IngelheimGoogle Scholar

HÄ/pb

  1. 1.
    v. Békésy N (1940) Biochem Zschr 303,368Google Scholar

SH

  1. 1.
    Flückinger E, Balthasar HU (1967) Arzneim Forsch 17:6–9Google Scholar
  2. 2.
    Aeilig WH, Berde B (1969) Br J Pharmacol 36:561–570Google Scholar
  3. 3.
    Berde B, Stürmer E (1978) Introduction to the pharmacology of ergot alkaloids and related compounds as a basis of their therapeutic application. In: Berde B, Schild HO (Hrsg.) Handbook of Experimental Pharmacology, Springer-Verlag, Berlin Heidelberg New York, S. 1–28Google Scholar
  4. 4.
    Rothlin E (1947) Bull Schweiz Akad Med Wiss 2:249–273PubMedGoogle Scholar
  5. 5.
    Rothlin E, Brügger J (1945) Helv Physiol Pharmacol Acta 3:C43–C44Google Scholar
  6. 6.
    Fregman BG, Gläser AH (1964) J Pharm Pharmacol 16:744–750Google Scholar
  7. 7.
    Pacha W, Salzmann R (1970) Br J Pharmacol 38:439P–440PPubMedGoogle Scholar
  8. 8.
    Rothlin E, Cerletti A (1949) Verh Dt Ges Kreislauf-Forsch 15:158–185Google Scholar
  9. 9.
    Whitney B (1965) J Pharm Pharmacol 17:465–473PubMedGoogle Scholar
  10. 10.
    Cripps H, Dearnaley DP (1972) J Physiol (London) 227:647–664Google Scholar
  11. 11.
    Gillespie JS, Kirkepar SM (1965) J Physiol (Lond) 176: 205–227Google Scholar
  12. 12.
    Wennmalm A (1971) Acta Physiol Scand 82:532–538PubMedGoogle Scholar
  13. 13.
    Clark BJ, Bucher T, Weite R (1984) Kardiovaskuläre Wirkungen von Co-Dergocrin. In: Bergener M, Grobecker H (Hrsg.) Hypertonie im Alter: Normvariante oder Krankheit? F.K. Schattauer Verlag, Stuttgart New York, S. 155–165Google Scholar
  14. 14.
    Mchedlishvili GI, Ormotsadze LG (1974) Pat Fiziol éksp Ther 5:79–81Google Scholar
  15. 15.
    Karlsberg P, Elliott HW, Adams JE (1963) Neurology (Minneap) 13:772–778Google Scholar
  16. 16.
    Gaddum JH;, Paasonen MK (1955) Br J Pharmacol 10:474–483Google Scholar
  17. 17.
    Duret RL (1951) Acta Clin Belg 6:85–106PubMedGoogle Scholar
  18. 18.
    Marques MG, Rato JA (1954) Cardiologica (Basel) 24:196–206Google Scholar
  19. 19.
    Clark BJ, Chu DH, Aellig WH (1978) Actions on the heart and circulation. In: Berde B, Schild HO (Hrsg.) Ergot Alkaloids and related Compounds, Handb Exp Pharmacol, Bd. 49, Springer-Verlag, Berlin Heidelberg New York, S. 321–420Google Scholar
  20. 20.
    Müller-Schweinitzer E (1982) Naunyn-Schmiedebergs Arch Pharmacol 318:225–233Google Scholar
  21. 21.
    Memo M, Saghedu G, Cappuba MO, Spano PF (1985) Life Sci 36:1.515–1.522Google Scholar
  22. 22.
    Georges D, Lallemand A, Coustenoble J, Loria J (1977) Thérapie 32:173–180PubMedGoogle Scholar
  23. 23.
    Siegl H (1985) J Pharmacol (Paris) 16(Suppl.III):129–144 (Engl ed 113–127)Google Scholar
  24. 24.
    Jubert-Gruart J, Suner F, Gairin J, Fabrega MT, Oiler M (1975) VIIº Symposium Internacional “Insuficienca Circulatoria Cerebral”, Sandoz S.A.E., Barcelona, S. 83–108Google Scholar
  25. 25.
    Markstein R, Wagner H (1975) FEBS Letters 55:255–257Google Scholar
  26. 26.
    Iwangoff P, Enz A, Chappuis A (1975) Int Res Commun System Med Sci 3:403Google Scholar
  27. 27.
    Depoorter H, Loew DM, Vigouret JM (1975) Triangle 14:73–79Google Scholar
  28. 28.
    Loew DM, Depoortere H, Bürki HR (1976) Arzneim Forsch 26:1.080–1.083Google Scholar
  29. 29.
    Loew DM, Vigouret JM, Jaton AL (1976) Postgrad Med J 52(Suppl.I):40–46PubMedGoogle Scholar
  30. 30.
    Wang SC, Glaviano VV (1954) J Pharmacol Exp Ther 111:329–334PubMedGoogle Scholar
  31. 31.
    Loew DM, Vigouret JM, Jaton AL (1979) Topics Gerontol 15:85–103Google Scholar
  32. 32.
    Cerletti A, Emmenegger H, Enz A, Iwangoff P, MeierRuge W, Musil J (1973) Effects of ergot DH-alkaloids on the metabolism and function of the brain. An approach based on studies with DH-ergonine. In: Genazzani E, Herken H (Hrsg.) Central Nervous System-Studies on Metabolic Regulation and Function, Springer-Verlag, Berlin Heidelberg New York, S.201–212Google Scholar
  33. 33.
    Roubicek J, Geiger CH, Abt K (1972) J Am Geriatr Soc 20:222–229PubMedGoogle Scholar
  34. 34.
    Meier-Ruge W, Enz A, Gygax P, Hunziker O, Iwangoff P, Reichelmeier K (1975) Experimantal pathology in basic research of the ageing brain. In: Gershon S, Raskin A (Hrsg.) Genesis and Treatment of Physiologic Disorders in the Elderly, Raven Press, New York, S. 55–126Google Scholar
  35. 35.
    Emmenegger H, Meier-Ruge W (1968) Pharmacology (Basel) 1:65–78Google Scholar
  36. 36.
    Van den Driessche J, Allain H, Bentué-Ferrer D, Feuillu A, Pape D, Milon D, Reymann JM, Sublet Y (1985) J Pharmacol (Paris) 16(Suppl. III):99–113 (Engl ed 85–99Google Scholar
  37. 37.
    Weil C (1989) Hydergin-Pharmakologische und klinische Befunde, Springer-Verlag, Berlin Heidelberg New York London Paris Tokyo, S. 137–147Google Scholar
  38. 38.
    Zoglio MA, Maulding HV (1970) J Pharm Sci 59:215–218PubMedGoogle Scholar
  39. 39.
    Meier-Ruge W, Schieweck C, Iwangoff P (1973) Int Res Comm Service Med Sci 7–10–3Google Scholar
  40. 40.
    Rothlin E (1947) Schweiz Med Wochenschr 77:1.161–1.163Google Scholar
  41. 41.
    Luntschli HJ, Goetz RH(1948) Am Heart J 35:873–894Google Scholar
  42. 42.
    Loew DM, Weil C (1982) Gerontology 18:54–74Google Scholar
  43. 43.
    Venn RD (1978) Clinical pharmacology of ergot alkaloids in senile cerebral insufficiency. In: Berde B, Schild HO (Hrsg.) Handbook of Experimental Pharmacology, Bd.49, Springer-Verlag, Berlin Heidelberg New York, S. 533–566Google Scholar
  44. 44.
    Oswald WD, Lang E (1980) Muench Med Wochenschr 122:59–62Google Scholar
  45. 45.
    Fanchamps A (1983) Controlled studies with dihydroergotoxin in senile cerebral insufficiency. In: Agnoli A, Crepaldi C, Spano PF, Trabucchi M (Hrsg.) Aging Brain and Ergot Alkaloids, Aging, Bd.23, Raven Press, New York, S. 311–322Google Scholar
  46. 46.
    Hamot HB, Patin JR, Singer JM (1984) Psychopharmacol Bull 20:142–150PubMedGoogle Scholar
  47. 47.
    Biel LM, Seus R, Struppler A (1976) Med Klin 71:2.177–2.184Google Scholar
  48. 48.
    Manolidis L, Themelis C, Tsiptsios I, Tsaligolpoulos M (1982) Galenos 24:1.095–1.108Google Scholar
  49. 49.
    Arranz Munecas T, Ganoza Garcia C, Forcadell Puyo F(1979) Inform Psychat 77:250–258Google Scholar
  50. 50.
    Hajioff J, Wallace MG (1982) Br J Clin Pract (Suppl.16):43–46Google Scholar
  51. 51.
    Gouret C, Raynaud GJ (1976) J Pharmacol (Paris) 7:161–175Google Scholar
  52. 52.
    Kappert A (1949) Helv Med Acta Ser A 16(Suppl.22):66–67Google Scholar
  53. 53.
    Von Storch TJC (1938) J Am Med Ass 111:293–300Google Scholar

KC

  1. 1.
    Peck RL, Hoffhine CE, Folkers K (1946) J Am Chem Soc 68:1390PubMedGoogle Scholar
  2. 2.
    Bartz QR, Controulis J, Crooks HM, Rebstock MC (1946) J Am Chem Soc 68:2163PubMedGoogle Scholar
  3. 3.
    Fried J, Wintersteiner O (1947) J Am Chem Soc 69:79PubMedGoogle Scholar
  4. 4.
    Ikeda H (1956) Proc Jap Acad 32, 48 und 53, zit. nach CA (1956) 50:13765Google Scholar
  5. 5.
    Moffat AC (Hrsg.) Clarkes Isolation and Identification of Drugs (1986) The Pharmaceutical Press, LondonGoogle Scholar
  6. 6.
    Bock K, Pedersen C, Heding H (1974) J Antibiot 27: 139–140PubMedGoogle Scholar

GU

  1. 1.
    Mar 29, S.216Google Scholar

vB

  1. 1.
    Ikeda H (1956) Proc Jap Acad 31, 48 und 53, zit. nach (1956) CA 50:13765Google Scholar
  2. 2.
    Moffat AC (Hrsgb.) Clarkes Isolation and Identification of Drugs (1986) The Pharmaceutical Press, LondonGoogle Scholar
  3. 3.
    Bock K, Pedersen C, Heding H (1974) J Antibiotics 27:139–140Google Scholar
  4. 4.
    Bartz QR, Controulis J, Crooks HM, Rebstock MC (1946) J Am Chem Soc 68:2163PubMedGoogle Scholar

GU

  1. 1.
    Brockhaus ABC Chemie, Bd.2 (1971) VEB F.A. Brockhaus Verlag, LeipzigGoogle Scholar
  2. 2.
    Westerhof P, Buisman JAK (1956) Recueil Trav. Pays-Bas 15:453Google Scholar
  3. 3.
    Mills III T, Roberson JC (1987) Instrumental data for drug analysis, 2. Aufl., Vol 1, Elsevier, New York, Amsterdam, LondonGoogle Scholar
  4. 4.
    Berman E, Luz Z, Mazur Y, Sheves M (1977) J Org Chem 42:3325PubMedGoogle Scholar

WO

  1. 1.
    Suda T, Hallick RB, DeLuca HF, Schnoes HK (1970) Biochemistry 9:1.651–1.657Google Scholar
  2. 2.
    Hallick RB, DeLuca HF (1972) J Biol Chem 247:91–97PubMedGoogle Scholar
  3. 3.
    Bosch R, Thijssen JHH, Duursma SA (1987) J Steroid Biochem 27:829–836PubMedGoogle Scholar
  4. 4.
    Pierides AM (1981) Drugs 21:241–256PubMedGoogle Scholar
  5. 5.
    Harrison HE, Lifshitz F, Blizzard RM (1967) N Engl J Med 276:894–900PubMedGoogle Scholar
  6. 6.
    Taylor A, Bikle DD, Norman ME (1988) J Clin Endocrinol Metab 67:198–202PubMedGoogle Scholar

bm

  1. 1.
    Roth HJ (1959) Arch Pharm 292:234–238Google Scholar
  2. 2.
    Jeske J, Jakimowska K, Kakolewski J, Stochla K, Trawkowski J (1961) Acta Polon Pharm 18:335Google Scholar
  3. 3.
    Patent Pol 59,071 (Cl.C07d),15 Mar 1970, Appl. 02 May 1967, zit. nach CA 73:45544dGoogle Scholar
  4. 4.
    Farbenfabriken Bayer & Co Elberfeld (1905–1907) Friedländer 8:1136–1137Google Scholar
  5. 5.
    Ott R (1958) Sci Pharm 26:217–224Google Scholar
  6. 6.
    Stuchlik M, Csiba J, Krasnec L (1967) Cesk Farm 16(4):187–189, zit. nach CA 67:67530zPubMedGoogle Scholar
  7. 7.
    Stuchlik M, Csiba J, Krasnec L (1969) Cesk Farm 18(2):91–92, zit. nach CA 71:24754rPubMedGoogle Scholar
  8. 8.
    Schunack W, Mutschier E, Rochelmeyer H (1965) Dtsch Apoth Ztg 44:1551–1552Google Scholar
  9. 9.
    Raber H (1964) Sci Pharm 32(2):122–127Google Scholar
  10. 10.
    Raber H (1967) Sci Pharm 35:220–224Google Scholar

LD

  1. 1.
    Mar 29, S. 1526Google Scholar

EH

  1. 1.
    Mar 29, S.662Google Scholar

vB

  1. 1.
    Mar 29, S.685Google Scholar

vB

  1. 1.
    Buczkowski Z, Gryff-Keller A, Zajaczkowska E (1972) Rocz Chem 46:1047–1057Google Scholar
  2. 2.
    Salman S, Bayradkar N (1983) Eczacilik Bul 25:30–33Google Scholar
  3. 3.
    Hartvig P, Handl W (1975) Acta Pharm Suecica 12:349–360Google Scholar
  4. 4.
    Vessmann J, Hartvig P, Strömberg S (1970) Acta Pharm Suecica 7:373–388Google Scholar
  5. 5.
    Hartvig P, Sundin H, Vessmann J (1972) Acta Pharm Suecica 9:269–282Google Scholar

gs

  1. 1.
    Buczkowski Z, Gryff-Keller A, Zajaczkowska E (1972) Rocz Chem 46:1047–1057Google Scholar
  2. 2.
    Egli RA, Tanner S (1979) Fresenius Z Anal Chem 295:398–401Google Scholar

gs

  1. 1.
    Patent Toyo Rayon Co. Fr. 1, 542, 199, v. 11.10. 1968, zit. nach CA (1969) 71:80.716sGoogle Scholar
  2. 2.
    Patent S.Wakamatsu, S.Hosaka Japan 6908, 207 v. 17.4. 1969, zit. nach CA (1969) 71:90.852xGoogle Scholar
  3. 3.
    Patent K.Maruyama, T.Kominami, T.Watanabe Japan v. 7.2. 1970, zit. nach CA (1970) 73:3.479fGoogle Scholar
  4. 4.
    Eryshev BY (1978) Zh. Khim. 1973, zit. nach CA (1979) 90:103.350bGoogle Scholar

NP

  1. 1.
    Husain S, Pratop G, Rao NR (1989) J. Chromatogr 475: 426–31, zit. nach CA (1990) 112:90.948yGoogle Scholar

NP

  1. 1.
    Sittig M (1988) Pharmaceutical Manufacturing Encyclopedia, 2. Aufl., Noyes Publications, Park Ridge, New Jersey USA, S. 494Google Scholar
  2. 2.
    EGIS Gyogyszergyar (1990) Jap Kokai Tokkyo Koho JP 02,221,266,zit. nach CA (1991) 114:81.898wGoogle Scholar
  3. 3.
    EGIS Gyogyszergyar (1990) Jap Kokai Tokkyo Koho JP 02,221,265, zit. nach CA (1991) 114:81.899xGoogle Scholar
  4. 4.
    Amos K, Auterhoff H (1979) Dtsch Apoth Ztg 119:1440Google Scholar

RE

  1. 1.
    Fogari R (1980) G Ital Cardiol 10:1.675–1.678Google Scholar
  2. 2.
    Taddei L, L’Abbate A (1985) Pharmacology 31:82–87PubMedGoogle Scholar
  3. 3.
    Cargini A, Condorelli E, Ceconi C, Curello S, Albertini A, Ferrari R (1987) Pharmacol Res Commun 19:341–357Google Scholar
  4. 4.
    Gupta JB, Seth SD, Singh U, Vyas DS (1989) Int Cardiol 23:165–171Google Scholar
  5. 5.
    Okluma M, Kanji K, Ushikubi F, Ishibashi T, Uchino H (1989) Arzneim Forsch 39:898–950Google Scholar
  6. 6.
    Nakagawa Y, Gudenzi M, Mustafa SJ (1986) Eur J Pharmacol 122:51–58PubMedGoogle Scholar
  7. 7.
    Nakagawa Y, Gudenza M ,Mustafa SJ (1986) Pharmacology 33:148–156PubMedGoogle Scholar
  8. 8.
    Tonini M, Perucca E, Manzo L, Marcoli M, D’ Angelo L, Saltarelli P, Onori L (1983) J Pharm Pharmacol 35:434–439PubMedGoogle Scholar
  9. 9.
    Yamauchi Y, Ikuta J, Shimizu S, Nakamura M (1990) Nippon Yakurigaku Zasshi 95:239–246PubMedGoogle Scholar
  10. 10.
    Poggesi L, Masotti G, Serneri GG, Carnovali M (1988) J Clin Pharmacol 28:43–47PubMedGoogle Scholar
  11. 11.
    Ibba GV, Terrosu P, Franceschino V, Contini GM (1986) Int J Cardiol 11:337–347PubMedGoogle Scholar
  12. 12.
    Saito D, Kusachi S, Magashima H, Haraoka S (1982) Arzneim Forsch 32:1.029–1.032Google Scholar
  13. 13.
    Kokayashi A, Ogawa K, Yamazaki N (1980) Jpn Heart J 21:85–94Google Scholar
  14. 14.
    Sambhi MP, Kannan R, Thananopavarn C, Ookhtens M, Gudenzi M (1989) J Pharm Sci 78:281–284PubMedGoogle Scholar

  1. 1.
    Sittig M (1988) Pharmaceutical Manufacturing Encyclopedia 2. Aufl., Noyes Publications, Park Ridge, New Jersey USA, S. 494Google Scholar
  2. 2.
    EGIS Gyogyszergyar (1990) Jpn Kokai Tokkyo Koho JP 02,221,266, zit. nach CA (1991) 114:81898wGoogle Scholar
  3. 3.
    EGIS Gyogyszergyar (1990) Jpn Kokai Tokkyo Koho JP 02, 221, 265, zit. nach CA (1991) 114:81899xGoogle Scholar
  4. 4.
    Amos K, Auterhoff H (1979) Dtsch Apoth Ztg 119: 1440Google Scholar
  5. 5.
    Dibbern HW (1978) UV-und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Editio Cantor Aulendorf; Spektr.-Nr. 1.419Google Scholar
  6. 6.
    Schriewer H, Rauen HM (1972) Arzneim Forsch 22:1455Google Scholar
  7. 7.
    Mannhold R, Rodenkirchen R, Bayer R, Haas W (1984) Arzneim Forsch 34:407Google Scholar
  8. 8.
    Daldrup T, Susanto F, Michalke P (1981) Fresenius’ Z Anal Chem 308:413Google Scholar
  9. 9.
    Sadana GS, Kunhipurayil PS, Sane RT (1986) Indian Drugs 23:427, zit. nach CA (1986) 105:12243fGoogle Scholar

sb

  1. 1.
    Webster LT (1985) Drugs used in the chemotherapy of protozoal infections, amebiasis, giardiasis, and trichomomiasis. In: Goodman and Gillman’s the pharmacological basis of therapeutics, 7. Aufl., McMillan Publ, New York, S. 1.050–1.051Google Scholar
  2. 2.
    Woodruff AW, Bell S (1960) Trans R Soc Trop Med Hyg 54:389–395PubMedGoogle Scholar
  3. 3.
    Khalil, HM, Fawzy AFA, Sarwat MA (1987) J Egypt Soc Parasitol 17:417–425PubMedGoogle Scholar
  4. 4.
    Nigam P, Dubey AL, Jain AK, Bajpeyi HS, Kala RP, Goyal BM (1978) Clinician 42:309–316Google Scholar
  5. 5.
    Shaldon S (1960) Trans R Soc Trop Med Hyg 54:469–470PubMedGoogle Scholar
  6. 6.
    Marsden PD (1960) Trans R Soc Trop Med Hyg 54:396–399PubMedGoogle Scholar
  7. 7.
    Ata AH, El-Haieg HO, Aboul Magd LA, Mansour AH (1984) J Egypt Soc Parasitol 14:213–218PubMedGoogle Scholar
  8. 8.
    Pehrson P, Bengston E (1983) Trans R Soc Trop Med Hyg 77:845–846PubMedGoogle Scholar
  9. 9.
    Pain AK, McKendrick GW (1979) J Infection 1:87–89Google Scholar
  10. 10.
    Salaki JS, Shirey JL, Strickland GT (1979) Am J Trop Med Hyg 28:190–193PubMedGoogle Scholar
  11. 11.
    Mason PR, Patterson BA (1987) Am J Trop Med Hyg 37:277–282PubMedGoogle Scholar
  12. 12.
    Viens P, Beal CC, Doucet J, Pichard JJ, Leonarth T, Musto K, N’Diri AG, Pothier MA (1972) Mèdecine d’Afrique Noire 19:541–547Google Scholar
  13. 13.
    Agrawal A, Pandey VC, Sagar P (1989) Zbl Bakt 271:244–248Google Scholar
  14. 14.
    Ey IL (1977) Ethiopian Medical J 15:101–105Google Scholar
  15. 15.
    Foll CV (1957) J Trop Med Hyg 60:216–217PubMedGoogle Scholar

HA

  1. 1.
    Dibbern HW (1978) UV-und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Verlag Editio Cantor, AulendorfGoogle Scholar

SH

  1. 1.
    Chaffman M, Brogden RN (1985) Drugs 29:387–454PubMedGoogle Scholar
  2. 2.
    Buckley MMT, Grant SM, Goa KL, McTavish D, Sorkin EM (1990) Drugs 39:757–806PubMedGoogle Scholar
  3. 3.
    Fleckenstein A (1983) Calcium antagonism in heart and smooth muscle, John Wiley & Sons, Inc. New YorkGoogle Scholar
  4. 4.
    Nayler W (1990) Calcium-Antagonisten, Springer-Verlag, Berlin Heidelberg New YorkGoogle Scholar
  5. 5.
    Kazda S, Knorr A (1990) Calcium antagonists. In: Ganten D, Mulrow PJ (Hrsg.) Handbook of Experimental Pharmacology, Bd.93, Pharmacology of Antihypertenive Therapeutics, Springer-Verlag, Berlin Heidelberg New York, S. 301–375Google Scholar
  6. 6.
    Hermann P, Morselli PL (1985) Acta Pharmacol Toxicol 57(Suppl.II):12–20Google Scholar
  7. 7.
    Smith MS, Verghese CP, Shand DG, Pritchett ELC (1983) Am J Cardiol 51:1.369–1.374Google Scholar
  8. 8.
    Kölle EV, Ochs HR, Vollmer KO (1983) Arzneim Forsch 33:972–977Google Scholar
  9. 9.
    Morselli PL, Rovei V, Mitchard M, Durand A, Gomeni R, Larribaud J (1979) Pharmacokinetics and metabo lism of diltiazem in man (observation on healthy volunteers and angina pectoris patients). In: Bing RJ (Hrsg.) New drug therapy with a calcium antagonist; Diltiazem Hakone Symposium 78, Excerpta Medica, Amsterdam-Princeton, S.152–167